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Preventing Vascular Injuries in Revision
Total Hip Replacement
James P. Waddell, MD, FRCSC
Surgeon-in-chief. St. Michael's Hospital, Toronto, Ont. Member, Editorial Board, the Canadian

Journal of Surgery

he association of vascular com
plications with total hip arthro
plasty is well known to most ortho
pedic surgeons. Acute vascular in
jury at the time of primary hip
surgery is rare, but inadvertent in
jury to the major vessels of the
pelvis and proximal femur may
occur as a consequence of perfora
tion of the acetabulum or proximal
femur during the standard bone
preparation necessary to ensure an
adequate fit for the prosthetic com
ponents. The possibility of injury is
greatly increased by the use of
power reaming equipment.
The most serious vascular prob
lems associated with total hip ar
throplasty relate to deep vein
thrombosis and subsequent pulmo
nary embolism. The debate over the
efficacy and safety of routine pro
phylaxis for deep vein thrombosis
after total hip arthroplasty contin
ues, and there is uncertainty as to
the most effective and safest antico
agulant for these patients.

T

A third subgroup of patients at
risk for vascular injury during or
after total hip arthroplasty has been
identified by Al-Salman and associ
ates on pages 261 to 264 of this
issue. Patients who undergo revi
sion total hip replacement may ex
perience unexpected vascular com
plications secondary to the gradual
erosion of their iliac vessels by
migrating acetabular components.
The authors identify a number of
warning signs in patients that will
alert the orthopedic surgeon to the
possibility of this rare complication:
a tender pelvic mass, a pelvic bruit
or unusual pelvic pain. The impor
tant preoperative radiographic find
ing is medial protrusion of the
acetabular component. Computed
tomography in patients in whom
radiopaque bone cement was not
used initially permits visualization
of radiolucent methylmethacrylate
in the pelvis.
In patients with these physical
and radiographic features, special

studies such as angiography were
100% accurate in demonstrating
iliac-vessel compression by the mi
grated total hip prosthesis.
The patients reported by Al-Sal
man and associates represent less
than 2% of patients presenting to
their institution with failed total hip
arthroplasty requiring revision.
However, they are an important
subset because of the possible grave
consequences of attempts to remove
the migrated acetabular component
by a lateral approach without prior
or simultaneous exposure and re
pair of the eroded iliac vessel.
Patients with failed total hip ar
throplasty, with or without pelvic
symptoms, should be evaluated
carefully for the possibility that the
migrated total hip component might
be responsible for significant intrapelvic complications. Patients
with the symptoms identified specif
ically by Al-Salman and associates
should be investigated for iliac-ves
sel compression or erosion.*

CJS, VOL. 35. N O . 3, J U N E 1992

223

QUILL ON SCALPEL

Ultrasonography — Whose Turf?
N. Schmidt, MD, MSc, FRCSC
Member, Editorial Board, Canadian Journal of Surgery. Clinical professor and director o f
continuing medical education, Department o f Surgery. University o f British Columbia,
Vancouver, BC

ltrasonography (US) was rele
gated to the basement in our
hospital in 1976 when the head of
the radiology department decided
that fluoroscopy was a more impor
tant modality. US held little interest
at that time. Slowly, though, it
became obvious that this non-x-ray
modality had something to offer: no
radiation and deep visceral penetra
tion to reveal outlines of solid and
cystic structures but high operator
dependence, and unfortunately to
the nonradiologist the images were
undecipherable and a waste of time.
But what changes have occurred
in the past 15 years — advanced
technology, real-time scanning,
Doppler sonography and computerenhanced imaging. For example, US
has replaced conventional radiogra
phy in many areas, including the
detection of calculi, deep abscesses
and fluid collections, and has
opened up the invasive aspects of
radiology to guided biopsy and cannulation of ducts, passages and
spaces. It has permitted evaluation
of hidden anatomical structures and
the delineation of developmental
stages and abnormalities in preg
nancy.
As a recent guest of the Alberta
Radiological Association’s Society
for Ultrasonography I was spell
bound to observe the guest speaker
demonstrate and describe in lucid
detail the entire spectrum of intra
uterine fetal abnormalities, diseases
of the pancreas and vascular abnor
malities of the portal venous sys

U
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tem. The images were clear, readily
discernible and most informative.
Among these and other advances
in US lie the advantages of intraop
erative US to the general surgeon.
In an article in the April issue (Can
J Surg 1992; 35: 151-153) Hanna
and colleagues presented a prelimi
nary report of their experience with
the intraoperative use of US in 29
cases — 28 for liver procedures and
1 for the evaluation of a splenic
cyst. The article reported the expe
rience of several authors espousing
the use of intraoperative US for
decision making in liver surgery. In
25% of the cases, intraoperative US
provided information that caused a
change in surgical decision making.
In 86% of these cases the informa
tion obtained spared the patient of
risk and unnecessary liver surgery.
There is no argument. Modern
surgery of the liver and pancreas
requires the intraoperative use of
US for more accurate staging and
delineation of the surgical problem.
Be it surgery for a malignant hepat
ic tumour or for complicated func
tional pancreatic tumours, one can
be quite adamant that surgery of
the liver and pancreas should not be
performed without the intraopera
tive guidance of US. In regard to
the liver the sensitivity in detecting
additional malignant lesions that
are grossly undetectable may be as
high as 93%d It would be extremely
poor management to proceed with
liver resection for secondary malig
nant disease without knowing

whether hidden secondary malig
nant lesions were present in other
liver segments. In the pancreas a
corollary exists by which the sur
geon, when exploring for functional
tumours, needs to know the loca
tion of a small tumour and whether
multiple functional tumours exist.
The critical point here is the
availability of US. Portable, highresolution US equipment is not
widely available in the average com
munity hospital and is not even
available in the operating rooms of
many of our tertiary and teaching
hospitals. Certainly dedicated equip
ment for US in the operating room
of most hospitals is a luxury few
can afford. Who should use the
equipment and interpret the images
is also questionable. Interpretation
of the findings of US requires train
ing, experience and frequent use of
the technique to be reliable. Few
surgeons have received training in
the use and interpretation of US,
and even though the risk in per
forming US is low, lack of experi
ence in interpretation could add to
the surgical hazard.
It has been argued, even in the
literature, that US should be avail
able as an office diagnostic tool to
primary physicians and specialists
of all types to enhance their clinical
evaluations. Lumps could be detect
ed and aspirated more easily; US
could aid in the detection of gall
bladder stones; obstetrical US
would be immediately available in
the physician’s office; heart lesions

ULTRASONOGRAPHY

could be visualized; abdominal
problems such as ascites, masses,
metastases and even trauma could
be evaluated rapidly. I don’t agree
that US in the hands of the general
physician would be especially valu
able. Inadequate and inaccurate in
formation could be detrimental. The
cost of the equipment and of inter
pretation would become an issue.
Even though one could become
expert at interpreting a particular
anatomical area, it is unlikely that
the widespread availability and use
of US would enhance general pa
tient care. Similarly, the lack of
general availability would not likely
diminish the quality of care.
On the other hand, if US is not

available should certain procedures
and treatments be limited or re
stricted? Highly complex and risky
procedures such as liver resection,
pancreatic surgery or endocrine
procedures should be done only at
institutions where skilled perfor
mance of US and expert interpreta
tion of the findings are available.
Who should control this diagnos
tic modality? This is really not a
debate since radiologists are clearly
trained in imaging and diagnosis
and will be the most frequent users
of the facilities. This is not to say,
however, that anyone who uses a
certain test or diagnostic tool fre
quently cannot become skilled in its
use and interpretation. Any surgeon

who is involved frequently in sur
gery in which intraoperative US is
beneficial should seek additional
training. Such surgeons should
make every effort to obtain the
equipment for the operating room
and be prepared to participate fully
in its use and interpretation of the
findings along with their radiology
colleagues.
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THE HISTORY OF ENDOCRINE
SURGERY. Richard B. Welbourn. 409
pp. Praeger, New York. 1990. $75.
(US). ISBN 0-275-92586-2
This is an important historical review
for general surgeons and students of
endocrinology. Its significance is em
phasized by the quote of Theodore
Billroth in the preface: “Only the man
who is familiar with the art and science
of the past is competent to aid in its
progress in the future.”
The book begins with a short over
view of the evolution of endocrine sur
gery from its origin to 1980, emphasiz
ing three major phases. Phase one was
the surgical revolution in the second
half of the 19th century when excision
of individual endocrine glands began as
a result of general anesthesia, antisepsis
and effective hemostasis. The second
phase was the emergence of endocrinol
ogy as a science in the early 1900s. The
ductless glands were found to produce
physiologically active products whose
absence caused disease and whose re
placement brought relief. The discovery
of cortisone initiated the third phase, in
which surgeons began to look at endo

crine surgery as a whole, a view pro
mulgated by Oliver Cope of Boston who
is regarded as the founder of modern
endocrine surgery.
Welbourn traces the surgical history
of the individual endocrine glands. He
begins with the thyroid gland, which
was first described as “glandulae thyroidoeis” in 1656 by Thomas Wharton of
London. Thyroid function was deter
mined from observation of the effects of
total thyroidectomy. Theodore Kocher
described the clinical entity of hypothy
roidism and termed it “cachexia strumipriva.” Thyroxin, isolated by Edward
Kendall in 1914 at the Mayo Clinic and
synthesized by Charles Harrington in
London in 1927, was subsequently used
in treatment.
The historical treatment of thyroid
goitre is reviewed, including medicinal
therapies with seaweed and algae, sur
gical treatment using setons, arterial
ligation with division of strap muscles
and cervical fascia, and simple enucle
ation. The first descriptions of thyro
toxicosis and exophthalmic goitre were
provided by Parry in 1825, Graves in
1835 and Von Basedow in 1840. In
1907, Charles Mayo introduced the

term hyperthyroidism, and his col
league, Henry Plummer, described the
entity of “toxic adenoma,” later known
as Plummer’s disease. Various methods
were used to treat hyperthyroidism,
including external irradiation, cervical
sympathectomy, intrathyroid injection
of boiling water, adrenal denervation
with or without unilateral adrenalecto
my and various forms of thyroidectomy.
Theodore Kocher recognized that the
response to thyroidectomy was related
to the amount of the gland that was
removed, and in the 1930s subtotal
thyroidectomy became the accepted op
eration for Grave’s disease. Two major
therapeutic advances provided alterna
tives to operation: the introduction of
radioiodine in 1942 and antithyroid
drugs in 1943.
Fine needle aspiration biopsy of thy
roid nodules was effectively used in
some centres in the early 1950s; howev
er, it was slow to gain acceptance
because of fear of tumour implantation.
In the 1970s it assumed increasing
diagnostic importance as a result of the

continued on page 227
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QUILL ON SCALPEL

T o Barb and Lloyd
Roger G. Keith, MD, FACS, FRCS, FRCSC
Chairman, Department of Surgery, University of Saskatchewan, Saskatoon, Sask. Member,
Editorial Board, Canadian Journal of Surgery

Only the gift that is never forgotten is
not lost to the giver.
Publilius Syrus

regret, the Edito
W ithrial deepest
Board and the Publisher
agreed to accept the resignations of
Dr. Lloyd D. MacLean and Dr. C.
Barber Mueller as coeditors of the
Canadian Journal o f Surgery.

Far too often the work of fellow
surgeons and colleagues is not rec
ognized. Never does this seem to be
more frequent than when the prod
uct of the endeavour reaches a
status of excellence that is accepted
as automatic. Our role models in
surgery did this in the operating
theatre. Reputed orators routinely
educated assemblies from the podi
um. Authors stimulated readers’ in
tellects with seeming ease through
the art and science of the written
word.
Communication, as thus exempli
fied, is defined as the act of passing
on news, information and feelings
and is derived from the verb “com
mune” — to feel at one with, be in
close touch, talk with in an intimate
way. Indeed, the end point of com
munication is truly personal.
In order to create a vehicle that
will deliver appropriate communica
tion to a selected audience, certain
requirements must be met. Among
these, the most important are
human elements that will assure a
style for the product, attract maxi
mal attention, produce breadth of
226
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Lloyd D. MacLean, OC, MD, PhD,
FACS, FRCSC

C. Barber Mueller, MD, FACS, FRCSC

content to cover the membership of
the selected groups, maintain supe
rior quality through evaluation by
wise and knowledgeable counsel,
and coordinate in a congenial and
stimulating fashion the activity of
all participants in its production. To
achieve this end on a repeated
schedule, the “human elements”
must be tireless, self-motivated, cre
ative and flexible. Because the grat
itude may seldom be expressed by
the unknowing audience, the ener
gies expended must be rewarded by
personal knowledge that a worthy
contribution has been made to the
recipients for their betterment.
The privilege of meeting and
working with great men and women

is one of life’s pleasures. A common
thread woven through this fabric of
society is humility. Another is time
lessness; always, time is available to
give. Barb Mueller and Lloyd MacLean walk on that path.
Throughout their academic ca
reers these two men have been
recognized as educators. As a resi
dent in general surgery in Toronto I
recall the hours each week that
Barb Mueller would spend teaching
the unteachable about wound heal
ing. That was while he was on
faculty at McMaster University.
Lloyd MacLean recently visited the
University of Saskatchewan as the
Janes Visiting Professor. Although
blue skies tend to tranquillize west-

THE COEDITORS RETIRE

erners, he was sincerely grateful for
the opportunity to spend many edu
cational hours alone with the medi
cal students and residents. The next
week he was elected president of
the American Surgical Association.
Canadian surgical ambassadors
are a rare asset. Ambassadors who
represent the constituency with
their respect and pride are uncom
mon in the most revered arenas. To
have two such individuals as coedi
tors of the Canadian Journal o f
Surgery has been invaluable to the
reputation of the publication.
In recent years, the continuity of

the journal had been at some risk
because of economic pressures.
Though Canada is not a large sur
gical community compared with our
American and European counter
parts, it is a source of national pride
that we want and need to have our
own surgical journal. The current
solvent state of the journal is in
part due to the Canadian Medical
Association; but to an equal or
perhaps greater extent it is due to
three Canadian surgeons who gave
freely of their own time to sustain
the journal: Drs. Jean Couture,
Lloyd MacLean and Barber Mueller.

Barb and Lloyd, the members of
the Editorial Board of the Canadian
Journal o f Surgery extend their
thanks for work well done. More
importantly, the national specialty
societies involved with the journal
extend their gratitude for all the
selfless contributions you have
made for many years and, specifical
ly, thank you for keeping our na
tional communication viable. I
would be remiss if I didn’t thank
you both for the spirit and leader
ship you have given to all of the
Canadian surgeons — your stu
dents.*

anatomist. In 1949 Thomas Addison of
London addressed the constitutional
and local effects of disease in the adre
nal glands in 11 patients, describing
adrenal insufficiency, subsequently
named Addison’s disease. The first op
eration on the adrenal gland was com
pleted in 1889 by Thornton, who re
sected a large cortical adenoma in a
woman with hirsutism. Pheochromocytoma was recognized and reported in
1886 by Felix Frankl. Epinephrine was
the first hormone discovered in 1897
and was isolated from pheochromocytoma tumour extracts in
1911. Between 1952 and 1955 aldost
erone was synthesized, and in 1954
Jerome Conn described the syndrome of
primary hyperaldosteronism.
Kendall. Hench and Reichstein re
ceived the Nobel Prize in 1949 for the
introduction of cortisone for therapeu
tic use. It was immediately used for
replacement therapy after adrenalecto
my and for suppression of androgen
secretion in congenital virilizing hyper
plasia. Preoperative localization of adre
nal tumours slowly evolved, with the
introduction of pyelography in 1930,
selective venous sampling in 1955,
computed tomography in 1975 and
iodocholesterol and iodine-131-mefa-

iodobenzylguanidine (MIBG) scanning
between 1970 and 1980.
Parathyroid tissue was first recog
nized by Richard Owen in 1850 at the
autopsy of an Indian rhinoceros from
the London Zoo. Ivar Sandstrom was
the first to present an anatomic descrip
tion of the parathyroid glands in man
and named them “glandulae parathyroideae” in the late 1870s. Under
standing of parathyroid gland function
began when tetany, was observed after
thyroidectomy in dogs in 1836. Gleu in
1892 demonstrated that tetany oc
curred only if the parathyroid glands
were removed. In 1923 Harold Salveson
of Oslo established the relationship of
the parathyroids to calcium metabolism
and tetany. Parathyroid surgery began
when Felix Mandl removed a parathy
roid tumour from a patient with von
Recklinghausen’s disease in Vienna in
1925. Human parathyroid allografts
were undertaken as early as 1903 for
treatment of tetany, and parathyroid
autografts were initiated after partial
thyroidectomy in 1926 by Frank Lahey
of Boston.
A historical summary of the endo-

BOOK REVIEWS
continued from page 225

work of Fer-Ola Granberg and his col
leagues in Stockholm.
The pituitary gland was first named
“hypophysis cerebri,’’ or outgrowth
under the brain, by Samuel von Soem
mering of Germany in 1778. Acromega
ly was described by Pierre Marie of
Paris in 1886. This was followed by the
first intracranial operation on the pitu
itary gland in 1889 by Victor Horsley of
London and the first extracranial opera
tion in 1906 by Schloffer in Austria. A
seminal year for surgery of the pituitary
gland was 1909 when Kocher, Halsted
and Cushing each introduced an inno
vative surgical approach to the pitu
itary. In 1932 Harvey Cushing de
scribed pituitary basophilic adenomas
and secondary adrenal hyperplasia, sub
sequently known as Cushing’s disease.
The introduction of cortisone in 1949
rendered pituitary surgery much safer
and made total hypophysectomy feasi
ble. The operating microscope was in
troduced by ear, nose and throat sur
geons in Europe in the 1950s and
established for use in selective transsp
henoidal adenomectomy by Jules Hardy
in the 1960s.
The adrenal glands were first recog
nized in 1552 as the glands lying on
the kidneys by Eustachius, a Roman

continued on page 274
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T h e End of a Chapter
Gillian Pancirov
Associate editor, Canadian Journal of Surgery

ith the publication of this
issue of the Canadian Journal
o f Surgery (CJS) an important chap
ter in its development comes to an
end. Our coeditors, C. Barber Muel
ler and Lloyd D. MacLean, have
decided that, after 20 years, the
time has come for them to pass
along the responsibility for the edi
torial content of the journal and to
relinquish their positions as coedi
tors, effective July 1, 1992.
During the years that these two
eminent surgeons have held their
positions the CJS has seen some
major changes. The most important
of these was sponsorship of the
journal by the Royal College of
Physicians and Surgeons of Cana
da, which took place in September
1974. The coeditors represented
the interests of the journal’s Edito
rial Board in the negotiations be
tween the Canadian Medical Associ
ation and the Royal College that

W

started in May 1971 and continued
until January 1974, when a joint
advisory board was established with
representatives from the two bodies
to oversee the arrangements. The
coeditors were elected as ex officio
members of that board.1 The new
arrangement with the Royal College
increased the circulation of the
journal from 1500 to over 7000,
and this provided an incentive for
advertisers of equipment and phar
maceuticals to consider the journal
as the principal means of reaching
Canadian surgeons. The sponsor
ship arrangement continued unin
terrupted until 1991, when the
Royal College decided to phase out
its involvement with the journal.
From that time on the coeditors
worked energetically, with many
others, to introduce the current
arrangement by which six surgical
societies sponsor the CJS.
During the 1980s the coeditors

welcomed the desire for closer ties
with the journal sought by the
newly formed Canadian Association
of General Surgeons. The journal
published selected papers from the
association’s annual meetings and,
in 1987, began to publish the ab
stracts of papers selected for pre
sentation at the Royal College meet
ing from the Canadian Association
of General Surgeons and the Cana
dian Society for Vascular Surgery.
The coeditors were also intimate
ly involved in the important design
changes that were made to the
journal during their tenure. For
example, in 1978 the size of the
journal was updated to the standard
8 x 1 1 inches and the text expand
ed from two columns to three.
There have been a number of major
changes to the journal cover since
they took office in July 1972 (Figs.
1 to 6), from the initial olive and
white cover, through an orange

FIG. 2. First issue, in orange and
white, sponsored by Royal College of
Physicians and Surgeons of Canada.

FIG. 3. New cover design, also in
orange, demonstrating new sponsor
ship arrangement with Royal College.
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FIG. 1. Cover design, in olive and
white, at time coeditors first took of
fice in 1972.
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cover that indicated the journal’s
sponsorship by the Royal College, a
cover with a different colour for
every issue and one with a colour
designated for each issue number to
the present design, which by a
picture and flags highlights sub
jects of interest in that issue. The
journal typeface and layout have
also changed several times.
The past 20 years have also been
a time of personal achievement for
our coeditors. As a sampling of
their achievements Lloyd MacLean
served as surgeon-in-chief at the
Royal Victoria Hospital in Montreal,
alternating as head of the Depart
ment of Surgery at McGill Universi
ty, between 1962 and 1988. He was
president of the Central Surgical
Association (1982), a vice-president
of the American Surgical Associa
tion (1983) and president of the
International Surgical Group
(1989-1990) and the James IV As
sociation of Surgeons; he was also
the 1988 Arthur Sims Common
wealth Travelling Professor. In
1985 he was made an Officer of the
Order of Canada, and in 1989 he
received the Gairdner Wightman
Award. In April this year Dr. Mac-

Lean was elected president of the
American Surgical Association, one
of the world’s most prestigious sur
gical appointments.
Barber Mueller served as head of
the Department of Surgery at
McMaster University between 1967
and 1972. He received the Distin
guished Service Award of the Asso
ciation for Academic Surgery
(1976) and of the American College
of Surgeons (1984), and at the
1992 annual meeting of the Royal
College of Physicians and Surgeons
of Canada he will be presented with
the Duncan Graham Award. He also
received the Founder’s Day Award
(1977) and the Alumni Achievement
Award (1987) of Washington Uni
versity, the Students’ Teaching Ex
cellence Award of McMaster Univer
sity (1988), and he was awarded
Doctor of Humane Letters, HC,
Blackburn College, Carlinville, 111.
(1987). He has sat on the Commit
tee on Examinations, the Basic Sur
gical Examination Committee, the
Surgical Test Committee and the
Committee on Publications of the
Royal College of Physicians and
Surgeons of Canada, the Examina
tions Committee of the Medical

Council of Canada and the Publica
tions Committee of the Canadian
Medical Association. Furthermore,
both coeditors have found time to
serve on the editorial boards of
other journals — Barb Mueller on
the board of the Journal o f Surgical
Research and Lloyd MacLean on
the boards of the Annals o f Surgery
and the World Journal o f Surgery.
The Publications Department
staff, the Publications Committee
and the Canadian Medical Associa
tion salute Barber Mueller and
Lloyd MacLean for 20 years of
consistent effort in raising the qual
ity and international profile of CJS
to its present standard. From our
viewpoint they have always worked
as a team, with tact, cooperation
and good humour, always helping
to make the editorial production of
the journal as smooth as possible,
never hesitating to write a lastminute editorial if necessary or to
take time to review a book. We
shall miss them.

Reference
1. MacLean LD, Mueller CB: T o our new
subscribers — welcome. Can J Surg

1974; 17: 257-258

The Canadian Journal of Surgery
Le journal canadien de chirurgie

FIG. 4. Change in size of journal
brought with it new cover, which used
different colour for each issue.

FIG. 5. Cover design introduced in
1980, highlighting articles of interest
from that issue.

FIG. 6. First issue that had picture on
cover, similar to current cover, which
indicates present sponsorship by six
surgical societies.
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CORRESPONDANCE

To the editors. I read with interest
the articles relating to laparoscopic
cholecystectomy in the February
1992 edition of the Canadian Jour
nal o f Surgery. I feel I must take
issue with the statement by Dr.
Fried (page 7) that it is important to
encourage prospective laparoscopic
surgeons to take an approved uni
versity-run course rather than an
industry-run course.
Early in 1991, when the three
general surgeons at our community
hospital decided to proceed with
training in laparoscopic cholecys
tectomy, the university system and
the Canadian Association of General
Surgeons let us down substantially.
For whatever reasons the university
system was not on the “cutting
edge” of this new procedure and
was unable to respond to the de
mand for training. The three of us
arranged to take separate industrysponsored courses, followed by clin
ical preceptorships in community
hospitals. We have now accumulat
ed nearly 150 cases with minimal
complications and a conversion rate
of 5%.
Laparoscopic cholecystectomy
has been community driven from
the onset, sometimes despite the
opposition of the university centres,
and a substantial number of Canadi
an surgeons have been trained
through industry-sponsored courses
and community-hospital facilities.
M.D. McIntyre, MD, FRCSC
General and vascular surgeon
McIntyre Medical Services Inc.
2 0 1 - 2 1 5 1 McCallum Rd.
Abbotsford, BC
V2S 3N8
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Physician
Ownership/Referral
Arrangements
To the editors. I was interested in
the exchange of views between Drs.
Rankin, Munk and Vellet and Dr.
Fry regarding the future of vascular
surgery in Canada (Can J Surg
1991; 34: 540-542), and 1 agree
with Dr. Fry that vascular imaging
should be provided by the bestqualified practitioner. However, I
take issue with his views on self
referral, and 1 would argue that all
physicians who refer their patients
to diagnostic laboratories in which
they have a financial interest are
guilty of self-referral. There is no
doubt that there are extenuating
circumstances that may make this
necessary or that there are physi
cians of high ethical standard who
engage in this practice, but self
referral it is.
Radiologist-owned practices are
structured in such a way that their
owners cannot engage in self-refer
ral, because radiologists do not con
trol the management of patients. A
radiologist who recommends an ad
ditional procedure is no different
from the vascular surgeon who rec
ommends a femoropopliteal bypass
for the patient referred by the gen
eral practitioner. This is not self
referral but standard medical prac
tice that can withstand the eye of
public scrutiny.
Commenting on the rampant
practice of self-referral in the United
States, Republican Congressman
Pete Stark remarked at a congres
sional hearing in October 1991,
“Physician ownership/referral ar
rangements represent an exploding
virus which ultimately will erode
the trust patients have traditionally
placed in their physicians. The sad

thing is that we are quickly getting
to the point where each of us is
going to have to wonder if we are
getting a service because we need it
or because it would fatten our phy
sician’s dividend.”1

p
r V

Ian Hammond, MD, FRCPC
Department of Radiology
Ottawa General Hospital
University of Ottawa
501 Smyth Rd.
Ottawa, ON
K1H 8L6
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To the editors. I appreciate the
opportunity to respond to the letter
from Dr. Hammond.
It would seem that the role of
vascular surgeons in the manage
ment of diagnostic vascular labora
tories and the issue of self-referral
have struck some sensitive cords. It
is easy, perhaps, to infer that vascu
lar surgeons are guilty of this prac
tice, but I think if Dr. Hammond
and others really look at the issue
they will find that the Canadian
system has many built-in safe
guards to prevent this practice.
There is no doubt that a vascular
surgeon may refer a patient for
noninvasive vascular studies to a
vascular laboratory directed by a
vascular surgeon. This constitutes,
in most cases, simply referring the
patient to the place where he would
get the best possible care. As Dr.
Hammond points out, when dis
cussing “the vascular surgeon who
recommends a femoropopliteal by
pass for the patient referred by the
general practitioner,” this is “not
self-referral but standard medical

4
i

-A

< «|

1

■ », |

Laparoscopic
Cholecystectomy: UniversityVersus Industry-Sponsored
Training

“

4 I

■i

k

CORRESPONDENCE

practice that can withstand the eye
of public scrutiny.”
There are numerous other exam
ples in the health care field where
this practice constitutes the best
available medical care. Some exam
ples are: the cardiologist who refers
a patient for further cardiac investi
gation, echocardiography, coronary
angiography or electrocardiogra
phy; the gastroenterologist who re
fers the patient for endoscopic pro
cedures; the urologist who refers
the patient for cystoscopy, urodynamic studies and so on; and the
surgeon who refers his patient for a
surgical procedure. I would respect
fully suggest to Dr. Hammond that
the radiologist who recommends
further radiologic investigations on
a given patient also falls into this
category.
Although Dr. Hammond suggests
that radiologists do not control the
management of patients, the impli
cations of ignoring a recommenda
tion for further investigation from a
specialist radiologist do carry a sub
stantial liability that not many phy
sicians are willing to incur. In other
words, the clinician would normally
fulfil the recommendations of the
specialist radiologist to pursue fur
ther radiologic investigation. Can
not this be considered “self-refer
ral” as well?
Dr. Hammond tries to draw a
parallel with the practice of self
referral in the United States health
care system. The situation in Cana

da is very different, at least where
vascular laboratories are concerned.
Canadian laboratories are primarily
hospital based and cannot be com
pared to the widespread private and
mobile vascular laboratories and ra
diologic facilities in the United
States, where physician remunera
tion for these facilities is unregulat
ed. This comparison is simply not
accurate for noninvasive vascular
laboratories in Canada. It may be
applicable for private radiology fa
cilities, which are far more preva
lent in Canada than private vascular
laboratories.
Vascular laboratories operated by
vascular surgeons are oriented to
ward providing information that is
most often of use to the vascular
surgeon. Hemodynamic and physio
logic data are central to the special
ty of vascular surgery, and the
laboratory operated by the vascular
surgeon most likely will produce
the information that is of the most
use to vascular surgeons. This is
not to decry the accuracy of labora
tories operated by radiologists but
implies simply that the focus given
to the information is a little differ
ent.
Traditionally, radiologists address
only imaging and provide little de
tail of the other features of the
vascular blood-flow assessment. Im
aging is a part, although a very
small part, of a vascular laboratory.
Unfortunately, well-meaning and
well-respected radiologists see only

that imaging is part of the vascular
surgery field and sometimes feel
threatened as a result. If only they
knew how little we rely on imaging
techniques they might be reassured
that vascular surgeons do not want
to take over the field of radiology.
Imaging for us is a means of readily
identifying the plaque or area of
stenosis so that we may then use
spectrum analysis to assess the de
gree of stenosis. It is this hemody
namic detail upon which we rely far
more than imaging.
It is clear that the idea of the
involvement of vascular surgeons,
who have developed all the tech
nology used in noninvasive vascular
assessment, in clinical care does not
sit well with some radiologists
across Canada. Nevertheless, it is
unlikely that vascular surgeons will
relinquish their interest, expertise
and research capabilities in this
area.
Finally, I would suggest that the
standards in Canada for the opera
tion of diagnostic facilities such as
vascular laboratories are high and
are peer reviewed, with quality as
surance programs in place that
maintain them well. In addition,
national standards in association
with the Canadian Medical Associa
tion are being established.
Peter D. Fry, MD, FRCSI, FRCSC
Head, Division of Vascular Surgery
University Hospital
Vancouver. BC
V6T 2B5
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BABY MICHAEL, 11 MONTHS OLD,
BROUGHT TO FAMILY DOCTOR WITH
FEVER, CONGESTION AND IRRITABILITY.
DIAGNOSED HAVING INFECTION OF THE
UPPER RESPIRATORY TRACT PRESCRIBED
AN ORAL ANTIBIOTIC AND SENT HOME.
4 DAYS LATER, TAKEN TO EMERGENCY
WITH CONTINUING FEVER, HEADACHE,
NECK STIFFNESS, RASH AND VOMITING.
PRESUMED MENINGITIS.
Suspected

Pathogens

Haemophilus influenzae
Neisseria meningitidis
Streptococcus pneumoniae

PAAB
CCPP

CAN ADA’S ONLY O N CE-A-D A Y im/ivA N TIBIO TIC

For prescribing information see page 324

Now, busy Doctors can
test-drive the all-new S-Class in the comfortof their own living room.

Call 1-800-387-4632
to receive your complimentary video The Future in Motion

ENGINEERED LIKE NO OTHER CAR IN THE WORLD

CANADIAN SOCIETY FOR VASCULAR SURGERY
SOCIETE CANADIENNE DE CHIRURGIE VASCULAIRE

Presidential Address, 1991.
Aortobifemoral Bypass — an Enduring
Operation
F. Michael Ameli, MB, ChB, FRCS(Edin), FACS, FRCSC
Aortobifemoral bypass (ABF) has been available as a method for treating patients
with aortoiliac occlusive or aneurysmal disease for 40 years. ABF has been
successful in alleviating the symptoms of claudication and critical ischemia. The
long-term patency rates have been excellent with low operative morbidity and
mortality. Major improvements have been made in indications, preoperative
assessment and operative and postoperative care. With careful follow-up the natural
history of a patient who undergoes ABF is known. Predicting outcome is now
possible and a costibenefit analysis can be made. ABF has proved to be a successful
and enduring procedure.

Le pontage aortobifemoral (PAB) est utilise depuis 40 ans, comme moyen de
traitement des occlusions ou des anevrismes aorto-iliaques. Le PAB s’est montre
efficace pour soulager les symptomes de claudication et d’ischemie critique. Le taux
de permeabilite a long terme s’est avere excellent et la morbidite, de meme que la
mortality operatoires sont basses. Des progres importants ont ete accomplis dans ces
indications, dans leur investigation preoperatoire, de meme que dans les soins
operatoires et postoperatoires. Avec un suivi minutieux, on connait revolution d’un
patient qui subit un PAB. II est maintenant possible de predire les resultats de cette
intervention et de realiser une etude du rapport cout/benefice. Le PAB s’est avere
une technique fructueuse et durable.

ortobifemoral bypass has been
part of the vascular surgeon’s
armamentarium for nearly 40 years.
The concept was originally postu
lated by Leriche in 1923.1 The
operation was made possible by the
advent of prosthetic graft material
developed and used in the early
1950s. Crawford and associates2
and DeBakey, Creech and Cooley3

A

appear to have used prosthetic graft
material in the aortobifemoral posi
tion in 1953.

Historical Background
The history of vascular surgery
goes back to ancient times, when
arterial injuries were treated with

From the Department o f Surgery, The Wellesley Hospital, Toronto, Ont.
Presented at the 13th annual meeting o f the Canadian Society for Vascular Surgery, held in
conjunction with the 60th annual meeting o f the Royal College o f Physicians and Surgeons o f
Canada, Quebec, Que., Sept. 22, 1991
Accepted for publication Mar. 3, 1992
Reprint requests to: Dr. F. Michael Ameli, 313 E.K. Jones Bldg., The Wellesley Hospital, 160
Wellesley St. E, Toronto. ON M4 Y1J3

compression and ligation. In the
second century Antyllus recom
mended ligation and excavation of
the sac of an aneurysm. In 1881
Czerny’s suture was used to repair
venous lacerations. Alexis Carrel
laid the foundation of modern vas
cular surgery with his important
concepts of suturing an anastomo
sis and by successfully grafting a
segment of a dog’s vena cava into
the carotid artery.4
In the 1940s and 1950s text
books of vascular disease contained
little on surgery other than lumbar
sympathectomy; instead they in
cluded a multitude of unusual treat
ments, such as baths and rocking
beds to stimulate the collateral cir
culation.
In Canada, Murray and Best5 re
ported on the use of heparin in
thrombosis. In 1938 they under
took a vein bypass operation and
used heparin for the first time in
conjunction with bypass surgery.
In North America, Julian and
associates,6 DeBakey, Creech and
Cooley3 and Szilagyi, Smith and
Overhulse7 all recorded their experi
ence with replacement techniques
for aortoiliac disease. But the first
cases of aortobifemoral grafting
were apparently performed by De
Bakey, Creech and Cooley.3
My own early experience with
vascular surgery and bypass graft
ing was at the University of Bir
mingham, England, in the surgical
professorial unit where Sir Geoffrey
CJS, VOL. 35, NO. 3, JUNE 1992
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Slaney had a major interest in vas
cular surgery.
In 1968 I worked under the
direction of Dr. R.J. Baird as a
research fellow in cardiovascular
surgery and in 1971 under the
direction of Drs. D.R. Wilson and
R.J. Baird as a senior resident. It
was during this period that I wit
nessed and performed my first aortobifemoral bypass graft proce
dures. My own experience with aor
tic reconstruction, therefore, spans
20 years, and during the course of
this address I intend to review some
of my experiences and those of
others with this enduring proce
dure.

Natural History
Generally patients with aortoiliac
disease are easy to identify by histo
ry and physical examination. Objec
tive measurements can be made by
Doppler studies, particularly before
and after exercise. More recently
transcutaneous oxygen measure
ments have provided more informa
tion about peripheral perfusion.8
The indications for reconstruc
tion are obvious in patients who are
critically ischemic. However, the
majority of patients present with
intermittent claudication, so it is
important to understand the natural
history of aortoiliac disease in both
the untreated and the treated pa
tient.
Vascular surgeons have always
been interested in the natural histo
ry of vascular disease, because their
patients tend to be elderly and the
surgery major. This has led to a
conservative approach for patients
with claudication. There is good
evidence to support this approach.
Crawford and associates2 published
their 25-year experience with aortobifemoral bypass grafting in
1981. They showed that the maxi
mum life expectancy after surgery
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was 20 years. Szilagyi and col
leagues,9 reviewing their 30-year
experience, found a similar situa
tion. The annual death rate for
these patients was approximately
7%, and death was usually due to
coexisting coronary artery disease,
cerebrovascular disease and, to a
lesser extent, malignant disease.
Critically ischemic patients had a
lower life expectancy, and younger
patients tended to survive longer.
In 1989 Dormandy and associ
ates10 reviewed the literature on
interm ittent claudication and
showed that only 5% of patients
subsequently required amputation.
They concluded that claudication is
a benign disease in a high-risk
group of patients. Therefore, the
evidence supports our conservative
approach.
In 1986 Sladen, Gilmour and
Wong11 introduced the important
concept of palliation in this group
of patients. Palliation is defined as
the absence of graft failure, ampu
tation, death or symptomatic recur
rence.
Some of the problems in evaluat
ing the literature are that it is
historical, often based on retrospec
tive series, and the results are often
biased because of patient selection.
It is therefore difficult to get an
accurate picture. I believe that
Rutherford and colleagues12 made
an important contribution in sug
gesting standardized practices for
reporting the results of arterial sur
gery.

In our experience we have found
that exercise electrocardiography or
identification of cardiac arrhythmias
are not predictors of cardiac compli
cations.14 The most useful test in
our hands is the left ventricular
ejection fraction (LVEF).15 Patients
who have an LVEF less than 0.50
appear to be at high risk and re
quire placement of a Swan-Ganz
catheter, whereas those with a
LVEF greater than 0.50 can be
monitored as effectively with a cen
tral-venous-pressure line, which is
certainly more cost-effective.

Angiography
My group has used standard ret
rograde femoral arteriography, but
when this was not possible because
of extensive disease in the aortoiliac
segment we have used the translumbar approach. This has been
complemented by intra-arterial digi
tal subtraction angiography to dem
onstrate the distal vascular tree and
pedal arch.
We have restricted the use of
intravenous digital subtraction an
giography (IVDSA) to demonstrate
localized lesions such as graft ste
nosis and false aneurysms, and this
has proven most helpful in identify
ing graft complications postoperatively.16 IVDSA has not helped to
demonstrate aortoiliac disease and
runoff because the dye load is too
large and the definition inadequate.

Surgery
Preoperative Assessment
The major cause of perioperative
complications is cardiac, and much
of our attention has naturally fo
cused on evaluating the patient’s
cardiac status preoperatively. It was
shown by Hertzer13 that most post
operative deaths result from cardiac
causes.

Surgery is a radical approach to
patients with aortoiliac disease. The
major concern in doing an aortobifemoral bypass instead of an
aortoiliac bypass was the increased
risk of graft infection. In 1968
Moore and colleagues17 addressed
this issue and pointed out the im
portance of the deep femoral artery
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and the low incidence of graft infec
tion and thrombosis.
Another important concern is the
extent of reconstruction necessary
in patients with multilevel disease.
Most surgeons believe in a staged
repair and initially perform aortobifemoral bypass grafting and
profundoplasty. This relieves or im
proves symptoms in more than 90%
of cases. This has also been our
experience. We have carried out
simultaneous repair (i.e., aortobifemoral bypass grafting and femoropopliteal bypass grafting) only
in patients with an inadequate deep
femoral artery.
Baird and associates18 believed
that a concurrent repair is rarely
necessary to relieve claudication, is
occasionally necessary for rest pain
and is quite often necessary for
incipient gangrene.
Dalman and associates19 took a
more aggressive approach and con
cluded that complete correction of
multilevel disease can be accom
plished with operative time, morbid
ity and patency equal to that of
single-level repair. However, they
did not show that such an aggres
sive approach was necessary!
Aortoiliac endarterectomy20 is an
other alternative. However, this ap
proach is time-consuming. There is
more blood loss, and long-term re
sults are not as good as for aortobifemoral bypass grafting. Histor
ically many of the patients who had
endarterectomies were those with
localized disease of the aortoiliac
segment. In the last 10 years these
patients have been suitable candi
dates for transluminal dilatation.

Technical Factors
The major outflow vessel for the
lower limb in the presence of severe
disease or occlusion of the superfi
cial femoral artery is the deep femo
ral artery. In patients with multilev

el disease the deep femoral artery is
usually stenosed at its origin, and a
profundoplasty adds to the relief of
symptoms and improves long-term
patency of the graft.
A more controversial area has
been the type of proximal anasto
mosis (i.e., end to end or end to
side). Theoretically the hemodynam
ics should be better with an end-toend anastomosis, but in our pro
spective series21 and in other se
ries22 there were no differences in
outcome with either type of anasto
mosis. However, an end-to-end
anastomosis is obviously indicated
in cases of aneurysm of the aorta or
occlusion. End-to-side anastomosis
is necessary in the hypoplastic aorta
or in severe disease of the external
iliac artery, because this technique
preserves flow to the internal iliac
arteries.

Graft Materials
Historically various types of
grafts have been used. The first
grafts were made from nylon, and
although there were no randomized
prospective studies to bring them
into clinical use they were surpris
ingly successful.
Dacron was introduced in the
mid-1950s and has probably been
the most successful graft material
to date.
A variety of grafts are available
with various forms of Dacron, in
cluding knitted, woven, double ve
lour and, more recently, collagenimpregnated grafts.
In 1988 Courbier, Sarradon and
Mangialardi23 compared polytetrafluoroethylene (PTFE) and Dacron
bifurcation grafts. They followed up
100 patients for up to 2 years and
found no difference in outcome.
In our randomized prospective
study of two Dacron grafts (USCI
International and Meadox Medical
Inc.) we found no difference in

outcome.24 All patients had comput
ed tomography (CT) at 1 year and
have been followed up for up to 7
years. The CT scans revealed no
significant dilatation, false aneu
rysm or infection and no difference
in graft patency. This indicates to
us that the Dacron velour graft is
very durable and successful.
It remains to be seen whether
collagen-impregnated Dacron grafts
offer any significant advantage in
either outcome or cost-benefit. The
Canadian Multicentre Hemashield
Study25 has shown that the poten
tial for bovine collagen to stimulate
an immune response after implanta
tion of a collagen-coated graft is
low and appears to be without clini
cal consequences.

Bowel and Biliary-Tract
Surgery Combined
With Aortobifemoral Bypass
Grafting
Initially multiple surgical proce
dures, such as bowel or biliary-tract
surgery, were suggested in conjunc
tion with aortobifemoral bypass
grafting. However, this approach
rapidly fell into disrepute because of
the risk of graft infection. Because
of cholecystitis in the perioperative
period we had performed cholecys
tectomy and aortobifemoral bypass
in 56 patients and experienced no
major complications.26 Although we
believed this could be done safely, it
possibly should not be done, partic
ularly now that laparoscopic chole
cystectomy is available.

Ureteric Obstruction
Ureteric obstruction after aor
tobifemoral bypass grafting is un
common. In 1991 Shein and
Saadia27 showed early hydronephro
sis in 10% to 20% of patients and
concluded that this was self-limiting
CJS, VOL. 35. NO. 3. JUNE 1992
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and heralded an impending graft
infection. This has not been our
experience. In a prospective study
of 198 patients who received an
aortobifemoral bypass graft we saw
no ureteric dilatation or infection
on CT at 1 year.

Hypoplastic Vessel Syndrome
Aortoiliac hypoplasia was de
scribed by Delaurentis and associ
ates in 1978.28 We described a
syndrome of hypoplasia of the
whole vascular tree from the ab
dominal aorta to the distal runoff.29
It was shown that the diagnosis
could be made preoperatively by
determining the ratio of the aortic
diameter to the transverse diameter
of the vertebral body. In hypoplastic
patients this was 22%, and in a
group of normal controls it was
40%.

Graft Failure
Graft failure can occur for a
number of reasons. Failures within
30 days of surgery are usually
technical and can be avoided. The
causes are inappropriate choice of
procedure and technical problems
with the anastomosis, particularly
leaving an intimal flap.31
Late failures relate to neointimal
hyperplasia at the distal anastomo
sis and progression of the athero
sclerotic process, which is exacer
bated by continued smoking.
Preoperative arteriography is es
sential when dealing with an oc
cluded limb of an aortobifemoral
bypass graft. The commonest surgi
cal approach has been thrombecto
my of the graft and a profundoplasty. When thrombectomy was unsuc
cessful, inflow was obtained with a
crossover femoral bypass.

Anastomotic Aneurysms
Postoperative Deep Vein
Thrombosis
Deep vein thrombosis (DVT) is a
common postoperative problem,
particularly in elderly patients who
undergo major surgery. One of the
interesting aspects in patients who
undergo major reconstructive sur
gery is the low incidence of DVT.
We have noted this phenomenon,
and we believe that it could be
attributed to the single dose of
heparin that is given intraoperatively.
In a prospective study30 it was
found that the incidence of DVT
detected radiologically using iodine
125 was only 7.1%, whereas in a
comparable group of general surgi
cal patients who had not received
heparin the incidence was 40%.
There is no doubt that heparin
given intraoperatively does protect
the patient from DVT postoperatively.
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These are a major concern be
cause they may herald graft infec
tion. The frequency of anastomotic
aneurysms in my experience is 2%.
The most common presenting
symptom was a mass and recurrent
claudication. Fortunately very few
patients had infection or bleeding.
Anastomotic aneurysms are also
common 5 years postoperatively.
The causative factors are multiple
surgical procedures, infection and
endarterectomy.
False aneurysms can be repaired
directly, usually with an interposi
tion graft to the deep femoral ar
tery. A recurrent false aneurysm is
extremely rare, unless infection is
the underlying etiologic factor.32

Outcome
Knowledge of the outcome of
aortobifemoral bypass grafting is an

important issue, not only in regard
to its benefit to the patient but also
in understanding the place of aor
tobifemoral bypass grafting in the
natural history of the patient’s ath
erosclerotic disease and in assessing
its cost-benefit.
In our prospective study of aor
tobifemoral bypass grafting33 in 105
patients with a 2-year follow-up we
found that the best predictor of
outcome was the number of preop
erative risk factors — age, ischemic
heart disease, ankle-brachial pres
sure index (ABI), transcutaneous
oxygen pressure measurements
(Ptc02), postoperative smoking and
angiographic runoff. The cumula
tive patency rate was 92.8%, surviv
al 84.5%, symptomatic relief 77.3%
and palliation 66.5%.
One of the most interesting new
developments has been the use of
angiography to assess arterial out
flow. We used a new grading sys
tem. Preoperative angiograms were
scored numerically, according to
the arterial status at the level of the
main segmental involvement. With
this scoring system angiographic
outflow successfully helped to pre
dict postoperative increases in ABI
and ftc 0 2 and the cumulative rates
of graft patency, symptomatic relief
and palliation.34

Summary and Conclusions
Aortobifemoral bypass has indeed
stood the test of time. We have
learned a great deal about the oper
ation, its indications and complica
tions and particularly the natural
history of atherosclerosis.
I have reviewed my experience
and that of others. New and inter
esting treatment modalities such as
angioplasty, stents, lasers and en
darterectomy catheters are unlikely
to supplant aortobifemoral bypass
grafting at present but will be a
useful adjunct to managing this
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disease process. New ideas should
be explored and compared scientifi
cally with current treatment modali
ties. The future remains bright and
interesting for vascular surgery.

I wish to express my gratitude to Mrs.
L. Thompson, secretary, Mrs. L. Aro,
research nurse, Dr. M. Stein, all of my
residents and colleagues and, finally,
my family for helping in the preparation
of this address.
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The authors report their initial experience in 52 patients with three different
techniques of peripheral artery atherectomy — the Tracwright (Kensey), used in 19
patients, the Simpson AtheroCath, used in 19 patients and the transluminal
extraction catheter, used in 14 patients. The indications for atherectomy were
claudication in 42 (80%) and limb-threatening ischemia in 10 (19%). There were no
deaths. Complications included three arterial perforations, one thrombosis and one
groin hematoma requiring operative evacuation. There were no distal embolizations.
Atherectomy was initially unsuccessful in 15 (29%) patients. For the successfully
completed procedures, the 1-year primary patency rates were as follows: Tracwright
(Kensey) catheter 56%, Simpson catheter (63%) and transluminal extraction catheter
(0%). Use of subsequent nonoperative procedures on recurrent stenoses produced
secondary patency rates of 77% for the Tracwright (Kensey) technique, 80% for the
Simpson catheter technique and 78% for the transluminal extraction catheter
technique. The authors conclude that their early results justify further evaluation of
these three techniques. Use of the transluminal extraction catheter is associated
with higher rates of occlusion and restenosis.

Les auteurs decrivent leur experience initiale, chez 52 patients, avec trois
techniques differentes d’atherectomie arterielle peripherique oil le catheter Tracw
right (Kensey) fut utilise chez 19 patients, le catheter Simpson, chez 19 patients, et
le catheter d’extraction transluminale, chez 14 patients. Une claudication justiflait
l’atherectomie dans 42 (80 %) cas et une ischemie menafant la survie du membre, 10
(19 %) fois. II n’y eut aucun deces. Les complications comprennent trois perforations
arterielles, une thrombose et un hematome inguinal necessitant une evacuation
chirurgicale. II n’y eut aucune embolie distale. Initialement, l’atherectomie reussit
chez 15 (29 %) patients. Dans le cas des interventions reussies, les taux de
permeabilite primaire apres 1 an etaient les suivants : catheter Tracwright (Kensey),
56 %, catheter Simpson, 63 % et catheter d’extraction transluminale, 0 %. L’utilisation subsequente d’interventions non chirurgicales dans les cas de recidives de
stenoses permit d’obtenir des taux de permeabilite secondaire de 77 % pour la
technique Tracwright (Kensey), de 80 % pour la technique Simpson et de 78 % pour
le catheter d’extraction transluminale. Les auteurs concluent que leurs resultats
initiaux justifient une evaluation plus poussee de ces trois techniques. L’emploi du
catheter d’extraction transluminale est possiblement associe a un plus haut taux
d’occlusions et de restenoses.
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ecently nonoperative tech
niques have been introduced in
the treatment of peripheral vascular
occlusive disease.1'2 These tech
niques include percutaneous tran
sluminal angioplasty, laser-assisted
angioplasty3-5 and various types of
atherectomy.6-10 In this report we
describe our initial experience with
three different techniques of periph
eral artery atherectomy.

R

Patients and Methods
From December 1989 to June
1991 atherectomy was performed at
two University of British Columbia
teaching hospitals on 52 femoral
artery lesions using three different
methods. The catheters used were
the Tracwright (formerly Kensey)
catheter (Dow-Coming, Inc., Arling
ton, Tenn.), the Simpson Athero
Cath (Devices for Vascular Interven
tion, Inc., Mountainview, Calif.) and
the transluminal extraction catheter
(TEC) (InterVentional Technologies,
Inc., San Diego, Calif.).
The study group consisted o f 27
men and 25 women, ranging in age
from 48 to 95 years (mean 71
years). The indications for the pro
cedure were claudication in 42 pa
tients (81%) and limb-threatening
ischemia in 10 patients. The Trac
wright catheter was used more
often for ischemia (Table I) and for
total occlusions, (Table II), whereas
the Simpson catheter and the TEC
were mainly used for claudication
and to treat stenoses.
The lesions treated included 34
stenoses (65%) and 18 total occlu-
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ATHERECTOMY

sions (35%). Lesion length varied
from 1.0 cm to 10.5 cm.
Technique
Access to the arterial circulation
was obtained percutaneously by the
Seldinger technique or through an
arterial cutdown in the groin. Bal
loon angioplasty is usually an ad
junct to Tracwright atherectomy
and may be used in both Simpson
and TEC atherectomy.
Tracwright Device
The Tracwright atherectomy de
vice consists of a high-speed rotat
ing cam tip attached to a central
drive shaft, housed within a flexible
polyurethane catheter. The rotating
tip is powered by an electric motor
that rotates up to 100 000 rpnn.
The catheter also has a lumen for
the infusion of radiopaque contrast
medium, which is infused during
the procedure as a radial jet, to
demonstrate the lesion fluoroscopically and to centre the catheter
within the artery (Fig. 1). It is
designed primarily to cross total
arterial occlusions and to allow the
subsequent passage of a guidewire
for routine balloon angioplasty. The
high-speed rotational motion pul

verizes the firm atherosclerotic
plaque into microscopic fragments
that dissipate into the arterial circu
lation. Interestingly, distal emboli
zation has not been a major prob
lem with this method.6 Because a
guidewire is not used in the initial
recanalization, arterial perforations
sometimes occur. This causes the
procedure to be abandoned but does
not result in hematoma formation.6
Simpson Catheter
The Simpson catheter consists of
a cutting chamber, retrieval cham
ber and opposing balloon. The cath
eter is guided through the lesion
with its own floppy guidewire so
the cutting chamber is positioned
adjacent to the atherosclerotic
plaque. The balloon is inflated to
press the plaque into the chamber
where a cutting blade, activated by
a motor drive unit, shears off the
plaque, which is pushed into the
retrieval chamber. This process is
repeated until the artery has been
opened (Fig. 2). The catheter is
withdrawn, and the atheromatous
particles are removed from the re
trieval chamber. This device is most
suitable for focal stenotic lesions,
often when the plaque is eccentric.
However, techniques for its use in

total arterial occlusions have been
described.8
Transluminal Extraction Catheter
(TEC)
The TEC device consists of an
atherectomy catheter with a cutting
head that rotates at 750 rpm.
Tracked over a central guidewire,
the cutting head is positioned fluoroscopically to lie adjacent to the
plaque. The drive unit is activated
to cut away the plaque, and suction
through the hollow core of the
head of the catheter extracts the
fragments (Fig. 3).
Patient follow-up, in the vascular
laboratory, was by assessment of
ankle-brachial pressure indices or
duplex scanning. In cases of sus
pected failure, angiography was
performed. Failure of primary pat-

T a b le 1. In d ic a tio n s f o r A th e re c to m y
G ro u p , n o . o f p a tie n ts
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T a b le II. L e s io n s T re a te d
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TEC

T o ta l

3
16
4 .4
1 .0 -1 0 .5

19
0
1.9
1 .0 -4 .0

12
2
4.1
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34
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FIG. 3. Transluminal extraction cathe
ter (TEC).
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ency included arterial thrombosis
and recurrent stenoses requiring
treatment. In some cases, secondary
patency was obtained by percutane
ous balloon angioplasty or repeat
atherectomy.

Results
Failure either to obtain arterial
access or to complete the atherecto
my procedure occurred in 15 cases
(29%). Of the remaining 37 cases,
balloon dilatation was used as an
adjunct in 27 (73%) (Table III).
There were no deaths. Complica
tions included three arterial perfora
tions, one thrombosis and one groin
hematoma requiring operative eva
cuation. Perforations caused the
procedure to be abandoned but did
not result in local hematoma forma

tion. Arterial thrombosis was treat
ed by immediate bypass grafting.
There were no distal embolizations.
Four failures of primary patency
occurred in the Tracwright group.
In two cases occlusion occurred,
and in two others percutaneous
balloon angioplasty (PTA) resulted
in secondary patency. In the Simp
son group, arterial occlusion oc
curred in one case, and secondary
patency was achieved in two cases
with PTA. In the TEC group there
were two arterial occlusions. In two
cases patency was re-established —
one with PTA and the other with
repeat atherectomy.
If we exclude the 15 initial fail
ures, the 1-year cumulative primary
patency rates were as follows: Trac
wright 56%, Simpson 63% and TEC
0% (Fig. 4). The use of subsequent
nonoperative procedures produced

Table III. Results
Group, no. of patients
Result
Access
Percutaneous
Open
Failure
Atherectomy procedure
Success
Failure
Baiioon

Tracwright

Simpson

TEC

Total

17
0
2

13
5
1

4
10
0

34
15
3

13
4
13

15
3
10

9
5
4

37
12
27

FIG. 4. One-year cumulative primary patency rate for Tracwright group (■),
Simpson group (+) and TEC group (*).
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the following cumulative secondary
patency rates: Tracwright 77%,
Simpson 80% and TEC 78%. The
number of patients at risk in the
TEC group at 1 year is small.

Discussion
The search for less-invasive
methods of re-establishing vascular
supply to the peripheral vessels is a
new frontier. Arteriographic identi
fication of atherosclerotic lesions in
the arterial tree has led to the
widely accepted technique of PTA.1
This technique effectively dilates le
sions of the iliac and femoropopliteal arteries, although the suc
cess rate is better when the lesions
are more proximal (i.e., common
iliac lesions rather than femoral
lesions), when the indication for the
procedure is claudication rather
than limb salvage, when there is
good arterial runoff below the le
sion and when the lesion is a steno
sis rather than an occlusion.2
Early enthusiasm for laser-assist
ed angioplasty has been dampened
by reports of poor long-term results.3-5 Critical analysis of the out
come of atherectomy procedures
has not been done, but theoretically
the procedures offer an alternative
to the potential thermal injury pro
duced by the laser. Although early
reports of atherectomy suggest ac
ceptable patency rates,11 there is
evidence that recurrent stenosis of
treated lesions is a problem.842
Some of the problems that result
ed in failure to complete the proce
dure in 29% of patients may be
attributable to early learning of the
technique and some to patient se
lection. The obese patient with a
high take-off of the superficial fem
oral artery may not be a suitable
candidate for the antegrade arterial
access that is required. Long, com
plex lesions of the femoral artery
may also contribute to failure to

ATHERECTOMY

complete the atherectomy because
of arterial perforations or inability
to pass a guidewire. If we include
the cases in which we were unable
to gain access or to traverse the
lesion, the 1-year cumulative prima
ry patency rates translate to 50%
(Simpson), 38% (Tracwright) and
0% (TEC).
Fortunately, complications asso
ciated with the procedure occurred
in only five cases (10%). There were
no distal embolizations.
Although the numbers are rela
tively small in each group, there are
some interesting
comparisons
among the methods of atherectomy.
The Tracwright catheter was used
more for total occlusions and for
longer lesions, and its use resulted
in a 1-year cumulative patency rate
similar to that with the Simpson
catheter (56% versus 63%). The
TEC seems to have a lower patency
rate at 6 months. There are too few
patients currently at risk for useful
comparison after 1 year. However,
with the current cohort of patients
it should soon be apparent if recur
rent disease will limit the usefulness
of these techniques.
The chief aim of our current
investigation was to demonstrate
the safety and initial success of the
three methods of atherectomy. We
believe that further evaluation is
justified by our early results.
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Arteritis Due to Salmonella
With Aneurysm Formation: Two Cases
F. Flamand, MD; K.A. Harris, MD, FRCSC; G. DeRose, MD, FACS, FRCSC; B. Karam, MD, FRCSC;
W.G. Jamieson, MD, FACS, FRCS, FRCSC
Although arterial infection due to Salmonella is rare, it remains one of the most
common causes of primary mycotic aneurysms. The presentation is one of sepsis,
cultures positive for Salmonella and rapid expansion or rupture of the aneurysm.
The authors’ experience at Victoria Hospital, London, Ont., includes two cases of
aneurysms infected with Salmonella — one aneurysm of the aorta and the other of
the common femoral artery. Both patients were treated by excision of the aneurysm,
extra-anatomic reconstruction in an area remote from the infected field and
long-term administration of appropriate antibiotics. One patient was alive and well
36 months after resection. The other died of multiple organ failure 10 days after
resection.
From a review of the English and French literature since 1948, 64 cases of
abdominal aortic aneurysms infected with Salmonella were found; half of the
patients survived the perioperative period.
The diagnosis of mycotic aneurysm must be considered in any patient with an
aneurysm and culture specimens positive for Salmonella. The authors favour wide
debridement of the infected aneurysm with extra-anatomic reconstruction. This view
is supported by a review of the literature. The appropriate antibiotic therapy is
bactericidal rather than bacteriostatic.
Bien que les infections arterielles a Salmonella soient rares, elles demeurent l’une
des principales causes d’anevrisme mycosique primaire. Le tableau clinique comprend sepsie, cultures positives pour Salmonella et expansion rapide ou rupture de
l’anevrisme. Les auteurs ont vu deux cas d’anevrismes infectes par la Salmonella a
l’Hopital Victoria de London, (O nt.): il s’agit d’un anevrisme de l’aorte et d’un de
l’artere femorale commune. Les deux patients furent traites par excision de
l’anevrisme, reconstruction extra-anatomique en un point eloigne du foyer d’infection et administration prolongee d’un antibiotique approprie. Un patient se porte
toujours bien, 36 mois apres la resection. L’autre est decede d’insuffisance
plurifonctionnelle, 10 jours apres la resection.
La revue de la litterature anglaise et francaise depuis 1948 denombre 64 cas
d’anevrismes de l'aorte abdominale infectes par Salmonella-, une moitie des patients
ont survecu la periode perioperatoire.
Le diagnostic d’anevrisme mycosique doit etre envisage chaque fois qu’un patient
souffre d’anevrisme et presente des cultures positives pour Salmonella. Les auteurs
favorisent un debridement large de l’anevrisme infecte et une reconstruction
extra-anatomique. Ce point de vue est consistant avec la litterature.
L’antibiotherapie appropriee se veut bactericide plutot que bacteriostatique.
From the Division o f Vascular Surgery, Victoria Hospital, London, Ont.
Presented at the 13th annual meeting o f the Canadian Society fo r Vascular Surgery, held in
conjunction with the 60th annual meeting o f the Royal College o f Physicians and Surgeons o f
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he term mycotic aneurysm,
although imprecise, is well en
trenched in the medical literature.
Patel and Johnston1 classifed my
cotic aneurysm according to the
pre-existing arterial status (i.e., nor
mal, atherosclerotic or aneurysmal)
and the source of infection (in
travascular versus extravascular
bacteremia). Mycotic aneurysms are
infrequent, accounting for 3% to 5%
of all aneurysms found at autop
sy.2'3 The causal organism in mycot
ic aneurysms of the abdominal
aorta is Salmonella in 18% to 35%
of cases.3'4
Aortic aneurysms infected by Sal
monella were fatal until 1962, when
Sower and Whelan5 reported a pa
tient treated by surgical excision
and replacement with an aortic bi
furcation graft. Since then, numer
ous surgical interventions have
been used to treat this disease. The
two main treatment methods are (a)
in-situ bypass grafting (insertion of
a prosthetic graft in continuity with
the normal vessel through the in
fected arterial bed) after debride
ment of the aneurysm and (b) vas
cular reconstruction by an extraanatomic route after debridement of
infected tissues. There is no consen
sus on the best treatment.
We report two cases of aneu
rysms infected with Salmonella, one
of the abdominal aorta and the
other of the common femoral ar
tery. On the basis of our review of
the English and French literature
using a MEDLINE search we dis
cuss appropriate antibiotic therapy
and address the issue of in-situ

T
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vascular reconstruction versus ex
tra-anatomic bypass grafting.

Case Reports
Case 1
A 65-year-old man presented with
a 2-week history of stabbing back
pain. Two days before admission to
hospital fever and chills had devel
oped, but he denied having nausea,
vomiting or diarrhea. His travel
history was not significant. His
medical history included two myo
cardial infarctions, chronic obstruc
tive pulmonary disease and alcohol
abuse.
His temperature was 38.2°C, and
he was normotensive and had a
heart rate of 90 beats/min. A ten
der, pulsatile mass was palpable in
the epigastrium. His hemoglobin
level was 134 g /L and his leuko
cyte count was 14.4 X 109/ L (93%
neutrophils). Blood and stool sam
ples were obtained for culture.
Chest x-ray films revealed an infil
trate in the lower lobe of the left
lung.
Abdominal ultrasonography re
vealed cholelithiasis, a normalcalibre common bile duct and an
infrarenal abdominal aortic aneu
rysm 8.5 cm in transverse diameter,
extending into the iliac vessels.
Over the next 2 days in hospital,
the patient continued to have spik
ing fevers, and his leukocyte count
rose to 21.5 X 109/ L (95% neutro
phils). The blood and stool cultures
revealed a growth of Salmonella
enteritidis sensitive to ampicillin
and gentamicin, which were admin
istered intravenously. Clinically the
abdominal mass was noted to have
expanded, and abdominal ul
trasonography on the third hospital
day showed that the aneurysm di
ameter had increased to 11 cm.
The patient was taken to the
operating room. At laparotomy, the

aneurysm was confirmed to be in
frarenal with bilateral extension to
the iliac arteries. Retroperitoneal
edema, but no pus, was discovered.
The proximal aorta and the distal
common iliac arteries were over
sewn. The aneurysm was excised
and the surrounding infected tissue
debrided. The abdomen was closed,
and a left axillobifemoral graft con
structed with 8-mm polytetrafluoroethylene (PTFE) through an area
remote from the infected field. Mi
croscopic examination of the aneu
rysm revealed laminated thrombus
with marked neutrophilic infiltra
tion. S. enteritidis was cultured
from the thrombus.
Postoperatively the patient con
tinued to receive ampicillin and gen
tamicin intravenously for 7 days,
then was given amoxicillin orally
for an additional 5 weeks. Thirtysix months after surgery the patient
was alive and had had no recur
rence of aneurysmal symptoms, al
though symptoms of myocardial
ischemia had worsened. Repeat ul
trasonography showed the aortic
closure to be intact.

Case 2
A 75-year-old man with a history
of diabetes, ischemic heart disease
and congestive heart failure pre
sented to another centre with a
2-month history of right thigh and
groin pain. Four days before admis
sion, his pain had become sharp.
The right groin was swollen and
painful, and a pulsatile mass was
felt; the flank was slightly bruised.
The leukocyte count was 14.4 X
109/L . The clinical diagnosis was a
ruptured femoral artery aneurysm.
During dissection of the groin to
repair the aneurysm an abscess was
entered lateral to the common fem
oral artery, a small branch of which
was damaged and repaired. The
wound was closed, a drain left in

the abscess and the patient trans
ferred to our centre.
His temperature was 37.3°C,
heart rate 92 beats/min., blood
pressure 135/88 mm Hg and respi
ratory rate 18 breaths/min. His
right groin was mildly erythema
tous around the incision, and a
pulsatile mass was felt. There was
drainage of serous fluid.
Over the next 2 days his condi
tion remained stable. Growth of
Salmonella was reported from mate
rial obtained at the first operation,
and intravenous ampicillin therapy
was started. He remained afebrile,
and his leukocyte count returned to
normal (9.6 X 109/L ). He was
found to have a coagulopathy (pro
thrombin time 15.6 seconds; partial
thromboplastin time 36 seconds),
elevated liver enzyme levels (aspar
tate aminotransferase 101 U /L , al
kaline phosphatase 252 U/L), a
high serum bilirubin level (196
jumol/L) and a low serum albumin
level (17 g/L). On the 2nd day,
while we investigated and treated
the coagulopathy and liver dysfunc
tion, vigorous hemorrhage from the
right groin drain occurred. The pa
tient was immediately taken to the
operating room with the clinical
diagnosis of a ruptured mycotic
aneurysm of the right common fem
oral artery.
Vascular control of the external
iliac artery was gained through an
extraperitoneal approach. Explora
tion of the right groin revealed a
ruptured small fusiform aneurysmal
weakening of the common femoral
artery. Culture specimens were ob
tained, and the infected region was
excised and debrided. The proximal
and distal arteries were closed with
monofilament sutures and the
wounds closed. Revascularization
with a 6-mm PTFE graft from the
left common femoral artery to the
right superficial femoral artery was
done through an uncontaminated
field.
CJS, VOL. 35. NO. 3. JUNE 1992
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S. enteritidis was cultured from
blood and right groin fluid obtained
in the operating room. Histologic
examination of the aneurysm re
vealed atherosclerosis with an at
tached thrombus and acute inflam
matory exudate.
The postoperative course was
complicated by worsening liver fail
ure, ventilator dependence and on
going requirement for inotropic
support. There was a large leak of
serous fluid from both groins, al
though the feet remained viable.
The patient died 10 days later of
multiple organ failure. Autopsy
confirmed the presence of micronodular cirrhosis of the liver
with portal hypertension and areas
of hepatocellular carcinoma. There
was also evidence of adult respirato
ry distress syndrome and coronary
artery disease.

Discussion
Our literature review revealed
only 64 cases of salmonellosis of
the abdominal aorta since 1948 and
fewer cases of salmonellosis of
other arteries.
Infection of the abdominal aorta
by Salmonella most frequently af
fects the population over 50 years
old, with a male to female ratio of
4.7:1. Only three cases have been
reported in patients less than 50
years old.6-8 Although Salmonella
has the potential to invade normal
endothelium,49 atherosclerosis ap
pears to permit the development of
arterial infection by Salmonella.610
Atherosclerotic arteries are at in
creased risk of infection and aneu
rysm formation when a patient has
Salmonella bacteremia.4 The risk of
endothelial infection from Salmo
nella bacteremia in those over 50
years old is 25%.11
Salmonella is gram negative and
includes only three species: S. typhi, S. choleraesuis and S. enteriti
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dis. The first two are the only
serotypes in their respective species,
whereas S. enteritidis consists of
1700 serotypes (e.g., S. typhimurium, S. dublin and S. enteritidis).
The higher virulence exhibited by
S. choleraesuis, S. typhimurium, S.
dublin and other serotypes is proba
bly due to a plasmid-encoded fac
tor.12 S. choleraesuis and S. dublin
are associated with a high incidence
of bacteremia and with extraintestinal sites of infection, including the
vascular tree.12 Other factors that
appear to increase the risk of meta
static infection by Salmonella in
clude diabetes mellitus, hepatic cir
rhosis and previous gastrectomy .2.10.12 Table I shows the frequen
cy of arterial infection by Salmonel
la at different sites.13 The abdominal
aorta is the most frequent site of
infection followed by the femoral
artery.13 From our review, the or
ganisms most commonly recovered
from aortic aneurysms infected by
Salmonella are S. typhymurium, S.
enteritidis and S. choleraesuis, in
that order.
In a patient who presents with
fever, abdominal or back pain and a
pulsatile abdominal mass, the diag
nosis of an infected abdominal aor
tic aneurysm should be con
sidered.14^16 Over 50% of patients
with mycotic abdominal aortic an
eurysms will have this clinical
triad.14"16 An elevated leukocyte
count and repeated episodes of bac
teremia with positive blood cul
tures14-15 should add suspicion of an
infected aneurysm.
Useful radiologic investigations
for these patients include ul
trasonography or computed tomog
raphy (CT). Ultrasonography is
rapid and practical for repeated ex
aminations. However, CT scanning
appears to be more sensitive and
can best reveal early signs of infec
tion of the aorta, including air in
the aortic wall, periaortic nodulari
ty, change in size of the aorta and a

saccular aneurysm in an otherwise
normal-looking aorta.4 Air in the
aortic wall is pathognomonic of an
infected aorta4 but is not specific
for Salmonella infections.
The management of arterial in
fection with Salmonella includes
correction of fluid and electrolyte
imbalance, intravenous administra
tion of antibiotics and surgery. The
patient’s presentation will affect the
rapidity of this course. If time per
mits, patients with mycotic abdomi
nal aortic aneurysm should have
full hemodynamic monitoring,
achieve cardiovascular stability and
have their systemic sepsis con
trolled with appropriate antibiotics
before surgical repair.17 Most re
ports suggest that antibiotic thera
py alone will not cure a mycotic
aneurysm.
The choice of antibiotics should
be directed by the sensitivity of the
organism. Many antibiotic regimens
have been used, including chloram
phenicol alone or in combination
with ampicillin or a cephalosporin.6-18"21 One study showed that
chloramphenicol used alone failed
to eradicate Salmonella,17 This sug
gests that bacteriostatic agents
should not be used alone in the
treatment of endovascular infec
tions. Bactericidal antibiotics are
favoured.6'1019'21"23 In the case of
Salmonella infections, ampicillin
given intravenously before and after
surgery, followed by oral amoxicil
lin therapy for at least 6 weeks,
appears to be adequate.10 Cephalo
sporins or gentamicin should be
reserved for cases in which the
Table I. Frequency of Arterial Infection by
Salmonella at Different Sites
Site
Aorta
Abdominal
Thoracic
Other/combined
Femoral artery
Iliac artery
Other

Frequency, %
72.9
52.1
8.3
12.5
14.6
2.1
10.4
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organism is resistant or the patient
is allergic to penicillin. We believe
that a combination of ampicillin
or a cephalosporin with gentamicin
is acceptable before laboratory
confirmation of bacteriologic sensi
tivity.
Surgical management of mycotic
aneurysms of the extremity includes
ligation, resection of the infected
arterial segment and extra-anatomic
bypass through a clean field.13-24
When possible, autogenous tissue
should be used.24 Many surgical
procedures have been used to treat
abdominal aortic aneurysms in
fected with Salmonella. All authors
agree on the need for wide debride
ment of infected tissue. In recent
years two types of vascular recon
struction have been favoured: the
in-situ and the extra-anatomic vas
cular bypass. Many authors have
reported success with the in-situ
technique.4-6-7-16-18-20 Some authors
have suggested that an in-situ graft
should be considered as an alterna
tive only if the infection is limited.9
However, dictum suggests that
prosthetic material should not be
inserted in an infected field and
supports vascular reconstruction
through a clean field.
Our review of 64 cases reported
since 1948 of salmonellosis of the
abdominal aorta (including our
own), revealed that 32 patients
(50%) survived the perioperative period.2-4"8-16-18"20-25-31 From 1948 to
1969, 21 cases were reported but
only 2 patients (10%) survived.5-8
Since 1970, 30 (70%) of 43 patients
have survived for 6 months or mo
re.2-4 ,6.7,16,18-20,25-3i T a b ]e j j shows

the number of cases according to
the type of primary procedure per
formed. The death rates for patients
who undergo in-situ reconstruction
and extra-anatomic vascular bypass
were 32% and 36% respectively.
At first glance, in-situ reconstruc
tion appears to be a valid option for
an infected aorta; however, before
making this assumption one must
consider the consequence of subse
quent prosthetic graft infection.
Four (19%) of the 21 survivors with
initial in-situ reconstruction re
quired reoperation and insertion of
an extra-anatomic bypass because
of infection of the prosthetic in-situ
graft.2-13-18-25 This very high rate of
graft infection is directly due to the
insertion of prosthetic material in a
field contaminated by virulent and
destructive bacteria. Thus, whereas
extra-anatomic bypass grafting has
a success rate of 64%, in-situ recon
struction has a success rate of only
55%. A prospective, randomized
study would be required to prove
which procedure should be used,
but this is not possible because of
the small numbers involved. For
limited infection, exceptional cases
might be treated by in-situ graft
ing.9 However, the extra-anatomic
bypass should be considered the
most appropriate treatment of ab
dominal aortic aneurysms infected
by Salmonella.
We believe that with a high de
gree of suspicion, early diagnosis,
the use of bactericidal antibiotics
and extra-anatomic bypass grafting,
higher survival rates can be
achieved in the treatment of these
aneurysms.

T a b le II. V a s c u la r P ro ce d u re s fo r S a lm o n e llo s is o f th e A b d o m in a l A orta
In it ia l p ro c e d u re

N o. of cases

N o . ( % ) o f s u rv iv o rs

N one
D ied in o p e ra tin g ro o m
A n e u ry s m re se c tio n
In -s itu re c o n s tru c tio n
E x tra -a n a to m ic va s c u la r b y p a ss

12
5
2
31
14

0
0
2 (1 0 0 )
21 ( 68)
9 ( 64)

T o ta l

64

3 2 ( 50)
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SESAP VII Question / Question SESAP VII
Item 263

The most common cause of superior vena caval obstruction in adults is

(A) lymphoma (Hodgkins or non-Hodgkins)
(B) benign thyroid or thymic tumors
(C) thoracic aortic aneurysms
(D) fibrosing mediastinitis
(E) bronchogenic carcinoma

For the incomplete statement above select the one completion that is best of the five given.
For the critique of Item 263 see page 311.
(Reproduced by permission from SESAP ’92- '93 Syllabus; Surgical Education and Self-Assessment Program
No. 7. For enrolment in the Surgical Education and Self-Assessment No. 7, please apply to the American College
of Surgeons, 55 E Erie St., Chicago, IL 60611.)
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Vascular Injury and Repair Associated
With Retroperitoneal Lymphadenectomy
for Nonseminomatous Germinal
Cell Tumours of the Testis
J.F. Morin, MD, FRCSC;* J.L. Provan, MB, BS, MS, FRCS, FACS, FRCSC;*
M.A.S. Jewett, MD, FRCSC;t F.M. Ameli, MB, ChB, FRCS, FACS, FRCSC*
Metastatic disease adjacent to major vascular structures in the retroperitoneum
sometimes necessitates planned removal of portions of these vessels, or the vessels
may inadvertently be injured when retroperitoneal lymphadenectomy is performed.
In 78 patients who underwent retroperitoneal lymphadenectomy, 17 (22%) required
vascular repair intraoperatively. The vena cava was most frequently involved (eight
cases) followed by inadvertent injury to the renal arteries (five cases) or the
infrarenal aorta (three cases).
Resection of the infrarenal aorta was planned in two cases without postoperative
complication. In six cases a resection of either the whole inferior vena cava or a
portion of it was needed to remove all of the tumour. There were nine cases of
inadvertent injury to the aorta, vena cava or a renal artery.
The outcome after arterial repair was satisfactory with the exception of the
inadvertent renal artery injuries, which required nephrectomy in three cases. Leg
swelling was not a long-term sequela of either caval repair or resection.
Les metastases adjacentes a des structures vasculaires retroperitoneales majeures
necessitent parfois de planifier la resection de parties des vaisseaux, a defaut de
quoi, les vaisseaux peuvent etre accidentellement leses lorsqu’une lymphadenectomie retroperitoneale est pratiquee. De 78 patients qui subirent une lymphadenectomie retroperitoneale, 17 (22 %) necessiterent une reparation vasculaire en cours
d’operation. La veine cave fut le plus souvent affectee (huit cas), suivie par les
atteintes par megarde des arteres renales (cinq cas) ou de l’ aorte sous-renale (trois
cas).
Une resection de l’aorte sous-renale fut planifiee dans deux cas et il n’y eut pas de
complications postoperatoires. Dans six cas, une resection complete ou partielle de
la veine cave fut necessaire pour permettre l’ablation totale de la tumeur. On compta
neuf cas de lesions accidentelles de l’aorte, de la veine cave ou de l’artere renale.
Les resultats des reparations arterielles furent satisfaisants, sauf pour les lesions
accidentelles des arteres renales, lesquelles occasionnerent une nephrectomie dans
trois cas. La reparation ou la resection de la veine cave n’entratna pas, a long terme,
d’inflammation des jambes.

etroperitoneal lymphadenecto
my is used as a staging proce
dure as well as definitive treatment

R

o f nonseminomatous regional nodal
metastases. It remains the standard
treatment for stage I and nonbulky
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stage II disease.1 With the introduc
tion o f bleomycin and cis-platinumbased multiple-drug therapy, the
role o f surgery expanded into the
management o f advanced (bulky
stage I and stage III) neoplasms.2
The morbidity associated with re
troperitoneal lymphadenectomy has
been reported to range from 0 to
53.2%.3"8 However, few studies
have described the need for repair
of adjacent vascular structures as a
result o f complications following
removal o f retroperitoneal metastat
ic nonseminomatous tumour.4’6’9
The purpose o f this study is to
review our experience with vascular
repair associated with retroperitone
al lymphadenectomy for non
seminomatous germinal cell tu
mours o f the testis.

Patients and Methods
Seventy-eight patients with non
seminomatous tumours o f the tes
tes underwent retroperitoneal lym
phadenectomy between 1976 and
April 1987. The age at diagnosis
varied from 16 to 49 years (mean
26 years). Metastatic disease was
confirmed by radiologic chest exam
ination with tomography and tu
mour markers (a-fetoproteins and
human chorionic gonadotropin). In
some cases bipedal lymphangiogra
phy, nuclear liver-spleen scanning
and computed tomography o f the
retroperitoneum were also used.
An anterior transperitoneal ap
proach, as described by Donohue,10
was used. Generally the dissection
CJS, VOL. 35, NO. 3, JUNE 1992
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was carried superior to the renal
hilum. The lateral limits were the
ureters. The inferior limits were the
inguinal ligament on the side of the
orchidectomy and the iliac bifurca
tion on the opposite side. The in
ferior mesenteric artery and the
lumbar vessels distal to the hilum of
each kidney were ligated and divid
ed, allowing these pockets of tissue
to be completely removed en bloc.
The sympathetic chains were identi
fied and if there was no gross
evidence of tumour these were pre
served, particularly in patients oper
ated on later in the series.

Results
Seventeen (22%) of the 78 pa
tients required vascular repair of
arterial or venous structures during
the retroperitoneal dissection; 3 pa
tients required repair of the abdomi
nal aorta, 8 needed repair of the
inferior vena cava and 6 required
additional procedures as a result of
inadvertent injury to adjacent vis
ceral vessels, usually a renal artery
(Table 1).
Aortic Repair

The aortic repairs followed inad
vertent injury in one case (a minor
laceration of the aorta) and required
considered removal of a portion of
the wall of the aorta or the aorta
itself in two other cases. One pa
tient had a large retroperitoneal
teratoma ( 5 X 7 cm) involving the
anterior wall of the aorta. During
the dissection the aorta had to be
stripped of its adventitia and media
to ensure tumour removal, and this
made the aorta extremely friable
and unsuitable for repair. The dam
aged segment of the aorta was
removed. After division of the com
mon iliac arteries an aortobi-iliac
bypass was performed and a 13 X
6.5-mm woven graft was inserted.
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A second patient required resec
tion of the aortic bifurcation, which
was occluded by extrinsic compres
sion by tumour and which was
replaced with a 13 X 6.5-mm
weave-knit bifurcated graft. This
repair was undertaken in conjunc
tion with removal of the inferior
vena cava, which was occluded by
tumour and thrombus.
The third patient sustained a
small puncture hole of the aorta
that was repaired by simple suture.
Inferior Venal Caval Repair

Venous excision or reconstruc
tion was most commonly needed
when resection of the vena cava or
a portion of it was necessary for
complete removal of the tumour
(six patients) or when there was
inadvertent minor injury to the vena
cava (two patients). In these two
patients the caval injury was ma
naged by simple suture.
Two of the six patients required
resection when the inferior vena
cava was found to be filled with
tumour and thrombus. Because of
the presence of large pelvic veins
secondary to chronic occlusion of
the cava, it was judged unnecessary
to reconstruct the resected venous
segment. One of these patients also
required resection of the aortic bi
furcation. Both patients had moder
ate swelling of the lower extremi
ties, which had to be controlled by
elastic stockings for a few months.
At 5 and 8 years after operation
they were asymptomatic but would
not consent to undergo venography

to determine the patency of the
vessel.
In four patients, during dissec
tion very close to the aorta or
inferior vena cava, small punctures
were made in the inferior vena cava,
aorta or renal artery. These small
holes, only a few millimetres in
dimension, did not require clamping
the major vessels and were repaired
by simple 5-0 Prolene suture. None
of the patients experienced any se
quelae or complications related to
these repairs.
In four other patients a portion
of the inferior vena cava had to be
removed because of local involve
ment by tumour. In one of them it
was considered possible to repair
the defect by lateral venorrhaphy
even though the venous defect was
sizable. This procedure resulted in
narrowing of the caval lumen. Im
mediately postoperatively swelling
of the patient’s lower abdomen and
legs developed. A vena cavogram
showed that the vessel contained
thrombus and measured about onethird of its normal size. At reopera
tion 5 days after retroperitoneal
lymphadenectomy a venous patch
was used to correct the defect. The
saphenous vein of the right thigh
was dissected, split longitudinally in
two pieces that were then sewn
together side-to-side to create a
large venous patch. Heparin was
given before clamping the inferior
vena cava and was continued post
operatively. The swelling subsided
and the patient was discharged
from hospital on Coumadin. Anoth
er patient had a similar venous

Table I. Arterial Repair Done During Retroperitoneal Lymphadenectomy
No. of patients

Planned
resection

Inadvertent
injury

Aorta
Vena cava

3
8

2
6

2

Visceral arteries

6

0

6

Vessel

1

Outcome
No arterial insufficiency
Initial lower extremity
swelling
All ultimately asymptomatic
3 had no detectable
abnormality
3 had nephrectomy

VASCULAR REPAIR AFTER RETROPERITONEAL LYMPHADENECTOMY

patch repair but was not given
anticoagulants postoperatively. In
two other patients it was judged
more expeditious to use a Gore-Tex
patch, which measured 3 X 6 cm in
each case. In none of these four
patients did swelling of the lower
extremities occur after insertion of
the patch. Unfortunately none of
them would agree to venography or
ultrasonography to determine the
patency of the vascular repair. None
of these patients suffered infection
related to this foreign body.
Visceral Vessel Repair

Six patients required repair to
visceral vessels as a result of inad
vertent injury.
One patient had a tumour that
was very adherent to his left renal
artery, and the media and adventitia
of the artery were stripped off dur
ing the dissection. No vascular re
pair was required for this injury.
Another patient had no pulse in his
left renal artery at the end of the
retroperitoneal dissection. The ar
tery appeared much smaller than
the renal artery on the contralateral
side, but after local application of
papaverine hydrochloride the vaso
spasm disappeared and a normal
pulse returned. There was no deteri
oration in renal function, which
remained normal postoperatively.
Another patient with Crohn’s dis
ease had a mild rise in his serum
creatinine level postoperatively. A
renal scan demonstrated no perfu
sion of the left kidney and spotty
perfusion of the right one. An angi
ogram showed complete thrombosis
of the left renal artery and a mild
infarct in the lower pole of the right
kidney, even though no arterial
injury had been apparent at opera
tion. A left nephrectomy was done.
Six months later the creatinine level
and function of the right kidney
were within normal limits.
Two patients sustained inadver

tent division of one renal artery
during dissection of a suprarenal
nodal mass. Immediate reanastomo
sis was carried out with a warm
ischemic time estimated at 30 min
utes in each case. In one case there
was no pulse distal to the anasto
mosis and the renal vein was empty.
A nephrectomy was done. In the
other renal reanastomosis there was
good proximal pulsation but spasm
and poor pulsation distally. The
kidney was not pale but dusky in
colour. Because there was no evi
dence of infarction, this kidney was
left in situ but had to be removed
15 months later because of renovas
cular hypertension.
The last patient had extensive
teratoma of the retroperitoneum
surrounding his celiac trunk. Dur
ing the dissection this arterial trunk
was inadvertently divided. Immedi
ate control was obtained by clamp
ing the aorta proximally and distal
ly. The distal celiac axis was over
sewn because it was extensively
covered in tumour. The distal sple
nic artery was then anastomosed to
the aortic orifice of the celiac axis
to revascularize the vessel and its
branches retrogradely after splenec
tomy was performed.

Discussion
The retroperitoneum contains
various important structures that
may be hidden or invaded by tu
mour in this area. Some authors
have reported that a greater inci
dence of vascular involvement oc
curred in patients with bulky dis
ease.4’5’n In our series, 12 (70%) of
17 patients had residual disease in
the retroperitoneum at the time of
surgery, and in most of the patients
the tumour being removed was
bulky, measuring between 5 cm and
10 cm in dimension. Half of this
group of patients had received che
motherapy or radiotherapy, or both,

before the retroperitoneal explora
tion, and this tended to increase
retroperitoneal fibrosis and the diffi
culty of the dissection.
The repairs that were required
fell broadly into two categories —
those in which removal of a vascu
lar structure was planned to com
pletely extirpate the tumour and
those in which inadvertent injury to
a vascular structure occurred dur
ing attempts to remove the tumour
while preserving adjacent arteries
or veins. There were four inadver
tent and minor lacerations of the
aorta, vena cava or renal artery
whose repair was simple and with
out sequelae. However, inadvertent
damage to a renal artery, which
occurred five times, ultimately re
sulted in thrombosis of three of the
reconstructed arteries leading to ne
phrectomy, either at the time of the
injury or later. This indicates the
need for careful repair of these
injuries by vascular surgeons expe
rienced in renal artery surgery.
With increasing experience, vas
cular surgeons have developed in
novative techniques and created ex
cellent results in the repair of arteri
al lesions. As illustrated in the
present series, a nonpulsatile renal
artery after repair should be consid
ered thrombosed, and since this is
usually a result of a technical prob
lem, further repair and correction
should be undertaken at once.
In contradistinction to arterial re
pair, the technical repair of venous
lesions is more controversial. The
considerable morbidity resulting
from ligation for treatment of ve
nous injuries during the Korean
War prompted Rich and Hughes12
and Rich and Spencer,13 to begin
repairing veins. However, it was
only during the Vietnam conflict
that a concerted effort was made by
vascular surgeons to repair venous
injuries whenever possible.1213
Our approach to the management
of venous injuries comes from the
CJS, VOL. 35. NO. 3, JUNE 1992
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early experience in Vietnam, initial
ly documented in the Vietnam vas
cular registry14 as follows: “the ini
tial impression is that the majority
of lateral vein repairs remain patent.
Autogenous vein grafts in the ve
nous system provide time for collat
eral circulation even if the graft
thromboses early. Recanalisation of
this thrombosis is possible.” There
is little margin for error in venous
replacement treatment.
The importance of precise, meti
culous and careful technique to
ensure success cannot be overem
phasized. Closure of the caval de
fect can be done by means of lateral
quilted sutures. It appears that nar
rowing of the lumen up to 50% may
produce no significant obstruction.
In the case of a large defect, we
favour a venous patch. In the small
experience presented in this paper
there was no clinical difference be
tween venous or prosthetic (GoreTex) patches. However, it would
have been of great value to have
venographic documentation of the
status of the reconstructed segment
at scheduled intervals to assess the
patency or to identify recanaliza
tion. None of these patients suf
fered pulmonary embolism, and
there was no late clinical evidence
of venous obstruction such as
edema or development of obvious
venous collaterals.
None of our patients required
graft replacement of the inferior
vena cava. From the literature it
can be said that, in general, autoge
nous vein is the best inferior vena
caval substitute.15 Both the panel
composite and the more recent spi
ral composite, constructed of autog
enous vein, allow the surgeon to
create vein grafts that are isodiametric with the intended recon
struction site. An alternative is the
jugular vein or the superficial femo
ral vein. Experimental studies with
a variety of synthetics (Gore-Tex,
woven silicone rubber, woven Tef
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lon and knitted or woven Dacron)
have not been uniformly success
ful.16 Possibly the externally sup
ported prosthesis may be more use
ful.
Although interposition grafts
may thrombose and the thrombosis
not be evident clinically, both vein
and material grafts have the capaci
ty to recanalize and function as
conduits later.1617 The role of ad
junctive techniques, including arte
riovenous fistulas, systemic an
ticoagulants and antithrombotic
materials bonded to the prosthetic
wall to improve patency has not
been extensively investigated.1618
Only one patient in our series was
kept on Coumadin for 6 weeks after
repair of the inferior vena cava with
a saphenous patch.
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We cannot overemphasize the
difficulty of the operation in pa
tients with advanced metastatic dis
ease in the retroperitoneum and the
necessity for the surgeon to have
considerable knowledge and exper
tise in understanding the retroperi
toneal anatomic relationships and
the ability to deal with inadvertent
injury to the major vessels and
retroperitoneal structures. Experi
enced renal and vascular surgeons
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multispecialty approach to the
treatment of testicular tumours.
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peritoneal lymphadenectomy to cen
tres with a wide range of resources
should be considered.

11.

12.

13.
14.

15.

16.

17.

References
18.
PG, S cardino PT: Thoracoabdomi
nal retroperitoneal lymphadenectomy for
nonseminomatous testicular cancer.
Urol Clin North Am 1983; 10: 371-379

1. W ise

Complications of thoracoabdominal re
troperitoneal lymph node dissection. J
Urol 1982; 127: 1107-1110
S aco AL, B all TP, N ovicki DE: Compli
cations of retroperitoneal lymphadenec
tomy. Urology 1979; 13: 241-243
B runner N, R orth M, S chultz H et al:
Secondary surgery in advanced testicu
lar germ-cell tumors. Scand J Urol Nephrol 1983; 17: 283-285
S tahel RA, von H ochstetler AR, L arc iarder F et al: Surgical resection of
residual tumour after chemotherapy in
nonseminomatous testicular cancer. Eur
J Cancer Clin Oncol 1982; 18: 12591265
B eck PH. S tutzman RE: Complications
of retroperitoneal lymphadenectomy for
nonseminomatous tumors of testis.
Urology 1979; 13: 244-247
D onohue
J: Retroperitoneal lym
phadenectomy: the anterior approach
including bilateral suprarenal-hilar dis
section. Urol Clin North Am 1977; 4:
509-521
W aters WB, Garnick MB, R ichie JP:
Complications of retroperitoneal lym
phadenectomy in the management of
nonseminomatous tumors of the testis.
Surg Gynecol Obstet 1982: 154: 501 —
504
R ich NM, H ughes CW: Vietnam vascular
registry: a preliminary report. Surgery
1969; 65: 218-226
R ich NM, S pencer RC: Vascular Trau
ma, Saunders, Philadelphia, 1978
R ich NM, H uches CW, B augh JH: Man
agement of venous injuries. Ann Surg
1970;171:724-730
B laisdell FW: Injury to the vena cava
and iliac veins. In B ercan JJ, Y ao JST
(eds): Surgery o f the Veins, Grune,
Orlando, Fla, 1985: 385
H iratzka LF, W right CB: Experimental
and clinical results of grafts in the
venous system: a current review. J Surg
Res 1978; 25: 542-561
R ich NM, S ullivan WG: Clinical reca
nalization of an autogenous vein graft in
the popliteal artery. J Trauma 1972; 12:
919-920
H aimovici H. H offert PW, Z inicola N
et al: An experimental and clinical evalu
ation of grafts in the venous system.
Surg Gynecol Obstet 1970; 131: 11731186

CANADIAN SOCIETY FOR VASCULAR SURGERY

T h e Role of Descending Venography
in the Management of Patients
With Chronic Venous Disease
of the Lower Extremity
W.G. Jamieson, MD, FACS, FRCS, FRCSC; G. DeRose, MD, FACS, FRCSC; K.A. Harris, MD, FRCSC;
J. Elliot, MD, FRCPC; P. Karam, MD, FRCSC
The purpose of this paper is to evaluate the efficacy and clinical information
obtained from the authors’ first 17 consecutive descending venograms. All 17
patients had chronic venous disease refractory to standard conservative and surgical
measures. The standard classification of valvular insufficiency was used in
evaluating these venograms. There were no deaths, slight morbidity and minimal
patient discomfort. In 16 patients meaningful clinical information was derived from
the venograms, with 7 patients having deep venous valvular surgery. Descending
venography will demonstrate the site of incompetent valves and estimate the degree
of reflux. This test is necessary before anticipated reconstruction of deep vein
valves.

Dans cet article, les auteurs font le bilan de l’efficacite obtenue et de l’information
clinique tiree des 17 premiers phlebogrammes descendants consecutifs qu’ils ont
realises. Tous les patients souffraient de pathologies veineuses chroniques resistantes aux mesures conservatrices ou chirurgicales classiques. La classification
standard des insuffisances valvulaires a ete utilisee pour Devaluation de ces
phlebogrammes. II n’y a eu aucun deces, une morbidity legere et une gene minimale
pour les patients. Chez 16 patients, une information clinique utile a pu etre tiree des
phlebogrammes, 7 patients beneficiant d’une chirurgie valvulaire veineuse profonde.
La phlebographie descendante peut mettre en evidence le foyer d’insuffisance
valvulaire et apprecier le degre de reflux. Cet examen est necessaire prealablement a
une reconstruction anticipee des valvules veineuses profondes.

C

hronic venous disease (CVD)
historically has been investigat
ed by an accurate history with spe
cial interest in previous attacks of

deep vein thrombosis, previous
trauma to the leg and attention to
possible congenital problems. Phys
ical examination, including the
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Trendelenburg and the Perthes
tests, noted swelling, superficial
varicose veins, ankle pigmentation,
brawny edema and ulcer formation.
The mainstay o f investigative test
ing was ascending venography with
or without tourniquet redirection o f
the contrast media. These investiga
tions proved most satisfactory in a
high percentage o f cases and led to
conservative or surgical therapy
that resulted in an overall 80%
positive result (i.e., long-term ulcer
healing).1
Recently, renewed interest has
been directed toward the manage
ment o f refractory CVD. This inter
est is derived from a cadre o f new
investigative techniques plus in
creased confidence in surgical pro
cedures directed at re-establishing
valvular competence. With the re
sults from these tests, it is possible
to determine preoperatively the site
o f valvular insufficiency and to plan
surgical correction o f incompetent
valves.

Patients and Methods
Seventeen consecutive patients
with suspected CVD o f the lower
extremity underwent descending ve
nography. The patients were select
ed for this test on the basis o f
symptoms (heavy feeling in the
CJS, VOL. 35, NO. 3, JUNE 1992
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legs, a bursting feeling on standing,
relief of symptoms with leg eleva
tion) and signs (swelling, venous
stasis, brawny edema, induration
and pigmentation in the gaiter area
plus or minus ulcer formation) of
CVD.
The classification of CVD used is
that suggested by the subcommittee
on reporting standards in venous
disease (Table I);2 of the 17 patients
in this series, 10 were in class 2 and
7 were in class 3. All patients also
underwent ascending venography
with tourniquet redirection of the
dye, venous Doppler examination,
duplex scanning and air plethys
mography. In this paper we will
discuss only the technique, interpre
tation and results from the 17 con
secutive descending venographic
examinations.
Technique
This procedure can be performed
either by an arm vein or by a direct
percutaneous catheter introduced
into the common femoral vein
(CFV). All patients had direct stab
of the CFV. With the patient in the
supine position, a short catheter
(no. 4 French) is introduced in the
CFV, and the tip is positioned at the
level of the upper femoral head.
Nonionic contrast medium is in
troduced with the patient in a su
pine position, and a bolus of dye is
given to verify the patency and
normality of the CFV, iliac vein and
vena cava. Reflux in this supine
position is noted. The table is then
tilted 60°, foot down, a second
bolus of dye is given and the reflux
noted. The dye injection is repeated
with the 60° tilt accompanied by a
Valsalva manoeuvre.
Interpretation
The contrast agent is heavier
than blood and, therefore, settles
into a valve cusp. Normally, with
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oral vein thrombosis. Worthwhile
information was derived from this
test for the remaining 16 patients.
The results of 16 descending ve
nograms were as follows: grade 0.
two patients — one had complete
long saphenous incompetence;
grade 1, two patients — mid-thigh
reflux (Fig. 1); grade 2, one patient
— reflux to knee (competent popli
teal valve) (Fig. 2); grade 3, five
patients — reflux to below knee
(Fig. 3); and grade 4, six patients
— reflux to ankle. Seven patients
underwent surgery on the basis of
the findings from clinical examina
tion, history and descending venog
raphy. Six patients had valvuloplas
ty, and one had popliteal vein trans
plant from the axillary vein.

quiet respiration, blood flows to the
heart with the valve cusp slightly
open, so a wisp of dye may escape
distally in perfectly normal valves.
Under stress, however, as with the
Valsalva manoeuvre, the valves are
closed. The greater the stress, the
tighter the valves close. This princi
ple is the mainstay of the interpre
tation of descending venograms and
differentiates between a normal
valve with physiological wispy re
flux and a grossly incompetent dis
eased valve.

Results
Seventeen consecutive descend
ing venograms were analysed. The
classification used to grade the
amount of reflux is given in Table
II.3 There were no deaths, no aller
gic reaction to the dye and minimal
morbidity with four cases of groin
ecchymosis with no palpable hema
toma. There was no groin infection,
and we were unable to complete one
venogram because of common fem

Discussion
CVD affects 25% to 30% of the
population in industrialized socie
ties. and 0.5% to 1.0% of the popu
lation has a venous ulcer problem.4
Unlike peripheral vascular disease

Table 1. Classification for Chronic Venous Insufficiency2
Class

Current
symptoms

Prior
symptoms

0
1

Asymptomatic
Mild

Same
Same

2
3

Moderate
Severe
(ulceration)

Same
Same

4
5
6
7

Anatomic
location
Unknown
Superficial
veins
Perforators
Deep (calf)

Origin
Unknown
Congenital
Post-thrombotic

Deep (thigh)
Deep (iliofemoral)
Deep (caval)
Combination of
3 -6 (any)

Table II. Grades of Reflux in the Deep Veins on Descending Venography
Grade

Description

0

No reflux below the confluence of the superficial and deep femoral veins, (i.e., the
uppermost valve of the superficial femoral vein is competent)
Reflux beyond the uppermost valve of the superficial femoral vein but not below the
middle of the thigh
Reflux into the superficial femoral vein to the level of the knee. Popliteal valves competent
Reflux to a level just below the knee. Incompetent popliteal valves but competent valves
in the axial calf veins
Reflux through the axial veins (femoral, popliteal, calf) to the level of the ankle

1
2
3
4

Reproduced by permission from Herman and associates.3

DESCENDING VENOGRAPHY AND VENOUS DISEASE

related to the old-age group, CVD
commonly involves the younger,
middle-age working population and
has a significant effect on the work
force.
Since the 1950s, interest in
chronic venous insufficiency has
seemed secondary when compared
with the interest in arterial prob
lems. In the last decade, however,
renewed interest has been shown in
CVD, probably because new venous
investigative tools are available in
most major hospitals, and valvular
surgery has produced reasonably
good surgical results.5-7
At Victoria Hospital in London,
Ont., an active interest in venous
disease has existed since World
War II. A.D. McLachlin and J.A.
McLachlin exhibited an active clini
cal and research interest in venous
disease that led to several profound
and lasting observations.8’9 Luke of
Montreal contributed significantly
to the early technique and under
standing of descending venogra
phy.10
New investigative techniques in
clude bidirectional Doppler flow

FIG. 1. Descending venogram with
Valsalva manoeuvre showing grade 1
reflux — competent valve thigh.

measurement, which is the simplest
and least expensive noninvasive
technique. Air, impedance, photo
and strain-gauge plethysmography
have been used, as has duplex im
aging using B-mode imaging of
anatomic changes and velocity sig
nal analysis of flow disturbance.
This latter technique allows direct
valvular visualization during com
pressive manoeuvres and thus per
mits assessment of valve function in
the deep and the superficial system;
perforating veins can also be delin
eated. This may soon be the investi
gation of choice.
Invasive techniques still use as
cending venography with tourni
quet redirection of the dye flow, in
conjunction with descending venog
raphy, for anatomical and graphic
delineation of the superficial, deep
and communicating systems of
veins.
Until 1989, chronic venous prob
lems in our institution were ma
naged on the basis of a complete
history, physical examination and
ascending venography. Since then,

we have added bidirectional Doppler
flow measurement, duplex scan
ning, air and impedance plethys
mography and, in the last 10
months, renewed interest in de
scending venography. Radiologic
interest was easily kindled in this
procedure, and descending venogra
phy is now an integral part of the
workup in patients with chronic
refractory venous disease. With
these tests, a surgical strategy can
be formulated and specific thera
peutic measures carried out.
Chronic venous insufficiency can
be pathologically classified as ob
structive (thrombosis) or malfunctional (valvular reflux), or a combi
nation of the two. It is helpful when
comtemplating therapy to think of
deep and superficial venous sys
tems. In the superficial system are
the long and short saphenous veins,
tributaries of these veins and the
perforating and communicating
veins. In the deep system (i.e., those

FIG. 2. Descending venogram with
Valsalva manoeuvre showing grade 2
reflux — competent “gait keeper”
valve at knee.

FIG. 3. Descending venogram with
Valsalva manoeuvre showing grade 4
cascading reflux into calf and down to
ankle.
CJS, VOL. 35. NO. 3. JUNE 1992
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deep to the fascia) are the common
femoral, superficial and deep femo
ral, popliteal and calf veins.
Before 1988, after the history
taking, physical examination and
ascending venography, treatment
was conservative — weight reduc
tion, active muscle strengthening
program (walking) and use of com
pression stockings. Support com
pression stockings range from mild
elastic support hose to elastic
stockings, pressure gradient stock
ings and viscopaste boots. Excellent
long-term results can be achieved
with support hose therapy.11 Sur
gery has involved removal of long
and short saphenous veins, tribu
tary removal and some form of
ligation of incompetent perforators.
This regimen successfully aided
80% of patients when the criteria
for success were relief of symptoms
of fullness, minimal swelling and no
recurrent ulcer formation.1 Surgical
support stockings are recommended
in the postoperative phase. The
results of this therapy are good
because an 80% ulcer-free postoper
ative course is recorded, despite
poor compliance in wearing elastic
stockings.
Recently, with new investigative
techniques, especially descending
venography and duplex scanning,
the deep system has been further
delineated. A classification of the
pathologic cause of deep valvular
problems has been developed: (a)
primary valvular insufficiency (PVI),
(b) post-thrombotic valvular insuffi
ciency and (c) congenital atresia of
the valves of the deep veins.
Descending venography showed
both the location of the malfunc
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tioning valves and the amount of
reflux.12 Many patients with CVD
have incompetence of the valves of
the superficial, perforating and deep
systems.3'13' 15
If all systems have incompetent
valves, we operate primarily on the
superficial system and the perforat
ing system with varicose-vein sur
gery and with ligation of the in
competent perforators. The patients
are followed up carefully, and if
ulcers will not heal, attention is
paid to deep vein valvular recon
struction in the form of valvuloplas
ty, valve transfer or valve trans
plant. We have done six valvulo
plasties and one valve transfer to
the popliteal vein from the axillary
vein. The early results are encour
aging. Follow-up between 3 and 7
months showed that six of seven
patients were improved, and no pa
tients showed valvular reflux on
duplex scanning at the site of the
valve repair.

Conclusions
We have reviewed our first 17
consecutive descending venograms.
The technique is well established,
morbidity and patient discomfort
are minimal, and venograms demon
strate the position and amount of
valvular reflux. Descending veno
graphy is now an integral part of
the workup for patients with CVD
refractory to standard treatment.
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Prevention of Vascular Injuries
in Revision Total Hip Replacement
M. Al-Salman, MB, BS;* D.C. Taylor, MD;* C.P. Beauchamp, MD;t C.P. Duncan, MDt
Iliac-vessel injury from total hip arthroplasty is associated with hemorrhagic
complications and an increased death rate. The authors identified seven patients
who had severe medial displacement of the acetabular prosthesis and associated
vascular injury to the iliac vessels after total hip replacement. One patient had two
hip replacements. Preoperative findings included a pelvic mass (three hips), pelvic
pain (eight), radiologic evidence of cement in the pelvis (three) and the acetabular
prosthesis in the pelvis (eight), computed tomographic evidence of cement in the
pelvis and proximity of the prosthesis to the iliac vessels (four), and arteriography
showing displacement or compression of the iliac vessels (seven).
Operative management in all cases involved medial exposure, mobilization and
repair of the iliac vessels before revision of the hip prosthesis.
Postoperative complications were deep vein thrombosis (three), in spite of
prophylaxis, and occlusion of a vein interposition graft (one) requiring placement of
a femoral crossover graft. There were no deaths, amputations or hemorrhagic
complications.
The authors advocate preoperative identification of patients who have iliac-vessel
involvement by their total hip prosthesis and initial medial extraperitoneal exposure
and repair of these vessels before removal of the displaced acetabular prosthesis.
Les lesions des vaisseaux iliaques lors d’une arthroplastie totale de la hanche sont
liees a des complications hemorragiques et a une augmentation de la mortalite. Les
auteurs ont identifie sept patients qui avaient subi un important deplacement interne
de la prothese acetabulaire et une lesion des vaisseaux iliaques apres un
remplacement total de la hanche. Un patient avait subi deux arthroplasties. On note
parmi les observations preoperatoires, une masse pelvienne (trois hanches), une
douleur pelvienne (huit), une preuve radiographique de ciment dans le bassin (trois)
et de la prothese acetabulaire dans le bassin (huit), des signes a la tomographie
axiale de ciment dans le bassin et de la proximite de la prothese aux vaisseaux
iliaques (quatre), et une arteriographie montrant un deplacement et une compres
sion des vaisseaux iliaques (sept).
Dans tous les cas, le traitement chirurgical a consiste en une exposition interne,
une mobilisation et une reparation des vaisseaux iliaques avant de proceder a la
revision de la prothese de hanche.
Les complications postoperatoires comprennent des thromboses veineuses profondes (trois) en depit d’une prophylaxie, et l’occlusion d’un greffon d’interposition
veineux (un) necessitant une derivation par greffe femorale. II n’y eut aucun deces,
amputation ou complication hemorragique.
Les auteurs recommandent l’identification preoperatoire des patients qui ont une
lesion des vaisseaux iliaques causee par leur prothese de hanche et l’exposition
interne extraperitoneale et la reparation de ces vaisseaux, avant de proceder a
l’enlevement de la prothese acetabulaire deplacee.
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pproximately 10 0 0 0 total hip
replacements are done annually
in Canada.1 Acute vascular compli
cations of total hip replacement
include hemorrhage, distal ischemia
from thrombosis or embolism, pseu
doaneurysm and arteriovenous fis
tula.2-9
Major hemorrhagic complications
can occur, especially in reoperative
hip surgery when the acetabular
component or its surrounding ce
ment has involved the iliac artery or
vein. Under these circumstances
bleeding can be difficult to control
from the lateral approach th at is
normally used for hip surgery, and
this has led to increased morbidity
and at times fatal exanguination.2
We have identified a group of
patients requiring reoperative total
hip replacement who have medial
protrusion of the acetabular pros
thesis and associated iliac-vessel in
volvement or injury. These patients
are at high risk of hemorrhagic
complications during hip replace
ment. We describe a technique th at
has prevented these hemorrhagic
complications. It involves initial me
dial exposure and repair of the iliac
vessels before the revision hip re
placement.

A

Case Report
A 63-year-old woman presented 4
years after left total hip replacement
done for avascular necrosis. She
had pain and swelling in the left hip
and groin and was unable to bear
weight on the left leg. On examina
tion she had moderate swelling of
the left leg and significantly de
creased range of motion in the left
hip. Pedal pulses and neurologic
function in both legs were normal.
CIS. VOL. 35, NO. 3, JU N E 1992
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Plain x-ray films showed protru
sion of the acetabular component of
the hip prosthesis medially into the
pelvis with extensive loss of bone.
Angiography showed medial dis
placement and compression of the
left external iliac artery (Fig. 1).
The patient had initial exposure
of the left iliac vessels through an
extraperitoneal approach medial to
the pelvis, with the femoral vessels
exposed through a longitudinal ex
tension of the same incision. The
acetabular prosthesis was seen to
be displaced medially through the
medial wall of the acetabulum. Spic
ules on the Lord acetabular pros
thesis had eroded into the external
iliac artery, necessitating primary
repair of the vessel. The external
iliac vein was thrombosed. The ace
tabular prosthesis and cement were
removed and replaced with bonegraft reinforcement to the pelvis.
Postoperative recovery was compli
cated by extension of the deep vein
thrombosis and swelling of the left
leg, which were managed with anti
coagulant therapy.
The patient presented again 18
months later with increasing left
hip pain. X-ray films showed dis
placement of the new hip prosthesis
beyond the medial wall of the left

FIG. 1. Arteriogram showing severe
medial displacement and compression
of external iliac artery by medially
displaced acetabular prosthesis.
262

JCC, VOL. 35, N ° 3, JUIN 1992

acetabulum (Fig. 2). Angiography
showed new medial displacement
and compression of the common
and external iliac artery. Duplex
ultrasonography showed chronic
occlusion of the left femoral and
iliac veins with collateral formation.
The left iliac vessels were ex
posed through an intraperitoneal
approach. The external iliac artery
was adherent to the acetabular
prosthesis with a deficient lateral
arterial wall requiring interposition
vein-graft replacement. The hip
prosthesis was removed and an is
chiofemoral arthroplasty performed.
Cultures grew Staphylococcus epidermidis, and the patient was placed
on long-term antibiotic therapy.
Postoperative recovery was com
plicated by vein-graft occlusion on
postoperative day 1. It was man
aged by placement of a Dacron
femoral crossover graft. Her further
recovery was uncomplicated, and

the bypass graft was patent 2 years
later.

Study Group

Between July 1987 and Decem
ber 1990 approximately 1600 total
hip replacements were performed at
our institution. Forty percent were
reoperative procedures, usually
done for mechanical failure or infec
tion of the original prosthesis.
We identified eight total hip re
placements (seven patients) with se
vere medial displacement of the ace
tabular component of the hip pros
thesis and probable iliac-vessel in
volvement by the prosthesis or its
surrounding cement. These patients
were considered to be at high risk
for severe hemorrhage from their
iliac vessels if the acetabular pros
thesis was removed through a later
al approach.

FIG. 2. Severe medial protrusion of acetabular prosthesis within pelvis, indicating
probable iliac-vessel involvement with risk of severe hemorrhage if acetabular
prosthesis is removed through lateral approach.

VASCULAR INJURY WITH HIP REPLACEMENT

In all cases initial exposure, con
trol and repair of the iliac vessels
were carried out before removal and
repair of the hip prosthesis. The
iliac vessels from the aortic bifurca
tion to the inguinal ligament were
exposed through an extraperitoneal
approach by an oblique incision
over the lower quadrant. Femoral
vessels were exposed through a
longitudinal extension if necessary.
Common and external iliac arteries
and vein were mobilized as neces
sary to free them from the acetabu
lar prosthesis and cement. Arterial
and venous repair was done either
primarily or with interposition graft
as required.
After mobilization and repair of
the iliac vessels, the revision total
hip replacement was done by stan
dard techniques from a lateral inci
sion. In some cases both the medial
vascular exposure and the lateral
exposure of the hip joint were done
through a single incision. The com
bined medial and lateral exposure of
the pelvis provided exposure of the
acetabulum, especially the anterior
column, superior to that of a lateral
approach alone. The acetabular
prosthesis and cement were re
moved from both the lateral and
medial incisions as required to pro
tect the vessels and femoral nerve.
The scar tissue over the medial wall
of the pelvis was closed to prevent
herniation and to add some support
to the inner wall of the acetabulum.
Both incisions were closed only
after completion of the total hip
revision.
All patients received perioperative
prophylaxis against deep vein
thrombosis with warfarin and se
quential calf compressors.

Findings
Preoperative clinical factors asso
ciated with iliac-vessel involvement
in revision total hip replacement

included identification of a usually
tender pelvic mass (three of eight
hips), pelvic bruit (two of eight
hips) and pelvic pain (eight of eight
hips). Preoperative radiologic find
ings included identification of the
acetabular prosthesis within the pel
vis on plain x-ray films (all cases),
cement within the pelvis on x-ray
films (three of eight cases), and
computed tomography scans show
ing cement in the pelvis and prox
imity of the migrated acetabular
prosthesis to the iliac vessels (four
of four scans). Computed tomogra
phy was not helpful in patients
having radiopaque cement because
of artifact but was helpful in identi
fying cases in which there was
unexpectedly a significant amount
of radiolucent cement within the
pelvis. Arteriography was done in
seven cases and in each case
showed displacement or compres
sion of the common or external iliac
artery. Venography was done in
only one case that showed displace
ment of the vessel.
The operative approach in each
case involved initial mobilization,
and repair if necessary, of the iliac
vessels. This was done through an
extraperitoneal approach in seven
cases and through an intraperitoneal approach in one case,
in which prior dissection and mobi
lization of the iliac vessels preclud
ed further extraperitoneal dissec
tion. After control of the vessels,
revision total hip replacement (sev
en cases) or excision only of the
total hip prosthesis (one case) was
performed through a lateral ap
proach.
At operation the involved vessels
were the external iliac artery
(eight), the internal iliac artery
(one), the external iliac vein (seven),
and the internal iliac vein (one). In
six cases only dissection and mobili
zation of the involved vessels were
required. In these six cases the
vessels were intimately involved

with, and adherent to or encased
by, the acetabular prosthesis or
surrounding cement, but actual ves
sel repair was not necessary. In one
case primary repair of the external
iliac artery was required. In one
case a vein interposition graft to the
external iliac artery was needed.
This graft thrombosed postoperatively and required a femoral cross
over graft.
Postoperatively there were three
cases of deep vein thrombosis.
There were no deaths, amputations
or major hemorrhagic complica
tions. There were no instances of
major hemorrhagic complications in
any other revision total hip replace
ments done during this period at
our institution.

Discussion
Acute vascular injuries related to
total hip replacement can be hemor
rhagic or thromboembolic.2-4 Hem
orrhagic complications include re
tractor injury to the common femo
ral vessels, reaming injury to the
external iliac vessels within the pel
vis and injury to the superior glute
al artery. The thromboembolic com
plications include thrombosis of the
femoral or iliac arteries related to
traction or manipulation of often
atherosclerotic arteries about the
hip joint. Both hemorrhagic and
thromboembolic complications usu
ally require urgent vascular inter
vention and are associated with in
creased death rate and risk of limb
loss. Shoenfeld and colleagues,2 in
their literature review of 63 cases of
vascular injury associated with total
hip replacement, found a death rate
of 7% and an amputation rate of
15% associated with vascular inju
ry. Acute deep vein thrombosis and
pulmonary embolism are well-recog
nized complications of total hip
replacement but do not usually re
quire surgical intervention.
CJS, VOL. 35, NO. 3, JUNE 1992
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The late vascular complications
of total hip replacement include
pseudoaneurysm, arteriovenous fis
tula and injury to the iliac vessels
from medial protrusion of the ace
tabular prosthesis or extravasation
of cement within the pelvis.2'5’6
The iliac vessels, particularly the
external iliac artery and vein, are at
risk in procedures replacing the
acetabulum because they lie just
medial to the acetabulum and can
be injured acutely by reaming de
vices or screws placed through the
pelvis.7-8 They can also be injured
when cement extravasates into the
pelvis or when the acetabular pros
thesis fails for mechanical or infec
tive reasons and migrates medially.
Reoperative surgery to revise or
replace the total hip prosthesis
when the iliac vessels are intimately
involved with either cement or the
acetabular prosthesis can be associ
ated with catastrophic hemorrhagic
complications when the cement or
prosthesis is removed by a lateral
approach.2'9"n The high mortality
and morbidity from hemorrhage
under these circumstances is related
to two factors. First, the hemorrh
age may be predominately within
the pelvis, and recognition may be
delayed. Second, if the hemorrhage
is recognized it cannot be rapidly
controlled from the lateral ap
proach, and the patient must be
repositioned and a retroperitoneal
approach to the iliac vessels per
formed for rapid exposure and re
pair.
To prevent major hemorrhagic
complications such as this in reop
erative total hip replacement we
identified a group of patients at risk
who had iliac-vessel involvement be
cause of cement or medial displace
ment of the acetabular prosthesis of
their total hip replacement. Initial
exposure, mobilization and repair of
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the iliac vessels were performed in
each case and prevented any major
hemorrhagic complications.
Preoperative factors that indicat
ed iliac-vessel involvement were a
tender pelvic mass, pelvic pain, a
pelvic bruit, severe medial protru
sion of the acetabular prosthesis on
x-ray films, or intrapelvic cement on
x-ray films or computed tomogra
phy scans. When indicated by these
factors, angiography was done to
assess arterial involvement, and
when significant displacement or
compression was seen initial vascu
lar exposure and repair were per
formed. Venography was not done
in most cases because venous in
volvement was assumed if the iliac
artery was involved.
We found involvement of the
external iliac artery in all eight
cases. In two cases there was direct
vessel erosion, and in the remaining
cases encasement of the vessel by
either cement or fibrosis around the
prosthesis. Removal of the acetabu
lar prosthesis from the lateral ap
proach would, we believe, have led
to severe hemorrhage from the ex
ternal iliac artery or vein in all cases
if adequate vascular control had not
been obtained before removal.
Postoperatively in spite of ag
gressive prophylaxis against the de
velopment of deep vein thrombosis
we had a high incidence of this
complication (three of eight cases).
This likely relates to the known
high incidence of deep vein throm
bosis in hip surgery, combined with
direct vessel injury from the cement
or prosthesis.
We believe that the preoperative
identification of patients requiring
reoperative total hip replacement,
who may have iliac-vessel involve
ment, and their management with
initial vascular exposure and con
trol, can prevent major hemorrhag

ic complications during this proce
dure. With the increasing number
of patients requiring revision of
their total hip replacement we antic
ipate that this approach to protect
ing the iliac vessels will become
increasingly important.
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Intraoperative Balloon Angioplasty:
a Surgical Approach
Mussad Al-Salman, MB, BS, FRCSC; D. Lynn Doyle, MD, FRCSC;
York N. Hsiang, MB, ChB, MHSc, FRCSC; Peter D. Fry, MD, FRCSC; Miguel Fragoso, DVM
Percutaneous balloon angioplasty is a recognized treatment for peripheral
atherosclerosis involving the iliac and femoropopliteal segments. From their
experience in 38 patients the authors have examined the efficacy of intraoperative
balloon angioplasty for tandem lesions requiring both balloon angioplasty and
surgical intervention.
Between January 1988 and July 1990, 43 intraoperative balloon angioplasties
were performed in 19 women and 19 men who required inflow or outflow
angioplasty in addition to surgical bypass. The indication for surgery was
incapacitating claudication in 32 (74%) patients and limb salvage in 11 (26%)
patients. Initial technical success was achieved in 17 (89%) of 19 patients who
required iliac surgery and in 22 (92%) of 24 patients who required femoropopliteal
balloon dilatations. There were four major complications (9%), all requiring surgical
intervention. In two cases there was dissection with thrombosis and in two cases
failure to improve the pressure gradient.
Patients were followed up for up to 24 months. Two of the inflow angioplasties
failed between 6 and 9 months. Two of the outflow angioplasties failed between 12
and 15 months. Three patients died in the follow-up period, two from myocardial
infarction.
In the authors’ experience intraoperative balloon angioplasty has proven a
worthwhile adjunct for tandem lesions in the iliac and femoropopliteal segments.

L’angioplastie percutanee par ballonnet est un traitement etabli de l’atherosclerose
des segments iliaques et femoropoplites. Les auteurs ont etudie, a partir de leur
experience chez 38 patients, l’efficacite de l’angioplastie peroperatoire par ballonnet
dans les lesions en tandem necessitant, a la fois, angioplastie par ballonnet et
chirurgie.
De janvier 1988 a juillet 1990, 43 angioplasties peroperatoires par ballonnet ont
ete pratiquees chez 19 femmes et 19 hommes qui necessitaient une angioplastie
d’arrivee ou de sortie en plus d’un pontage. Les indications chirurgicales etaient
une claudication invalidante dans 32 (74 %) cas et la conservation d’un membre, 11
(26 %) fois. Une reussite technique initiale a ete obtenue chez 17 (89 %) des 19
patients qui necessitaient une chirurgie iliaque et chez 22 (92 %) des 24 patients qui
necessitaient une dilatation femoropoplitee par ballonnet. On a enregistre quatre
complications graves (9 %) necessitant toutes une intervention chirurgicale. II y eut
deux cas de dissection avec thrombose et deux fois, on ne reussit pas a ameliorer le
gradient de pression.
Les patients ont fait l’objet d’examens de controle pour des periodes allant jusqu'a
24 mois. Deux des angioplasties d'arrivee se sont stenosees apres 6 a 9 mois. Deux
angioplasties de sortie n’etaient plus permeables apres 12 a 15 mois. Trois patients
sont decedes pendant cette periode, dont deux d’infarctus du myocarde.
Dans cette etude, l’angioplastie peroperatoire par ballonnet s’est averee utile
comme traitement d’appoint dans les cas de lesions en tandem des segments iliaques
et poplites.

ince the initial description by
Dotter and Judkins1 in 1964,
transluminal angioplasty has be
come well recognized as a treat
ment for peripheral vascular athero
sclerotic occlusive disease. Multilev
el disease and tandem lesions are
particular management problems.
Usually, only correction of inflow is
necessary to restore satisfactory cir
culation, but it is insufficient in up
to 30% of patients with tandem
lesions.2 For these patients addi
tional surgery or percutaneous
transluminal angioplasty (PTA) may
be necessary. The advantages of
PTA before surgery include reduced
operative morbidity and mortality,
reduced costs and long-term results
similar to those for surgery. A
5-year secondary patency rate of
88% has been demonstrated by
Brewster and associates3 for com 
bined iliac PTA and distal recon
structive surgery.
Several authors4 5 have suggested
that balloon angioplasty be per
formed intraoperatively. The advan-
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tages of this technique are its great
er efficiency and its ability to allow
prompt recognition and correction
of angioplasty-related complica
tions. The principal criticism of in
traoperative balloon angioplasty
(IBA) is less optimal fluoroscopy,
which may compromise its success
compared with PTA performed in
the radiology suite. For the past 3.5
years we have used IBA for selected
patients with multilevel occlusive
disease. In this study we examine
the technical success and short- and
medium-term outcome of our expe
rience with IBA performed in the
first 2.5 years.

Methods
We conducted a retrospective re
view of all patients who underwent
simultaneous IBA and peripheral
bypass procedures at University
Hospital, University of British Co
lumbia site, between Jan. 1, 1988,
and July 31, 1990. Data concerning
patient demographics, associated
diseases, preprocedure symptoms
and outcome were recorded. For the
purpose of this study, coronary ar
tery disease was assumed to be
present if there was clinical, electro
cardiographic or radiologic evidence
of myocardial ischemic disease. Hy
pertension was diagnosed if the
patients were taking antihyperten
sive medications or if resting systol
ic pressures exceeded 160 mm Hg
or diastolic pressures exceeded 90
mm Hg. Diabetes was considered to
be present if the patients were tak
ing hypoglycemic medications or
insulin or if there was documenta
tion of fasting hyperglycemia.
Smoking history and serum choles
terol and triglyceride levels were
obtained. Cerebrovascular disease
was diagnosed if patients had a
history of transient ischemic at
tacks or stroke. Limb salvage was
defined for all cases of critical isch
266
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emia causing rest pain, distal ulcers
and gangrene. Cumulative patency,
interval patency and the standard
error were all calculated according
to the standards recommended by
the Ad Hoc Committee of the Soci
ety for Vascular Surgery.6
All IBAs were performed in the
operating room by surgeons famil
iar with endovascular techniques or
by vascular fellows under the guid
ance of trained radiologists and sur
geons. Patients were heparinized,
and planned reconstructive surgery
was performed. Just before comple
tion of the femoral anastomosis a
no. 8 or 9 French sheath was
introduced into the femoral artery
and passed antegrade or retrograde,
as appropriate. Under fluoroscopic
control a 0.035-in (0.89-mm) guidewire was passed across the stenosis
or occlusion. Next, a previously
selected low-profile balloon angio
plasty catheter (sizes 3 to 20 mm in
length) was positioned under fluroscopic control across the full extent
of the lesion. The balloon catheter
was inflated to eliminate any residu
al waist. The balloon was inflated
for 30 seconds then deflated. The
balloon was inflated a second time
for 30 seconds and completion an
giograms were obtained. Care was
taken when selecting the balloon
angioplasty catheter to match the
normal diameter of the artery. For
suprafemoral lesions predilatation
intra-arterial pressures above and
below the stenosis were recorded.
Postdilatation intra-arterial pres
sures were also recorded.
After satisfactory balloon angio
plasty the sheath was removed and
femoral anastomosis completed.
Acetylsalicylic acid therapy was
started postoperatively and contin
ued indefinitely.
A successful balloon angioplasty
was defined as a reduction in the
hemodynamic pressure gradient to
less than 10 mm Hg at rest and an
increase in lumen size of at least

50%, determined angiographically.
For the purpose of this study, pa
tency was based on Johnston's crit
eria7 and defined as improvement in
symptoms with at least two of the
following: an increase in distal
pulse volume as assessed by clinical
examination; an ankle-brachial
index (ABI) greater than 0.15 over
the preoperative level; or angio
graphic confirmation of patency.

Findings
IBA was performed 43 times in
38 patients (19 women, 19 men)
whose average age was 68 years.
Thirty-two patients were smokers.
Seventeen patients were hyperten
sive, and symptomatic coronary ar
tery disease was documented in 16
(Table I).
Reconstruction was performed
for limb-threatening critical isch
emia in 11 patients and incapacitat
ing claudication in 32 patients. The
mean preoperative resting ABI was
0.67 ± 0.15. Ten limbs had either
no or only one patent tibial artery.
IBA was performed in 12 common
iliac arteries, 7 external iliac arter
ies, 20 superficial femoral arteries
and 4 popliteal segments (Table II).
The type of lesion and length and
severity of stenosis are shown in
Table II.
IBA was performed to correct
inflow stenosis in 19 instances; the
reconstruction was distal bypass
grafting in 11 cases and femoral
thromboendarterectomy in 8. IBA
was performed to correct an out
flow problem in 24 limbs; in 4, the
associated surgical procedure was a
proximal bypass, in 15 it was a
proximal thromboendarterectomy
and in 5 a profundaplasty.
Thirty-nine procedures were a
technical success, but 2 inflow and
two outflow procedures failed and
surgery was required (Table III). In
one case of iliac IBA axillofemoral

INTRAOPERATIVE BALLOON ANGIOPLASTY

grafting was required 24 hours
postoperatively to establish inflow.
In another the procedure appeared
angiographically to be successful,
but 24 hours postoperatively the
outflow tibial vein graft became
occluded and the patient underwent
an aortobifemoral bypass and a suc
cessful vein graft thrombectomy.
One outflow superficial femoral
artery IBA thrombosed immediately.
This patient underwent a femoropopliteal bypass at that time. Recon
struction with a femoropopliteal
outflow IBA failed to achieve limb
salvage in a patient with no patent
tibial vessels. Three weeks after
IBA, a below-knee amputation was
required for severe rest pain.

Discussion
PTA is a well-established tech
nique for treating short-segment
stenoses of the iliac, femoral and
popliteal arteries. Use of this proce
dure has been expanded recently to
include short-segment occlusions of
the same vessels. In the past, the
procedure has always been per
formed in the radiology suite. In
1981 Lowman and associates8 de

scribed the first applications of IBA
to the iliac, femoral and popliteal
arteries. Since then several authors5-9’10 have reported mediumand long-term success of IBA at the
time of other vascular reconstruc
tive procedures.
Inflow balloon angioplasty com
bined with reconstructive vascular
surgery has been effective in pa
tients with multilevel occlusive dis
ease. Compared with multiple-stage
surgical procedures, PTA with sub
sequent surgical revascularization
appears effective, efficient and eco
nomic. The PTA is usually per
formed first. This allows assessment
of the need for an additional surgi
cal procedure and for the technical
success of the PTA to be deter
mined.
The management of patients with
multilevel vascular disease is diffi
cult as is the selection of patients
who require correction of both in
flow and outflow problems to
achieve satisfactory results. Al
though a direct comparison of IBA
and vascular reconstruction with
PTA followed by subsequent surgi
cal recontruction will not fully ad
dress the patient selection prob
lems, it may indicate which patients

Table 1. Clinical Characteristics of 38 Patients Who Underwent Intraoperative
Balloon Angioplasty (IBA) (43 Procedures)
Mean age, yr
Sex, no. of patients
Men
Women
Associated diseases, no (%) of patients
Smoking
Hypertension
Coronary artery disease
Diabetes mellitus
Abnormal cholesterol and triglyceride
levels
Cardiovascular disease
Indications, no. (%) of procedures
Claudication
Limb salvage
Resting ankle-brachial pressure index, mm Hg
Preoperative
Postoperative
Preoperative runoff status,
no. (%) of procedures
0-1 vessels
2 -3 vessels

would best be served by a single
procedure and by a staged proce
dure.
There may be specific instances
when PTA is contraindicated in
high-risk patients with severe mul
tilevel disease (e.g., significant iliac
stenosis associated with a juxta
posed ulcer or aneurysm). Because
of the risk of discharging emboli
from a balloon dilatation, IBA
might be more suitable. Distal em
bolization could be prevented by
distal vascular clamps. Any dis
charged embolic material could be
flushed through the arteriotomy.
IBA may be superior to staged
procedures in patients who require
Table II. Characteristics of Lesions Treated
by IBA
Characteristic

No. (% ) of
lesions

Location
Common iliac
External iliac
Femoral
Popliteal
Length of stenosis or occlusion
< 5 cm
> 5 cm
Type of lesion
Occlusion
Stenosis
Severity of stenotic lesions,* (%)
< 50
50 -7 5
76 -9 0
> 90

12 (28)
7 (1 6 )
20 (47)
4 ( 9)
31 (72)
12 (28)
3 ( 7)
40 (93)
0 ( 0)
11 (28)
22 (55)
7 (1 8 )

*40 lesions

68
19
19

Table III. Initial Results of IBA Procedures
Procedure/result

32 (84)
17 (45)
16 (42)
8(21)
7(18)
6(16)
32 (74)
11 (26)
0.67 ± 0.15
0.96 ± 0.09
10 (23)
33 (77)

Inflow IBA
Primary success
Primary failure*
Outflow IBA
Primary success
Primary failuret

No. (% ) of
procedures
1 7 (8 9 )
2 (1 1 )
22 (92)
2 ( 8)

*ln one case axillofemoral grafting was
required 24 h postoperatively, and throm 
bosis of an outflow graft 24 h postopera
tively necessitated aortobifemoral grafting.
tOne superficial femoral artery IBA throm 
bosed immediately and required a femoro
popliteal bypass. One patient had a poplite
al dilatation to relieve rest pain, but lack of
patent tibial arteries resulted in amputation
below the knee.
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inflow operative repair as well as
angioplasty. If a distal PTA was
performed preoperatively, it could
be expected to fail because of poor
inflow. Postoperative PTA can be
accompanied by technical difficul
ties associated with an antegrade
puncture in a heavily scarred groin.
Skill in the techniques of IBA is a
valuable asset for surgeons treating
patients with multilevel vascular
disease. We, like others,3"5 have
demonstrated the value of IBA com
bined with either proximal or distal
vascular reconstruction. Patency
rates are acceptable. Complications
are low and seem comparable to
those of staged procedures. The
potentially slightly inferior radiolog
ic images achieved in the operating
room do not seem to compromise
the results of the balloon angioplas

ty. Attention to technical detail is
important.
6.
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Symposium on Laparoscopic Surgery
1. Opening Remarks
E.C. Poulin, MD, FRCSC
I me fait plaisir de vous souhaiter
la bienvenue au premier sympo
sium sur la chirurgie par voie laparoscopique dans l’histoire de l’Association canadienne de chirurgiens
generaux. C’est un heureux hasard
que cette session soit presentee au
Quebec, car les chirurgiens d’ici ont
fait figure de proue dans l’acceptation.le developpement et l’enseignement de cette technique d’avantgarde.
Over the last year a storm of
laparoscopic surgery has literally
blanketed the world, sometimes to
the dismay of scientists among us
who would have preferred more
reflection, more testing and more
study. Yet the audacious and the
clairvoyant, more comfortable with
the art perspective in surgery,
quickly recognized the potential of
laparoscopic surgery and set out to
prove its benefit to the majority of
patients after having witnessed its
advantages to a few.
In Quebec, like many other cities,
laparoscopic cholecystectomy was
pioneered by a thoughtful com
munity surgeon who had witnessed
the art of French surgeons a little
over a year before.

I

As I speak, all hospitals in this
area are either performing endo
scopic surgery or waiting for equip
ment to do so. Chance would have
it, then, that the first symposium on
laparoscopic surgery held by the
Canadian Association of General
Surgeons would be held in this city,
which is well accustomed to bridg
ing the cultures of France and
Europe with that of North America.
I believe it is time for us to take
stock, to summarize what we have
learned so far and to look toward
the future.
For this purpose, we have assem
bled colleagues from across the
country to present papers at this
symposium.
From Vancouver we have Dr.
Alex Nagy, a long-time proponent
of laparoscopy for the general sur
geon. Dr. Nagy has just returned
from the People’s Republic of China
where he joined Dr. Zucker and an
American delegation in teaching en
doscopic surgery. On pages 271 to
274 Dr. Nagy gives the historical
background to laparoscopic sur
gery.
From the University of Toronto
and Mount Sinai Hospital, Dr. Stev

From the Department o f Surgery, Hopitaldu Saint-Sacrement, Quebec, Que.
Introduction to the symposium “ Laparoscopic Surgery” presented at the 14th annual meeting
o f the Canadian Association o f General Surgeons, held in conjunction with the 60th annual
meeting o f the Royal College o f Physicians and Surgeons o f Canada, Quebec, Que., Sept. 22,
1991

en Strasberg, the first surgeon to
perform laparoscopic cholecystecto
my in Toronto, describes the com
plications of laparoscopic surgery
and how they may be avoided
(pages 275 to 280).
From London and the University
of Western Ontario, Dr. Murray
Girotti, chief of surgery at Victoria
Hospital, gives us a detailed de
scription of the basic armamentari
um needed to perform laparoscopic
surgery (pages 281 to 284).
From the Saskatoon City Hospi
tal, Dr. Demetrius Litwin, the Cana
dian surgeon who has probably the
single largest experience in laparo
scopic cholecystectomy, discusses
(pages 291 to 296) the experience
of 58 surgeons from across Canada.
We are extremely privileged to
welcome as our guest speaker Dr.
Karl Zucker,* associate professor of
surgery at the University of Mary
land. Dr. Zucker has just published
a textbook on surgical laparoscopy.
He has been on the front line of
American surgeons performing and
teaching endoscopic surgery. Dr.
Zucker looks toward the future of
laparoscopic surgery (pages 297 to
304).
Finally, 1 discuss (pages 285 to
289) the different strategies and
concerns of conventional versus la
paroscopic cholecystectomy. ■
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2. History of Laparoscopic Surgery
Alexander G. Nagy, MD, FRCSC;* Eric C. Poulin, MD, FACS, FRCSC;t
Murray J. Girotti, MD, FACS, FRCSCit Demetrius E.M. Litwin, MD, FRCSC;§
Joseph Mamazza, MD, FACS, FRCSCH
Since the beginning of the 20th century physicians have promoted laparoscopy as a
valuable adjunct to the diagnosis of diseases of the abdominal cavity. Laparoscopy,
however, failed to become popular among abdominal surgeons until the advent of
laparoscopic cholecystectomy. This single new operative approach to the treatment
of gallbladder stones gave rise to such enthusiasm among general surgeons that
other innovative laparoscopic procedures are now being promoted in ever-increasing
numbers. The general surgeon has again become the leader in the introduction of a
new surgical approach. This new technique must be developed with great care, and
there must be rigorous criteria for its use, critical analysis of the technique and
honest reporting of results.

Depuis le debut du 20e siecle, les medecins ont favorise l’utilisation de la
laparoscopie comme aide au diagnostic des maladies de la cavite abdominale. Malgre
tout, jusqu’a l’avenement de la cholecystectomie laparoscopique, la laparoscopie
n’avait pas reussi a gagner l’appui des chirurgiens abdominaux. Toutefois, cette
nouvelle approche chirurgicale au traitement des calculs biliaires suscita un tel
enthousiasme parmi les chirurgiens generaux, que d'autres interventions laparoscopiques innovatrices sont maintenant proposees en nombre toujours grandissant. Le
chirurgien generaliste a repris sa place de chef de file pour l’introduction d’une
nouvelle approche chirurgicale. Cette nouvelle technique doit etre developpee avec
precaution, en lui appliquant des criteres rigoureux, en la soumettant a une analyse
critique et en rapportant honnetement les resultats.

aparoscopy, the endoscopic vi
sualization of the contents of
the peritoneal cavity, was not wide
ly popular in general surgery until
the advent of laparoscopic cholecys
tectomy.

L

It was erroneously assumed by
surgeons that laparoscopy was a
gynecologic procedure with little
application to general abdominal
surgery. Over the last four decades
gynecologists have been leaders in
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the rebirth and development of la
paroscopy and laparoscopic proce
dures. However, many other physi
cians and surgeons since the turn
of the century have promoted the
endoscopic assessment of the peri
toneal cavity. Outstanding pioneers
in this regard must be acknowl
edged.
The curiosity and adventurous
approaches by these clinicians laid
the groundwork for modern-day la
paroscopy. The primitive instru
mentation available initially did not
deter them from exploring the hid
den secrets of the abdominal cavity.
Georg Kelling of Dresden coined
the term “ celioscopy” when he first
reported the insertion of a cystoscope through the anterior abdomi
nal wall of a living dog in 1901.1 He
viewed the viscera after insufflating
the abdomen with air filtered
through a sterile cotton swab. He
described the instrumentation need
ed and speculated on the future
possibilities for this technique.
About the same time Ott, a gynecol
ogist from Petrograd, reported on
“ventroscopy,” an examination of
the peritoneal cavity of a pregnant
patient.2 He used a head mirror and
a speculum introduced into a culdoscopic opening.
In 1910, Jacobeus of Sweden
described “ laparoscopy” in humans
and reported on a series of pa
tients.3 The first diagnostic laparos
copy in the United States was car
ried out in 1911 by Bertram Bernheim,4 who used a proctoscope and
ordinary light to examine the ab
dominal cavity.
Many of the innovators, especialCJS, VOL. 35, NO. 3, JU N E 1992
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ly in Europe, struggled to devise
new instrumentation to improve the
diagnostic yield by the use of the
laparoscope. Others developed in
struments and lens systems to im
prove biopsy capabilities.5 Kalk of
Germany developed an oblique view
ing lens in 1929 and promoted the
use of laparoscopy for the diagnosis
of liver disease.6 In 1934 Ruddock,
an American internist, reported on a
new lens system and built-in biopsy
forceps7 and subsequently published
data on the use of peritoneoscopy
in surgery.8
Janos Veress of Hungary devel
oped a new needle for inducing
pneumothorax in 1938.9 The Ver
ess needle is now frequently used
for the creation of pneumoperito
neum. Raoul Palmer of Paris pro
moted monitoring of intra-abdomi
nal pressure as early as 1947.10
Professor Kurt Semm of Kiel, Ger
many, a gynecologist and engineer,
developed an automatic insufflation
device to monitor intra-abdominal
pressure and gas flow. He became
one of the most innovative and
productive researchers and clini
cians in the field of laparoscopy.
Many of the instruments and tech
niques devised by Semm are still
used today. Certainly, he and his
research team at the University of
Kiel perfected the principles of lapa
roscopic surgery.11
Surgeons, however, were slow to
adopt laparoscopy as a valuable
diagnostic tool. It was considered
by many a “blind” procedure. It
was also thought that the examina
tion through the laparoscope was
incomplete, because certain areas of
the abdominal cavity were not ac
cessible to view or to palpation.
Nevertheless, leaders emerged in
the late 1960s and 1970s who
continued to promote the tech
nique, especially in gynecology.
Many pioneering individuals persist
ed, with great enthusiasm, to popu
larize laparoscopy as a valuable
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diagnostic and therapeutic modali
ty. Steptoe12 of Great Britain, Go
mel1314 of Canada, Hulka and asso
ciates15 and Hasson16 in the United
States, Dagnini17 in Italy and many
others18-24 showed through publica
tions of clinical data the enormous
benefit to patients of laparoscopy.
General abdominal surgeons and
gastroenterologists began to pay
attention to the successes reported.
Berci25 of Los Angeles published
data attesting to the value of lapa
roscopy in general surgical patients.
He became one of the most fervent
promoters of laparoscopy in general
surgery. Despite the excellent re
sults from a few isolated centres,
laparoscopy failed to gain a foot
hold in general surgical practice.
Laparoscopy lost further ground
when computed tomography was
perfected and ultrasonographically
directed biopsies became widely
available.26 In locations where these
techniques were not available, lapa
roscopy continued to be a useful
adjunct in diagnosing acute abdom
inal problems and evaluating malig
nant disease. The experience with
laparoscopy also showed that it
compared favourably with imaging
techniques in the assessment of
operability of malignant tumours27
and in the evaluation of causes of
lower abdominal pain, especially in
young women.28
Laparoscopists were not content
with laparoscopy for diagnostic pro
cedures alone and began to explore
the possibilities of its use for opera
tive procedures.29
In 1978, Frimdberg in Europe
performed laparoscopic cholecygtotomy in pigs.30 Laparoscopic
cholecystostomy was subsequently
carried out in isolated locations in
Europe and the USSR and in North
America. (K. Bowes and P.J. O’Re
gan: Personal communications.)
Kurt Semm31 performed the first
laparoscopic appendectomy in
1983. Philippe Mouret also per

formed laparoscopic appendectomy
in France. Patrick O’Regan of Van
couver carried out laparoscopic ap
pendectomy in 1986, using person
ally designed instruments without
videoimaging (personal communica
tion).
Laparoscopic cholecystectomy in
the animal model was performed by
Filipi, Mall and Reosma in 1985.29
Schultz of Minnesota experimented
with the procedure, as did Daykhovsky of Los Angeles and Patrick
Leahy of New York.32 In 1987
Philippe Mouret in Lyon, France,
performed the first laparoscopic
cholecystectomy in man.33 This
event led to the revolution that we
are now witnessing.
Perissat and colleagues, in
France, initially described percuta
neous lithotripsy and cholecystosto
my under laparoscopic control.34
Soon, however, they realized that
definitive removal of the gallbladder
after lithotripsy was desirable and
promoted this technique, especially
for large gallbladder stones.35
Dubois quickly adopted the tech
nique and performed his first lapa
roscopic cholecystectomy in May
1988.36 Soon after, he reported his
initial series of 36 patients who
underwent coelioscopic cholecystec
tomy.37
Barry McKernan, a general sur
geon, and William Saye, a gynecol
ogist in Georgia, described the tech
nique of laparoscopic cholecystecto
my using the argon laser and a
five-puncture technique in June
1988 (personal communication).
In September 1988 Reddick and
colleagues38 of Nashville, carried
out laparoscopic cholecystectomy
with the KTP laser using a fourpuncture technique. They enthusi
astically promoted this approach
and had a phenomenal response
from general surgeons,39 who trav
elled from all over the world to
Nashville to witness firsthand a
technique that in a very few months
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would drastically change the treat
ment of cholecystolithiasis. Al
though apprehensive at first, sur
geons recognized that this minimalaccess surgical approach for chole
cystectomy was here to stay. Cuschieri, Berci and McSherry40 have
cautioned against inadequate prepa
ration for this procedure. They rec
ommended stringent preparation
criteria before performing laparo
scopic cholecystectomy. Indeed, an
ecdotal reports began to surface on
initial experiences with laparoscopic
cholecystectomy that pointed to a
possible increased incidence of dam
age to the common bile duct. It is
likely that many serious complica
tions have not yet been reported.39
It is our responsibility therefore
to evaluate carefully the results of
this technology before embarking
on other techniques through the
laparoscope. Already some innova
tive procedures are being per
formed; laparoscopic choledocholithotomy,41 posterior truncal vagoto
my and anterior seromyotomy,42 in
guinal hernia repair,43 and Nissen
fundoplication. 44 Other procedures
will surely follow.33
Laparoscopic cholecystectomy
has placed the general abdominal
surgeon in a position of leadership
in the development of laparoscopic
techniques in other surgical special
ties. To maintain the trust of our
colleagues we must continue to
evaluate critically our results with
each new laparoscopic procedure.
We must insist on criteria for train
ing on an ongoing basis. Residency
training programs need to interact,
more than ever, to achieve common
standards.
Laparoscopic surgery has revolu
tionized the practice of general sur
gery. The future holds great prom
ise! However, our goals will only be
achieved by rigorous criteria, criti
cal analysis and honest reporting of
results. The greatest dangers for
setting back our advances lie in our

adopting an attitude of bravado and
in possible complications. We must
accept with humility the fact that
the developments in laparoscopic
surgery are forcing us back into a
learning situation.
In laparoscopic surgery our
motto must be: “ He who goes slow
ly goes wisely and goes far!” Keep
ing this in mind will undoubtedly
help us achieve good results for our
patients through the coming de
cades.
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BOOK REVIEWS
continued from page 227

crine gut and pancreas was written by
S.R. Friesen and began with a review of
the landmark discovery of pancreatic
neuroendocrine cells in 1869 by Langerhans. Similar cells were subsequently
identified in the gastric mucosa by
Heidenhain in 1870 and in the crypts of
Lieberkuhn by Kulchitsky in 1897. To
date 12 separate endocrine cells have
been identified throughout the rest of
the gut. The discovery of secretin by
Bayliss r - d Starling in 1902 was early
evidence that the small intestine was an
endocrine organ. All of the neuroendo
crine cells had a common property of
arnine-precursor uptake and decarboxyl
ation recognized by Everson Pearse,
who designated them as APUD cells in
the early 1970s. Other peptide hor
mones of the gastroenteropancreatic
system were identified and came to the
forefront in the 1970s when immuno
logic techniques were developed.
Friesen summarized the endocrine
gastroenteropancreatic syndromes, in
cluding carcinoid and malignant car
cinoid syndromes, insulinoma, gas
trinoma, vipoma, glucagonoma, somatostatinoma and PPoma. Diagnosis was
first made on clinical grounds and inci
dentally at operation or autopsy but
progressed rapidly with the introduc
tion of peptide radioimmunoassays. Ex
pertise in angiography and selective
venous sampling was acquired in the
1960s and 1970s for localization of
small endocrine tumours. Some of the
landmark historical events included the
recognition of carcinoids arising from
the Kulchitsky cells in the ileum in
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1907 by Oberndorfer, the discovery of
insulin by Banting and Best in 1922,
the first report of insulinoma at the
Mayo Clinic in 1927 and the initial
description of Zollinger-Ellison syn
drome in 1955.
Welbourn concludes his book with a
brief description of the multiple endo
crine adenopathies, paraendocrine syn
dromes, the use of endocrine surgery to
treat breast and prostate carcinoma,
essential and renal hypertension and the
endocrine response to stress.
Christopher R. McHenry, MD
MetroHealth Medical Center
3395 Scranton Rd.
Cleveland, OH 44109
USA

SHACKELFORD’S SURGERY OF
THE ALIMENTARY TRACT, 5 Vols.
3rd edition. Edited by George D.
Zuidema. 2513 pp. Illust. W.B. Saun
ders Company/Harcourt Brace Jovanovich, Inc., Philadelphia. 1991. $475.
ISBN 0 -7 2 1 6 -2 5 0 5 -3

The first edition of this book was edited
by Richard T. Shackelford of The Johns
Hopkins Medical School and published
in 1955. When I was a resident,
“Shackelford” was the “bible” of ab
dominal surgery. The coeditor of the
expanded second edition was George D.
Zuidema, and he now serves as the
editor of this five-volume third edition.

Each edition has been revised, refined
and enlarged, resulting in this superb
production.
Zuidema has selected, for each vol
ume, one coeditor who is a renowned
leader in the related field. The coeditor
for volume I (esophagus) is Mark B.
Orringer, volume II (stomach and duo
denum; incisions) William P. Ritchie,
Jr., volume III (pancreas, biliary tract,
liver and portal hypertension; spleen)
Jeremiah G. Turcotte, volume IV (colon)
Robert E. Condon and volume V (mes
enteric circulation; hernia; small intes
tine) Lloyd M. Nyhus. Each volume is
well organized and divided into chapters
and sections, written by a total of 190
contributing authors, including 8 Cana
dians, who are acknowledged experts in
their specific areas.
This is a complete gastrointestinal
surgical text, with the history, anato
my, physiology, science and an atlas
like description of techniques. There are
classical and key references at the end
of each chapter, and each volume has
its own index.
Since laparoscopic gastrointestinal
surgery was just getting under way at
the time of this third edition, its appli
cation and techniques are not included.
However, this is an otherwise compre
hensive gastrointestinal surgical book
for the surgical housestaff or practising
surgeon. The price may be high for
residents, so the surgeon should make

continued on page 280
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3. Complications of Laparoscopic
Cholecystectomy
Steven M. Strasberg, MD, FACS, FRCSC; Juan R. Sanabria, MD; Pierre-Alain Clavien, MD
Laparoscopic cholecystectomy is an extremely safe procedure. The most common
serious complications are bile-duct injury and injury to vessels or bowel secondary
to the insertion of trocars. These complications may be avoided with appropriate
precautions. Indirect complications of surgery, such as pulmonary and cardiac
complications, appear less common than with open cholecystectomy.

La cholecystectomie par laparoscopie est une intervention suivie de peu de
complications. Les plus serieuses sont les lesions biliaires et les lesions vasculaires
ou intestinales secondaires a l’insertion des trocars. Toutefois, ces complications
peuvent etre evitees par une technique soigneuse. Celles indirectement liees au
geste chirurgical comme les complications pulmonaires ou cardiaques sont plus
rares que lors de cholecystectomies conventionnelles.

aparoscopic cholecystectomy is
a new and highly beneficial
treatment for patients with symp
tomatic cholelithiasis. Complica
tions are infrequent and usually are
not serious. The purpose of this
paper is to describe the complica
tions of this operation and to sug
gest how they may be avoided.
Complications of laparoscopic
cholecystectomy may be divided
into those that are directly related
to the operative technique and
those that are indirectly related and
may occur after any abdominal pro
cedure. This division is useful but
somewhat arbitrary.

L

Direct Complications
These complications include tro
car injuries, intraoperative bleeding,
bile-duct injury, loss of stones and
bile into the peritoneal cavity, sub
cutaneous emphysema and postop
erative bile leakage and fluid collec
tions (Table I1-12).
Trocar Injuries

The two most common serious
injuries occurring as a result of
laparoscopic cholecystectomy are
bile-duct injury and disruption of
major blood vessels. The latter is
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most likely to occur during inser
tion of trocars. The trocars used in
this operation are very sharp since
they must penetrate the fascia of
the abdominal wall. If they pene
trate veins or arteries life-threaten
ing hemorrhage may ensue.
One may establish pneumoperito
neum by an open minilaparotomy
technique or by a closed technique
with the Veress needle. In the open
technique the first or primary trocar
(Hasson trocar) is simply placed
through the minilaparotomy inci
sion, and the pneumoperitoneum is
then created.13 In the closed tech
nique the primary trocar is inserted
blindly after establishing the pneu
moperitoneum with the Veress nee
dle. To our knowledge, all reported
complications have occurred with
the closed technique. In both tech
niques the secondary trocars are
inserted under direct vision, the
laparoscope being inserted through
the primary portal to allow observa
tion of the secondary trocars enter
ing the peritoneal cavity.
The Veress needle technique is
safe, provided it is used exactly as
described and its use is combined
with good surgical judgement.
Bladder and stomach should be
empty. The bladder may be emptied
by preoperative voiding or by cathe
ter if necessary, and the stomach
can be emptied by nasogastric tube
inserted after induction of anesthe
sia. The surgeon must direct the
needle and the first trocar into the
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midline, toward the pelvis, to avoid
injury to the aorta and the iliac
vessels. The level of bifurcation of
the aorta is at about the top of the
iliac crest so that, in most cases,
the needle and the primary trocar
do not have to be directed at an
angle of more than 15° from the
vertical to avoid the aorta. Greater
deviation from the vertical can re
sult in failure to penetrate the peri
toneum and preperitoneal insuffla
tion.
Neither the Veress needle nor the
primary trocar should be advanced
a distance greater than the per
ceived thickness of the abdominal
wall. If the trocar has penetrated
this distance and the expected find
ings are not encountered, the sur
geon should start again or convert
to the open technique of pneumope
ritoneum. When inserting any
pointed trocar, the force applied
must be strictly controlled by the
left hand of the surgeon on the
shaft of the trocar. We recommend
a supine grip on the shaft of the
trocar for this purpose. The possi
bility of plunging is also reduced by
turning or screwing the trocar into
the abdominal wall, since this mo
tion inherently controls forward

force better than a straight-ahead
pushing motion from the shoulder.
Finally, all secondary trocar inser
tions must be adequately observed
by the surgeon. The secondary tro
cars should be directed in a posteri
or direction to pass through the
abdominal wall, but once the point
of the trocar can be seen just
penetrating the peritoneum, it may
be directed horizontally into the
open peritoneal cavity rather than
backward toward intra-abdominal
s tru c tu re s . Secondary tro cars
should never be advanced without
good visibility. It is most helpful if
the camera operator leads the tro
car so that the surgeon can see well
into the space that the trocar will
be entering. In our opinion the use
of a trocar with a retractable guard
at the tip increases the safety of
inserting the first trocar.
The surgeon should never hesi
tate to stop and convert to the open
method of pneumoperitoneum
whenever the procedure is not pro
gressing smoothly and should be
particularly vigilant whenever the
patient has had abdominal surgery
or infection previously. Even pelvic
surgery can cause adhesions that
tether the bowel immediately under

the abdominal wall or restrict the
movement of the bowel so that it
cannot move away from a trocar.
Unquestionably, the Veress nee
dle technique is the more popular
one.27'9’12-14 In our experience with
this method no complications have
occurred in more than 400 laparo
scopic cholecystectomies, and we
have converted to the open pneu
moperitoneum technique in about
3% of cases. But should we be
teaching this closed technique to
residents when an open and inher
ently safer technique is available? If
the serious complication rate is
even 1 in 10 000, the method will
result in 8 to 10 serious injuries
every year in a country with the
population of Canada’s. We are cur
rently using both techniques but
have decided to convert completely
to the open technique for this rea
son.
Of course care must also be used
with the open technique. A larger
subumbilical incision is necessary in
obese patients, and although the
fascia is easy to find and divide, a
large deposit of preperitoneal fat
may make getting to and through
the peritoneum difficult. Lifting the
fascia with two Kocher clamps may

Table I. Complications of Laparoscopic Cholecystectomy Directly Related to the Procedure
No. of
patients

Series
Dubois, Berthelot and Levard,
19891
Dion and Morin, 19902
McKernan and Saye, 19903
Reddick and Olsen, 19904
Bailey et al, 1991s
Cooperman, 19916
Grace et al, 19917
Neugebauer et al, 1991s
Peters et al, 19919
The Southern Surgeons Club,
199110
Wilson et al, 199111
Zucker et al, 199112
Current study
Total
Percent

Bleeding

Bile
leak

Trocar
injury

Spillage

Subcutaneous
emphysema

63
60
12
83
375
90
50
100
283

0
0
0
0
5
0
0
1
1

1
0
0
1
0
0
1
0
0

2
1
0
0
1
0
2
0
3

0
0
0
1
0
0
1
0
1*

0
0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0
0

1518
180
100
200

7
1
2
0

5
1
0
2

3
1
0
0

4
2*
0
0

2
0
0
0

4
1
0
0

3114

17
0.5

11
0.4

13
0.4

9
0.3

2
0.1

5
0.2

'Duodenal fistula, one case in each series
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be helpful, and placing the fascial
incision very close to the umbilicus
is also effective, since the fascia and
peritoneum are closely adherent
here, even in obese patients. Aware
ness of the possibility of adherent
bowel is important, especially when
there has been previous surgery.
The Hasson trocar is a great aid in
doing an open pneumoperitoneum,
but if it is unavailable the two
fascial sutures may be wound
around the insufflation port on a
standard portal after wrapping the
base of the portal with a wet gauze.
This system is sufficiently airtight
to allow the operation to proceed.
Bleeding
Hemorrhage during laparoscopic
cholecystectomy may be substantial
and even life-threatening, but this is
quite rare. The main causes of the
severe hemorrhage are injury to a
major vessel during trocar insertion
or to a hepatic artery or portal vein
during the dissection of the gall
bladder. (The latter type of injury is
unlikely to be reported in the litera
ture.) One potential reason for such
an injury is undue persistence with
the laparoscopic technique during a
very difficult cholecystectomy. Inex
perience based on inadequate train
ing may also be a cause. Avulsion
of the cystic artery is another cause
of substantial bleeding; such injury
has been reported.12 This complica
tion can be prevented by dividing
the cystic artery before dividing the
duct, thus avoiding a situation in
which the artery is the sole struc
ture entering a gallbladder that is
still being retracted. When division
of the artery before the duct is not
possible, gallbladder retraction
must obviously be done with great
care once the cystic duct is divided,
and the cystic artery should be
divided as soon as possible thereaf
ter.
Minor hemorrhage is more com

mon during laparoscopic cholecys
tectomy. Such bleeding is much
more troublesome than in open
cholecystectomy because it cannot
be cleared as easily and it interferes
with visibility. It may extend operat
ing time, lead to conversion to open
cholecystectomy or even contribute
to ductal injury. This is particularly
true in the scarred or inflamed
gallbladder in which anatomical
identification is already more diffi
cult. Minor bleeding in this situa
tion may be due to attempts to
retract or grasp the thick gallblad
der, especially with toothed instru
ments. We find that retraction in
these circumstances can best be
obtained by placing a O-Prolene
(Ethicon Inc., Peterborough, Ont.)
mattress suture through the gall
bladder and retracting the suture.
Bleeding can also occur when a
densely adherent gallbladder is
being dissected from the liver bed,
although this is much less of a
problem if the cystic structures
have already been properly identi
fied and dealt with.
The treatment of intraoperative
bleeding depends upon type and
position. It is best to have a patient
attitude toward minor bleeding, par
ticularly venous bleeding, which
will usually stop spontaneously. Pa
tience or pressure with a dental
pledget or hemostatic gauze is usu
ally sufficient. Cautery is useful but
must never be applied near or on
the common bile duct or in the
triangle of Calot when the position
of the major structures is uncertain.
Small arteries or even the cystic
artery may be clipped or cauterized
when the major structures are iden
tified or when one is working away
from the area of these structures.
When bleeding is continuous or
when it continues to hamper visibil
ity, the procedure must be convert
ed. The same proscription about
blind clipping, clamping or cauteriz
ing in the porta, which has long

been a precept in open cholecystec
tomy, applies doubly here!
Injury to Bile Ducts
This is the single most important
complication of cholecystectomy be
cause of its seriousness and fre
quency. The reported incidence is
0.5%.9'10 There is a tendency to
underreport such injuries, and the
true incidence can be obtained only
if strict reporting techniques are
used. One must be sceptical of data
gathered from multiple centres un
less specific steps have been taken
to assure that all cases performed in
every centre up to the closing date
of the trial have been included, as
was done in a recent large case
series.10 Ductal injuries occur com
monly because of misidentification
of the cystic duct, failure to recog
nize the presence of aberrant ducts
and improper use of cautery during
dissection.
The common bile duct may ap
pear to be a cystic duct in the
following circumstances; when the
common bile duct is narrow; when
there is inflammation drawing the
common bile duct toward the gall
bladder; when the pouch of Hart
mann is retracted anterosuperiorly,
which brings the common duct into
alignment with the cystic duct;15
when there is a large stone in the
pouch of Hartmann that prevents
adequate retraction of this part of
the gallbladder with the laparoscop
ic instruments to expose the cystic
duct; and when the cystic duct is
short or absent. Aberrant ducts
from the right side of the liver may
cross the triangle of Calot to join
the common hepatic duct, the cystic
duct or the junction of these ducts.
In this situation, the aberrant duct
may be injured even if the common
ducts and the cystic duct have been
identified.
To avoid injuries of this type
there must be conclusive identificaCJS, VOL. 35, NO. 3, JUNE 1992

277

STRASBERG, SANABRIA, CLAVIEN

tion of the ductal anatomy before
division of any structures. Conclu
sive identification of the cystic duct
does not necessarily mean that the
common duct must be exposed. In
most cases conclusive identification
is best accomplished by completely
dissecting the triangle of Calot to
expose the common bile duct and
common hepatic duct and by taking
the base of the gallbladder off the
liver bed. When the triangle of
Calot has been completely cleared
and the bottom of the gallbladder is
visible where it has been taken off
the liver bed, two, and only two,
structures must be seen to enter the
gallbladder separately (Fig. 1). This
view means that the structures are
the cystic duct and artery and that
there are no aberrant ducts. Al
though it is preferable to visualize
the common bile duct and common
hepatic duct whenever possible, this
may be difficult, and the surgeon
should not persist in attempts to

FIG. 1. Schematic diagram showing
completed dissection with conclusive
identification of cystic duct without
exposing common duct. Reproduced by
permission from Methods of Laparo
scopic Cholecystectomy, Medifilm Inc.,
Toronto.
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visualize them, especially if bleeding
results. If dissection cannot be com
pleted as described then the gall
bladder should be taken down from
above, once again providing proof
that the two structures entering the
gallbladder are the cystic struc
tures. The cystic artery may be
taken during the dissection if it is
clearly pulsatile, is of appropriate
size and enters the gallbladder. Be
ware of the possibility of a tented
common bile duct and common he
patic duct. These do not constitute
two separately entering structures.
The techniques described above are
often best learned through viewing
instructional videotapes that detail
the techniques.16
Cholangiography should be done
if any doubt regarding ductal anato
my continues. We do not often use
cholangiography for this purpose
because if the procedure is done
through the misidentified common
duct, the operation will have to be
converted to an open cholecystecto
my. However, cholangiography for
ductal identification is sometimes
required. Also, when the ductal
anatomy is uncertain, the opening
in the common bile duct that is
made during cholangiography
should not be considered a form of
ductal injury unless it leads to duc
tal malfunction or the need to re
construct the duct then or later.
This last consequence simply means
that cholangiography was properly
performed or the duct was other
wise injured during the operation.
Conclusive identification by rigid
criteria in every case is necessary if
bile-duct injury is to be avoided. It
is sobering to remember that sur
geons with considerable experience
in biliary surgery have encountered
this complication.
Before taking the cystic duct, the
surgeon should relax the tension so
as not to tent-up the common duct.
The first clip should define the safe
lower limit of the cystic duct, and

no clips should be applied below
this point. There is no benefit in
clipping the cystic duct close to the
common bile duct. Long cystic
ducts do not give rise to problems
postoperatively, provided they are
free of stones. One proof of this is
that often the cystic duct parallels
the common bile duct for several
centimetres before joining it. In
these patients the cystic duct rem
nant is quite long, yet there is no
increase in postoperative symptoms
in such patients.
The potential for cautery injuries
to ducts has already been noted. To
avoid such injuries, cautery should
be at a low setting in the triangle of
Calot, it should not be used on or
near the bile duct, and hooks
should be moved away from these
ducts when coagulating.
Stone and Bile Spillage
Bile is usually sterile, and as long
as it is removed by suction and
irrigation spillage will rarely lead to
postoperative complications. The
opening in the gallbladder can be
clipped, sutured or grasped until
the gallbladder is removed. It can
also be closed with an Endoloop
(Ethicon Inc.). It is not uncommon
to have minor degrees of bile spill
age especially during difficult proce
dures. The consequences of loss of
stones into the peritoneal cavity are
unclear, but they seem to be minor.
Nevertheless, if stones enter the
peritoneal cavity they should be
retrieved whenever possible. Mas
sive stone and bile loss into the
peritoneal cavity may be an indica
tion for conversion to open chole
cystectomy. Avoidance of this com
plication is based upon techniques
of careful and gentle dissection.
Subcutaneous Emphysema
This is an uncommon and usually
innocuous event. It may occur as a
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result of removing a trocar during a
procedure or by passing needles
into the peritoneal cavity during the
operation. The emphysema is usual
ly local and asymptomatic.
Postoperative Bile and Blood
Collections

This again is an uncommon cornT a b le II. In d ire c t C o m p lic a tio n s o f
L a p a ro s c o p ic C h o le c y s te c to m y
C om plication

34
14
13
7
6
3
3
2
1
1
1
1
1
1
1
1
1
2

T o ta l
*3 % o f 3 1 1 4 a tte m p ts
c h o le c y s te c to m y

of residual stones in various series
is shown in Table III.112 The pre
vention and management of residual
stones is a separate topic.

indirect Complications

Conversion to open cholecystec
tomy is neither a complication nor a
negative outcome but rather a suc
cessful completion when conditions
are unsuitable for laparoscopic cho
lecystectomy. The reasons for con
version and the numbers of conver
sions in the series we analysed are
given in Table IV. Conversion is
mandatory when ductal identifica
tion is not obtained laparoscopically
or when there is any question of the
patient’s safety. When teaching this
procedure emphasis should not be
on the importance of a low conver
sion rate or on speed but on conclu
sive ductal identification, gentle and
progressive dissection and rhe over
all safety of the procedure.
In summary laparoscopic chole
cystectomy is an extremely safe
procedure, which is becoming safer
as the cause and prevention of

When we analysed the literature
up to October 1991, we found 158
complications (5.1%) in 3114 cases
of laparoscopic cholecystectomy; 93
(3.0%) of them were not specifically
related to the procedure (Table II).
The commonest were wound infec
tions, urinary retention, postopera
tive ileus and pulmonary complica
tions. What is most notable about
indirect complications is their infre
quent occurrence. Pulmonary com
plications and fever are much less
common after laparoscopic chole
cystectomy than after open chole
cystectomy, and this is one of the
major benefits of this procedure.

No. of cases

W o u n d in fe c tio n o r
d is c h a rg e o r h e m a to m a
U rin a ry in fe c tio n o r
re te n tio n
P o s to p e ra tiv e ile u s
P u lm o n a ry e d e m a o r
in fe c tio n
P o s to p e ra tiv e fe v e r
G a stro d u o d e n a l u lc e r
P o s to p e ra tiv e a rrh y th m ia
H e m a to c rit fa ll (n o t tre a te d )
B le e d in g re q u irin g
tra n s fu s io n
In c is io n a l pain
P le u ritic pain
C o s to c h o n d ritis
C a u te ry burn
S u p e rfic ia l th ro m b o p h le b itis
D eep v e in th ro m b o s is
P a n c re a titis
P e rito n itis
D rug re a ctio n

plication, but it may signal an un
recognized bile-duct injury. Another
cause is insecurely placed cysticduct clips. Treatment may be expec
tant, with or without antibiotics,
percutaneous drainage or laparoto
my, depending on circumstances.

Residual Stones

93*
at

la p a ro s c o p ic

This is a failure to cure rather
than a complication.1 The incidence

T a b le III. R e p orted In c id e n c e o f R etained S to n e s and C o n v e rs io n to O pen C h o le c y s te c to m y in
3 1 1 4 A tte m p ts at L a p a ro s c o p ic C h o le c y s te c to m y

S eries

No. of
patien ts

R e ta in e d
stones

Conversion
to open
ch o le c y stec to m y

D u b o is, B e rth e lo t and L e va rd , 1 9 8 9 1
D io n and M o rin , 1 9 9 0 2
M cK e rn a n and S aye, 1 9 9 0 3
R e d d ick and O lsen, 1 9 9 0 4
B aile y e t al, 1 9 9 1 s
C o o p e rm a n , 1991®
G race e t al, 1 9 9 1 7
N e u ge b a u e r et al, 1991®
P ete rs e t al, 1 9 9 1 s
T h e S o u th e rn S u rg e o n s C lu b , 1 9 9 1 10
W ils o n e t al, 1 9 9 1 11
Z u c k e r e t al, 1 9 9 1 12
C u rre n t s tu d y

63
60
12
83
375
90
50
100
283
1518
180
100
200

N M **
1
0
0
0
1
NM
NM
2
6
3
1
1

8
0
0
0
23
0
6
NM
8
72
10
5
9

T o ta l
P erce n t

3114

14
0 .4

141
4.5

N M = n o t m e n tio n e d

Conversion Is Not a
Complication

T a b le IV . R e p o rte d R a tio n a le f o r and
In c id e n c e o f C o n v e rs io n to O pen
C h o le c y s te c to m y
R a tio n a le

No. of c a s e s

A d h e s io n s /c h r o n ic
in fla m m a tio n
A c u te in fla m m a tio n
A b e rra n t a n a to m y
B le e d in g
B ilia ry -tra c t in ju ry
P y o c h o le c y s titis
C h o le d o c h o lith ia s is
D e v ic e fa ilu re /m e c h a n ic a l
p ro b le m s
C a n ce r
B o w e l in ju ry
T o rn g a llb la d d e r
B ile le a k
C h o le d o c h a l c y s t
C a lc u li s p illa g e
T o ta l

50
18
12
12
12
7
7
6
6
5
3
1
1
1
141*

* 4 .5 % o f 3 1 1 4 a tte m p ts a t la p a ro s c o p ic
c h o le c y s te c to m y
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complications become known. The
two major causes of complication,
trocar injury and bile-duct injury,
are avoidable.
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sure that this valuable book is available
in the hospital library.
Mervyn Deitel, MD, FRCSC
University of Toronto
St. Joseph’s Health Centre
30 The Queensway
Toronto, ON
M6R 1B5

SURGICAL MANAGEMENT OF THE
DIABETIC PATIENT. Edited by Mi
chael Bergman and Gregorio A. Sicard.
427 pp. Illust. Raven Press, New
York. 1991. $85. ISBN 0-88167726-4
This 427-page text comprises 29 chap
ters contributed by 53 American au
thors. There are three sections, all of
which are directed to students at the
postgraduate level or to practising sur
geons.
In the first section are chapters deal
ing with the complex aspects of carbo
hydrate metabolism and the effects of
surgery on normal metabolism; the
medical management of the diabetic
patient who undergoes minor and major
surgery, emergency surgery and sur
gery while receiving parenteral nutri
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tion; nutritional support of the diabetic
surgical patient and basic and clinical
studies on wound healing in diabetes
mellitus.
The second section consists of 11
chapters, most of which deal with com
plications of diabetes that present diffi
culties for the surgeon during general
and specific operative therapy. Chapters
cover diabetic nephrology, advanced
cardiovascular disease, specific infec
tions associated with diabetes, diabetic
neuropathy and diabetes in the pediatric
surgical patient. Other chapters in this
section deal with special medical condi
tions occurring in diabetics that present
for surgery. Examples are hypertension
and diabetes, diabetes and other endo
crine disorders and pancreatitis associ
ated with diabetes mellitus. Lastly, two
chapters in this section provide guid
ance for outpatient surgery in diabetics
and predischarge planning for the post
operative surgical patient with diabetes
mellitus.
The 13 chapters of the final section
are directed to special surgical problems
that frequently occur in diabetes mel
litus. Three separate chapters address
foot problems in the diabetic. In addi
tion, there is a chapter on peripheral
vascular surgery and one dealing with
lower-extremity amputations in the dia
betic; unfortunately, this is often neces

sary with uncontrolled vascular disease
and foot problems. Carotid artery dis
ease investigation and surgery in the
diabetic are presented in this section. A
separate chapter deals with the unusual
autonomic gastrointestinal problems in
diabetics and discusses the acute abdo
men, elective biliary surgery and pan
creatic neoplasms associated with diabe
tes. In the chapter on urologic compli
cations, infections and the neurogenic
bladder are dealt with, though the main
emphasis is on assessment and treat
ment of impotence. Two successive
chapters summarize the current state of
renal and pancreatic transplantation in
diabetic patients. There is a short chap
ter concentrating on the peripartum
aspects of pregnancy in diabetes mel
litus, followed by a long chapter on
surgery for obesity in the diabetic pa
tient, which details the effects of vari
ous procedures on diabetes mellitus.
The final chapter deals with diabetic eye
disease related both to nonophthalmic
surgery and specific ophthalmogic pro
cedures in diabetic patients.
Overall, this book is an excellent
reference text for residents and practis
ing surgeons. It contributes complex
information on management of the dia-

continued on page 284
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P. mirabilis, P. aeruginosa, S. aureus, S. pneumoniae
Due to the nature of the underlying conditions which usually predispose patients to Pseudomonas infections of the respiratory
tract, bacterial eradications may not be achieved in patients who display clinical improvement despite evidence of in vitro
sensitivity. In patients requiring subsequent courses of therapy, CIPRO® should be used alternately with other antipseudomonal
agents. Some strains of Pseudomonas aeruginosa may develop resistance during treatment. Therefore, susceptibility testing
should be performed periodically during therapy to detect the emergence of bacterial resistance.
Urinary Tract Infections: Upper and lower urinary tract infections, such as complicated and uncomplicated cystitis, pyelonephritis,
and pyelitis, caused by: C. diversus, C. freundii, E. cloacae, E. coli, K. pneumoniae, K. oxytoca, M morganii, P. mirabilis,
P. aeruginosa, S. marcescens, S. aureus, S. epidermidis, S. faecalis
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hydrated and alkalinity of the urine should be avoided. The recommended daily dose should not be exceeded.
Pseudomembranous colitis has been reported with virtually all antibacterial agents, including ciprofloxacin, and may range in
severity from mild to life-threatening. Therefore, it is important to consider this diagnosis in patients with diarrhoea subsequent
to the administration of antibacterial agents.
Subsequent to diagnosis of pseudomembranous colitis, therapeutic measures should be initiated. Mild cases will usually respond
to discontinuation of drug alone. In moderate to severe cases, consideration should be given to the management with fluids,
electrolytes, protein supplementation and treatment with an antibacterial drug effective against C. difficile.
Prolonged use of CIPRO® and CIPRO® I.V. may result in the overgrowth of nonsusceptible organisms. Careful observation of the
patient is therefore essential, and if superinfection should occur during therapy, appropriate measures should be taken.
Pregnancy The safety of CIPRO® and CIPRO® I.V. in pregnancy has not yet been established. CIPRO® and CIPRO® I.V. should not
be used in pregnant women unless the likely benefits outweigh the possible risk to the fetus. CIPRO® and CIPRO® I.V. has been
shown to be non-embryotoxic and non-teratogemc in animal studies.
Nursing Mothers Ciprofloxacin is excreted in human milk. A decision should be made to discontinue nursing o r to discontinue the
administration of CIPRO® and CIPRO® I.V., taking into account the importance of the drug to the mother and the possible risk to
the infant.
Drug Interactions Concurrent administration of ciprofloxacin with theophylline may lead to an elevated plasma concentration and
prolongation of elimination half-life of theophylline. This may result in increased risk of theophylline-related adverse reactions. If
concomitant use cannot be avoided, plasma concentrations of theophylline should be monitored and dosage adjustments made as
appropriate.
Ciprofloxacin has been shown to interfere with the metabolism and pharmacokinetics of caffeine. Excessive caffeine intake should
be avoided.
Some quinolones, including ciprofloxacin, have been associated with transient increases in serum creatinine levels in patients who
are concomitantly receiving cyclosporine.

Skin and Soft Tissue Infections: caused by: £ cloacae, E. coli, K. pneumoniae, P. vulgaris, P. mirabilis, S. pyogenes, P. aeruginosa,
S. aureus, S. epidermidis

Quinolones have been reported to increase the effects of the oral anticoagulant warfarin and its derivatives. During concomitant
administration of these drugs, the prothrombin time or other appropriate coagulation tests should be closely monitored.

Bone and Joint Infections: caused by: S. marcescens, P aeruginosa, S. aureus, E. cloacae

Probenecid blocks renal tubular secretion of ciprofloxacin and has been shown to produce an increase in the level of ciprofloxacin
in the serum.

Infectious Diarrhea: (When antibacterial therapy is indicated) caused by: E. coli [enterotoxigenic strains], C. jejuni, S. flexnen,
S. sonnei
B) Intravenous Administration
CIPRO® I.V. (Ciprofloxacin injection) may be indicated for the treatment of patients with the following infections caused by
susceptible strains of the indicated microorganisms:

Concomitant administration of a nonsteroidal anti-inflammatory drug (fenbufen) with a quinolone (enoxacin) has been reported to
increase the risk of CNS stimulation and convulsive seizures.
Antacids containing aluminum or magnesium hydroxide have been shown to reduce the absorption of ciprofloxacin. Concurrent
administration with these agents should be avoided.

Respiratory Tract Infections: acute pneumonia caused by: £ coli, K. pneumoniae, E. cloacae, P. mirabilis, P. aeruginosa,
H. influenzae, H. parainfluenzae, S. pneumoniae

Administration of sucralfate prior to CIPRO® resulted in a 30% reduction in absorption of ciprofloxacin. Concurrent
administration with ciprofloxacin should be avoided.

Due to the nature of the underlying conditions which usually predispose patients to Pseudomonas infections of the respiratory
tract, bacterial eradications may not be achieved in patients who display clinical improvement despite evidence of in vitro
sensitivity. In patients requiring subsequent courses of therapy, CIPRO® should be used alternately with other antipseudomonal
agents. Some strains of Pseudomonas aeruginosa may develop resistance during treatment. Therefore, susceptibility testing
should be performed periodically during therapy to detect the emergence of bacterial resistance.

Oral ferrous sulfate at therapeutic doses decreases the bioavailability of oral ciprofloxacin, therefore concomitant therapy is not
advised.

Urinary Tract Infections: Upper and lower complicated urinary tract infections including pyelonephritis caused by: C. diversus,
E. coli, K. pneumoniae, P. mirabilis, P. aeruginosa
Skin or Skin Structure Infections: caused by: E. cloacae, E coli, K. pneumoniae, M. morganii, P vulgaris, P. mirabilis,
P. aeruginosa, S. aureus, S. pyogenes
Septicemia: caused by: £ coli, S. typhi
Bone: caused by: £ cloacae, P. aeruginosa

The use of calcium supplement reduces the absorption of ciprofloxacin. Concurrent administration should be avoided
Renal Impairment Since ciprofloxacin is eliminated primarily by the kidney, CIPRO® and CIPRO® I.V. should be used with caution
and at a reduced dosage in patients with impaired renal function. (See DOSAGE AND ADMINISTRATION).
Hepatic Impairment In preliminary studies in patients with stable chronic liver cirrhosis, no significant changes in ciprofloxacin
pharmacokinetics were observed. The kinetics of ciprofloxacin in patients with acute hepatic insufficiency, however, have not been
fully elucidated. An increased incidence of nausea, vomiting, headache and diarrhea were observed in this patient population.
ADVERSE REACTIONS
CIPRO® (ciprofloxacin hydrochloride tablets) and CIPRO® I.V. (ciprofloxacin injection) are generally well tolerated. During
worldwide clinical investigation, 16,580 courses of ciprofloxacin treatment were evaluated for drug safety.

Appropriate culture and susceptibility tests should be performed prior to initiating treatment in order to isolate and identify
organisms causing the infection and to determine their susceptibilities to ciprofloxacin. Therapy with CIPRO® and CIPRO® I.V.
may be initiated before results of these tests are known. However, modification of this treatment may be required once results
become available or if there is no clinical improvement. Culture and susceptibility testing performed periodically during therapy
will provide information on the possible emergence of bacterial resistance. If anerobic organisms are suspected to be contibuting
to the infection, appropriate therapy should be administered.

Adverse events, possibly, probably or highly probably related to ciprofloxacin occurred in 1395 (8.8%) of patients. The adverse
reactions according to treatment (oral, iv, and sequential therapy) show that the incidence of adverse reactions was 8.0% for the
group treated orally, 17% for the group treated with CIPRO® I.V. and 15.3% for the group treated sequentially. The difference
between the oral and iv group relates to adverse vascular reactions which are known to be associated with iv administration.

CONTRAINDICATIONS
CIPRO® (ciprofloxacin hydrochloride tablets) and CIPRO® I.V. (ciprofloxacin injection) are contraindicated in patients who have
shown hypersensitivity to ciprofloxacin or other quinolone antibacterial agents.

In patients treated with CIPRO® I.V., the most frequently reported events, possibly, probably drug-related were: rash (1.8%),
diarrhea (1.0%), and injection site pain (1.0%).

WARNINGS
Children The safety of CIPRO® and CIPRO® I.V. (ciprofloxacin hydrochloride tablets and ciprofloxacin injection) in children has not
yet been established. Damage to juvenile weight-bearing joints and lameness were observed both in ra t and dog studies but not
in weaned piglets (see TOXICOLOGY in Product Monograph). Histopathological examination of the weight-bearing joints in
immature dogs revealed permanent lesions of the cartilage. Consequently, CIPRO® and CIPRO® I.V. should not be used in
prepubertal patients. Experience in pubertal patients below 18 years of age is limited.
Pregnancy The safety of CIPRO® and CIPRO® I.V. in the treatment of infections in pregnant women has not yet been established
(see PRECAUTIONS).
PRECAUTIONS
General Anaphylactic reactions including cardiovascular collapse have occurred rarely in patients receiving therapy with CIPRO®
and CIPRO® I.V. (ciprofloxacin hydrochloride tablets and ciprofloxacin injection). These reactions may occur within the first 30
minutes following the first dose and may require epinephrine and other emergency measures.
CIPRO® and CIPRO® I.V. may cause central nervous system (CNS) stimulation which may lead to tremor, restlessness, light
headedness, confusion, and very rarely to hallucinations or convulsive seizures. Therefore, CIPRO® and CIPRO® I.V. should be
used with caution in patients with CNS disorders, such as severe cerebral arteriosclerosis or epilepsy. Patients with known
convulsive seizure disorders should only be treated with CIPRO® and CIPRO® I.V. if anticonvulsant therapy has been initiated.
SERIOUS AND FATAL REACTIONS HAVE BEEN REPORTED IN PATIENTS RECEIVING CONCURRENT ADMINISTRATION OF
CIPRO® I.V. AND THEOPHYLLINE. These reactions include cardiac arrest, seizure, status epilepticus and respiratory failure.
Similar serious adverse events have been noted with administration of theophylline alone, however, the possibility that
ciprofloxacin may potentiate these reactions cannot be eliminated. If concomitant use cannot be avoided, the plasma levels of
theophylline should be monitored and appropriate dosage adjustments should be made.
Severe hypersensitivity reactions characterized by rash, fever, eosinophilia, jaundice, and hepatic necrosis with fatal outcome
have also been reported to occur very rarely in patients receiving ciprofloxacin in combination with other drugs. The possibility
that these reactions were related to ciprofloxacin cannot be excluded. Ciprofloxacin should be withdrawn at the first appearance
of a skin rash or other signs of hypersensitivity.
Crystalluria related to ciprofloxacin has been reported only rarely in man because human urine is usually acidic. Crystals have
been observed in the urine of laboratory animals, usually from alkaline urine. Patients receiving ciprofloxacin should be well

In orally treated patients enroled in clinical trials, the most frequently reported events, possibly,probably drug-related were:
nausea (1.3%) and diarrhea (1.0%).

Events possibly, probably drug-related occurring at a frequency of less than 1% with ciprofloxacin oral and i.v. treatment during
clinical trials and subsequent post-marketing surveillance are as follows:
Gastro-lntestinal: vomiting, dyspepsia, abdominal pain, flatulence, dysphagia, enlarged abdomen, dry mouth, stomatitis,
gastrointestinal moniliasis, anorexia, jaundice. The following have been reported very rarely: constipation, tooth discoloration,
ulcerative stomatitis, pseudomembranous colitis, intestinal perforation, esophagitis, increased appetite, gastro-intestinal
hemorrhage, melena, liver damage, tenesmus, ileus, toxic megacolon, hepatomegaly, glossitis.
Cardiovascular system: palpitation, tachycardia, phlebitis. The following have been reported very rarely: hypertension, hot flashes,
cerebrovascular disorder, syncope, kidney vasculitis, vasodilation, atrial fibrillation, cardiac arrest, angina pectoris,
electrocardiogram abnormality, myocardial infarct, substemal chest pain, pulmonary embolus, pericarditis, hypotension.
Nervous System: increased sweating, dizziness, agitation, tremor, somnolence, insomnia, confusion, hallucinations, convulsion,
headache. The following have been reported very rarely: anxiety, depression, nervousness, apathy, depersonalization, abnormal
dreams, hemiplegia, sleep disorder, neuritis, paresthesia, polyneuritis, diplopia, meningism, migraine, increase of intracranial
pressure. In some instances these reactions occurred after the first administration of CIPRO®. In these instances, CIPRO® has
to be discontinued and the doctor should be informed immediately.

X
V

y

Respiratory System: dyspnea. The following have been reported very rarely: hiccup, increased cough, stridor, larynx edema, voice
alteration, lung edema, pharyngitis, hyperventilation, lung hemorrhage.
Skin and Appendages: rash, pruritus. The following have been reported very rarely: urticaria, photosensitive dermatitis,
angioedema, alopecia.
Special Senses: tinnitus, abnormal vision, taste perversion. The following have been reported very rarely: conjunctivitis, comeal
opacity, eye pain, colour blindness, chromatopsia, diplopia, ear pain.
Urogenital System: albuminuria, hematuria. The following have been reported rarely: leukorrhea, dysuria, urinary retention, acute
kidney failure, abnormal kidney function, nephritis, vaginitis
Hypersensitivity: rash. The following have been reported rarely: pruritus, drug fever, anaphylactic/ anaphylactoid reactions
including facial, vascular and laryngeal edema, serum sickness, petechiae, haemorrhagic bullae and small nodules (papules) with
crust formation showing vascular involvement (vasculitis), Stevens-Johnson-syndrome, interstitial nephritis, hepatitis: very rarely,
major liver disorders including hepatic necrosis, joint pain, Lyell Syndrome.

ij

ciprofloxacin
injection

THE FIRST AND ONLY
I.V. FLUOROQUINOLONE
▼Broad spectrum coverage *1 for the treatm ent of
nosocomial infections
•Excellent gram negative coverage
•Provides gram positive activity
▼Indicated for a wide range of difficult infections 1
• Respiratory tract
•Urinary tract
• Skin or skin structure
•Bone
• Septicemia
T Additional benefits for use in combination regimens 1
•Excellent safety profile
•Antimicrobial streamlining - Cipro I.V. to Cipro oral
•Cost effective2
• In vitro activity does not necessarily imply a correlation with in vivo results.

Blood and Blood constituents: eosinophilia, leukocytopenia. leukocytosis, anaemia. Very rarely: haemolytic anaemia,
thrombocytopenia, thrombocytosis, altered prothrombin levels.

Sequential IV/PO Therapy

Laboratory values: increased alkaline phosphatase, Gamma • GT, transaminases, cholestatic parameters, lactic dehydrogenase,
BUN, NPN, AST, ALT, decreased creatinine clearance, hypercholesteremia, albuminuria, bilirubinemia, hyperuricemia, increased
sedimentation rate. The following have been reported rarely: electrolyte abnormality, hypercalcemia, hypocalcemia, acidosis,
crystalluria and haematuria.
Other thrombophlebitis. Very rarely, asthenia, death.
M ost of the adverse events reported were described as only mild or moderate in severity.There have been 5 4 reports of
arthropathies with CIPRO®. Ten of these reports involved children. Arthralgia was usually the first symptom which led to rapid
assessment and withdrawal of the drug. No irreversible arthropathies have been observed.

In patients receiving intravenous ciprofloxacin, oral ciprofloxacin may be substituted when clinically indicated at the discretion of
the physician. Clinical studies evaluating the use of sequential IV/PO therapy in septicemia have not yet been completed.

Impaired Renal Function
Ciprofloxacin is eliminated primarily by renal excretion. However, the drug is also metabolized and partially cleared through the
biliary system of the liver and through the intestine. This alternate pathway of drug elimination appears to compensate for the
reduced renal excretion of patients with renal impairment. Nonetheless, some modification of dosage is recommended,
particularly for patients with severe renal dysfunction. The following table provides a guideline for dosage adjustment. However,
monitoring of serum drug levels provides the most reliable basis for dosage adjustments. Only a small amount of ciprofloxacin
(<10%) is removed from the body after haemodialysis or peritoneal dialysis.

Creatinine Clearance
ml/s (ml/min)

SYMPTOMS AND TREATMENT OF OVERDOSE
Overdose has not yet been reported with CIPRO® and CIPRO® I.V. (ciprofloxacin hydrochloride tablets and ciprofloxacin injection)
In the event of acute overdosage, the stomach should be emptied by inducing vomiting or by gastric lavage. The patient should be
carefully observed and given supportive treatment.

D0SA6E AND ADMINISTRATION
The determination of dosage for any particular patient must take into consideration the severity and nature of the infection, the
susceptibility of the causative organism, the integrity of the patient's host-defense mechanisms, and the status of renal function.

Oral Administration
CIPRO® (Ciprofloxacin hydrochloride tablets) may be taken before or after meals. Absorption is faster on an empty stomach.
Patients should be advised to drink fluids liberally and not take antacids containing magnesium or aluminum.

Adult The recommended dosages of oral CIPRO® are:
Location of Infection

Type/Severity

Unit Dose

Frequency

Daily Dose

Urinary Tract

Mild/Moderate
Severe/Complicated

250 mg
500 mg

q 12h
q12h

500 mg
1000 mg

Lower Respiratory Tract
Bone 8, Joint
Skin 8 Soft Tissue

Mild/Moderate
Severe/Complicated*

500 mg
750 mg

q 12h
q 12h

1000 mg
1500 mg

Infectious Diarrhea

Mild/Moderate/Severe 500 mg

q 12h

1000 mg

> 0 .5 (30)

No Dose adjustment

< 0 .5 (30)
and patients on haemodialysis or
peritoneal dialysis

Use recommended dose once daily or
half usual dose twice daily

When only the serum creatinine concentration is available, the following formula (based on sex, weight and age of the patient!
may be used to convert this value into creatinine clearance. The serum creatinine should represent a steady state of renal
function:

Creatinine Clearance ml/sec
Males:

Weight (kg) x (140 - age)
49 x serum creatinine (|mol/L)

Females:

0.85 x the above value

In traditional units ml/min
Males:

Weight (kg) x (140 - age)
72 x serum creatinine mg/100 mL

Females:

0.B5 x the above value

Children
The safety and efficacy of CIPRO® and CIPRO® I.V. in children have not been established.

* e.g. hospital-acquired pneumonia, osteomyelitis
Depending on the severity of the infections, as well as the clinical and bacteriological responses, the average treatment period
should be approximately 7 to 14 days. Generally, treatment should last 3 days beyond the disappearance of clinical symptoms or
until cultures are sterile. Patients with osteomyelitis may require treatment for a minimum of 6 to 8 weeks and up to 3 months.
W ith acute cystitis, a five-day treatment may be sufficient.

CIPRO® and CIPRO® I.V. should not be used in prepubertal patients (see WARNINGS).

AVAILABILITY OF DOSAGE FORMS
Tablets:
CIPRO® 250

Adult The recommended adult dosages of CIPRO® I.V. (ciprofloxacin injection) are:
Location of Infection

Type/Severity

Urinary Tract

Moderate/Severe/
Complicated

Lower Respiratory Tract
Skin or Skin Structure
Blood
Bone

Moderate

Frequency

Daily Dose
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4. Laparoscopic Surgery — Basic
Armamentarium
M.J. Girotti, BSc, MD, FRCSC, FACS; A.G. Nagy, MD, FRCSC; D.E.M. Litwin, MD, FRCSC;
J. Mamazza, MD, FACS, FRCSC; E.C. Poulin, MD, ABS, FACS, FRCSC
The introduction of laparoscopic techniques into standard intracavitary surgery has
received widespread acceptance in North American surgical practice in a very short
time. To complete these procedures successfully a basic armamentarium is required
by surgeons. The equipment should provide safe conduct of the procedure and
maximum flexibility in the types of surgical procedures to be undertaken. The basic
laparoscopic equipment needed to facilitate minimal-access-site surgery is reviewed,
from the operating table and lighting in the operating room through optics, cameras
and television monitors to the instruments and agents needed for the surgical
techniques and for securing hemostasis.

L’addition des techniques laparoscopiques aux interventions endocavitaires
courantes a ete largement acceptee par la pratique chirurgicale nord-americaine et
ceci, en tres peu de temps. Afin de pouvoir pratiquer ces interventions avec succes,
le chirurgien doit disposer d’un arsenal therapeutique fondamental. Cet equipement
doit assurer la conduite des interventions en toute securite, tout en procurant une
flexibilite maximum pour les types de chirurgie a entreprendre. L’essentiel de
l’equipement laparoscopique requis pour faciliter un acces au champ operatoire est
passe en revue, a partir de la table d’operation et l’eclairage de la salle d’operation
jusqu'aux instruments d'optique, cameras et moniteurs de television, sans oublier
les instruments et medicaments necessaires pour les techniques chirurgicales et
pour assurer l’hemostase.

he widespread introduction of
intracavitary endoscopic sur
gery has resulted in dramatic
changes in the basic armamentari
um needed for both therapeutic and
diagnostic laparoscopic surgical
procedures. The historical back
ground against which the essential
hardware for major pelvic, abdomi
nal and thoracic surgery developed
spans nearly 100 years.1 However,
it has only been during the past 5

T

years that general surgeons have
adopted and integrated laparoscopic
surgery as a basic component into
their day-to-day surgical practice.
Without doubt, the major techno
logic event that enabled classical
general surgical procedures to be
performed through the laparoscope
was the “ability to see.” Fibreoptics
and sophisticated television (TV)
cameras rapidly complemented a
growing understanding of the

From the Department o f Surgery, Victoria Hospital and the University o f Western Ontario,
London, Ont.
Presented as part o f the symposium “Laparoscopic Surgery ” at the 14th annual meeting o f the
Canadian Association o f General Surgeons, held in conjunction with the 60th annual meeting o f
the Royal College o f Physicians and Surgeons o f Canada, Quebec, Que., Sept. 22, 1991
Accepted for publication Nov. 11, 1991
Reprint requests to: Dr. M.J. Girotti, Victoria Hospital, 375 South St., London, O N N 6K 4G5

human physiological responses (car
diac, respiratory, renal) during pro
longed pneumoperitoneum to allow
surgeons to initiate minimal-accesssite surgery and to minimize postoperatively the focal and distant
effects of the surgical wound.2
L ap aro sco p ic su rg e ry (also
known as minimal-access surgery or
endoscopic surgery) describes sur
gery that is performed with special
ly designed, small instruments in
serted through the abdominal or
thoracic body walls under direct
visual control of a TV monitor with
no compromise of the operative
field.2 The purpose of this paper is
to review the basic armamentarium
required to undertake laparoscopic
surgery.
Depending on the surgical proce
dure planned, the basic operative
set-up may vary. A number of ele
ments of the instrumentation are
the same regardless of surgical pro
cedure.

The Environment
Simply stated, laparoscopic sur
gery must be performed in a mod
ern operating theatre capable of
immediate standard open surgery.
The m ost urgent complications of
laparoscopic surgery, such as bleed
ing, parenchymal injury or other
untoward laparoscopic misadven
tures, may require immediate open
laparotomy or thoracotomy. All
operating-room personnel m ust
constantly be reminded of this even
CJS, VOL. 35, NO. 3, JUNE 1992
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though these situations seldom
occur (1% to 3%).3 However, full
anesthetic and operating-room
backup is mandatory. In this re
gard, access to complete patient
monitoring during anesthesia, de
signed to match the patient’s opera
tive risk as assessed preoperatively,
is required. Most operating rooms
provide online monitoring of patient
transcutaneous oxygen saturation,
blood pressure and end-tidal carbon
dioxide levels. The importance of
being able to monitor or estimate
blood levels of carbon dioxide ten
sion must be emphasized in that the
pneumoperitoneum is usually creat
ed and maintained by carbon diox
ide (readily diffusible across semipermeable membranes such as the
peritoneal cavity) at varying pres
sures (10 to 20 mm Hg) for pro
longed periods.
The Operating Room

The operating room should have
the capability to control ambient
light and light scatter so as to
maximize visualization of operative
images on the TV monitor. The
theatre itself must be large enough
to accommodate all the necessary
equipment comfortably and to pro
tect the attending health profes
sionals from unnecessary injury.
Multiple electrical outlets on sepa
rate circuits must be available to
meet the demands of the laparo
scopic equipment and not interfere
with the quality of the TV images
when ancillary electrical equipment
(e.g., the electrosurgical unit) is
used simultaneously. If lasers are
used, the operating theatre and per
sonnel must meet the accreditation
standards for laser use established
by the provincial or national regula
tory authorities, or both.
The Operating Table

The operating table must provide
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adequate patient safety and possess
the flexibility to adjust to patient
body position. Laparoscopic surgery
may at times require several differ
ent body positions for the patient
during the same procedure. Leg
straps and patient foot boards are
strongly recommended, depending
upon the procedure. Stirrups may
also be required. The operating
table must allow intraoperative radi
ography to be carried out as re
quired.

“ Seeing Is Believing”

The ability to differentiate, criti
cally, subtle anatomical variations
has extended an ever-increasing list
of laparoscopic abdominal and tho
racic surgical procedures.4’5 This
aspect of laparoscopic surgery can
conveniently be divided into optics
and light sources, cameras and,
finally, the TV monitor.

transmission. These light sources,
when directed toward an operative
target, should not be regarded as
“cold” light. It must be remem
bered that they are capable of ignit
ing paper drapes and burning
human tissue.
Cameras

Most endoscopic TV cameras em
ploy a “three-chip” camera with an
automatic iris, which reduces glare,
to produce a detailed colour TV
image. The chips may vary in loca
tion (telescope or camera), number
and size. These variations may re
sult in subtle differences in the
sensitivity and definition of the op
erative field. Cameras are now avail
able that will allow direct, multipleimage endoscopic viewing simul
taneously. Variable magnification
and zoom capabilities are also stan
dard features.
TV Monitors

Optics and Light Sources

The last few years have seen the
rapid and sophisticated development
and refinement of high-quality opti
cal systems originally based on the
Hopkins rod-lens system.5 Several
of the disadvantages, such as pe
ripheral distortion and reduced light
transmission, have recently been
overcome. Durable, high-quality in
ternal lens systems abolish the dis
tortion, and high-intensity light
sources (xenon or halide) increase
the amount of light delivered to the
operative site. The rod-lens system
may vary in diameter from 3 to 12
mm, and the degree of lens angula
tion may vary from 0° to 30° at the
tip of the telescope. The 30° lens
has been helpful in some intra
abdominal procedures but is not
mandatory for basic intracavitary
surgery. Cable design for light
transmission (fluid versus 2-m stan
dard fibreoptic cable) improves light

The standard TV monitor is not
adequate to reproduce the detailed
anatomy of an endoscopic operative
field. The lines of resolution must
be increased to accept and faithfully
reproduce image definitions. With
out a suitable TV monitor, the
purchase of sophisticated lens and
optical light systems is undermined.
Most TV monitors can be connected
to a video cassette recording system
to allow video-home-system (or oth
er) recordings of the operative pro
cedures or for simultaneous, remote
operative viewing.
Future Changes

Anticipated changes in these sys
tems include safer, more powerful
light sources, better optics possibly
providing rudimentary three-dimen
sional viewin, and enhanced “hand”
control of camera features and op
tions.

ARMAMENTARIUM FOR LAPAROSCOPIC SURGERY

Creation and Maintenance
of Pneumoperitoneum
The creation of a pneumoperito
neum can be accomplished by sever
al different methods: Veress needle,
Hasson or modified Hasson tech
nique or cutdown.2 Each method
has its strong proponents, depend
ing upon the surgeon’s familiarity
and the patient’s needs. Our person
al preference is to use the Veress
needle (retractable protective shield)
in the commonly encountered “lowrisk” abdomen (i.e., no previous
major surgery, especially upper ab
dominal surgery). In the typical
abdominal surgical procedure, the
abdominal cavity can be entered
periumbilically using a disposable
10- to 11-mm trocar with a protec
tive locking external shield de
signed to prevent bowel and vascu
lar injury. This trocar permits the
introduction of the optical system.
Trocars without this added poten
tial safety shield feature can be used
in this manner with caution. The
trocars, regardless of mechanical
design and diameter (3 to 15 mm),
must maintain competency in pre
venting gas loss and also be adapt
able to allow different-sized operat
ing instruments to enter the abdom
inal cavity. They should have an
exterior surface that reduces the
amount of light reflected off the
trocar surface. At least two trocars
should be adapted to provide access
ports for gas insufflation.
The pneumoperitoneum is initiat
ed and maintained with continuous
carbon dioxide (sometimes nitrous
oxide) insufflation at various rates
up to a predetermined maximal in
tracavitary pressure set point. In
sufflators usually offer the follow
ing features, some of which, in our
opinion, are mandatory:
• Variable flow-rate monitor and
display (mandatory)
• Intracavitary pressure monitor
and display (mandatory)

• High intracavitary pressurepoint sensor and selector (mandato
ry)
• High- (mandatory) and lowpressure alarms (auditory and visu
al)
• High intracavitary pressure re
lease valves (mandatory)
• Monitor and display of insuf
flation tank volumes (optional)
• Monitor and display volume of
gas infused (optional).
The flow rates of the insufflator
can be adjusted between 1 and 6
L/min. There does not appear to be
a clear advantage to higher gasflow rates. In fact they may be
harmful with respect to cardiac and
respiratory responses experienced
by the patient during rapid insuffla
tion or reinsufflation.

“The Chopsticks”
These instruments are the sur
geon’s hands, 45 cm from the oper
ative field. They permit accurate
identification, delicate dissection
and, when needed, ligation and fa
cilitation of tissue removal. Instru
ment design will vary with respect
to the operative procedure under
taken. The “chopsticks” should
have the following features to make
them suitable for laparoscopic sur
gery: they should be durable and
strong, able to withstand varying
torque; they should be insulated for
use in electrosurgery; they should
be areflective if possible; locking
instruments must employ a mecha
nism that is familiar to the surgeon;
and the “control mechanism”
should be on the instrument at the
surgeon’s fingertips.
Desirable features of newer in
strumentation include rotating op
erative heads to facilitate comfort
able operator hand positions. Fu
ture instrumentation includes endo
scopic stapling devices, advanced
knot tiers, enhanced needle drivers

and, finally, abdominal-wall and vis
ceral mechanical retractors.
The recent widespread use of
laparoscopic surgery initially
sparked a controversy regarding the
routine use of either lasers of vari
ous types or electrosurgical units to
facilitate dissection and hemostasis
intraoperatively. Some data suggest
that there is little advantage in the
routine use of lasers in laparoscopic
surgery.6 Future trials must address
their potential in laparoscopic sur
gery.

Securing Hemostasis
Proper patient selection will mini
mize the potential problem of he
morrhage encountered during lapa
roscopic surgery. However, even
with appropriate patient selection,
serious life-threatening (acute or
ongoing) bleeding can occur. Sever
al options are available to the sur
geon to achieve hemostasis intraop
eratively from one of the many
recognized sites: abdominal wall (intra- and extracorporeally); ooze or
deep bleed from solid parenchymal
tissue (e.g., liver); the bleeding soli
tary vessel (i.e., cystic artery).
These options include the follow
ing:67
• Direct suture ligation either
intra- or extracorporeally
• Use of surgical clips (perma
nent, single or multi-fire, or dissolv
able) or premade surgical ligatures
• Direct pressure applied by in
tracavitary instruments
• Electrocoagulation current ap
plied to tissue through a variety of
specially designed instruments
• Lasers (Nd:YAG, KTP)
• Application of hemostatic
agents to surfaces or within paren
chymal tears (surgical, specially
packed collagen derivatives).
Most surgeons are familiar with
all of these techniques and, with the
exception of the laser, employ them
CJS, VOL. 35. NO. 3, JUNE 1992
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singly or in combination during
routine endoscopic surgery.

Summary
Laparoscopic surgery has experi
enced a virtual explosion in its
application to an increasing list of
intracavitary surgical procedures. In
a short time, currently used “open”
procedures have been successfully
converted to laparoscopic ones.3
Older procedures are being “revisit
ed” and are challenging nonopera
tive management strategies for nonmalignant disease processes.8 The
basic armamentarium to perform

these diverse procedures remains
roughly equivalent. However, this is
clearly not a static field. Within the
next 3 to 5 years, the basic arma
mentarium in use today will likely
be replaced with a more sophisticat
ed one. It would even be fair to say
that the current equipment might
be regarded with the same historical
interest as we view the early work
of Kelling1 in the mid-1920s.
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betic surgical patient, with the addition
of summation literature on specific
medical and surgical conditions of inter
est to the surgeon who operates on
these patients. The contents are pre
sented at a level that provides valuable
data for the academic as well as the
community surgeon. This publication
should be considered by surgical li
braries as a reference text.
Roger G. Keith, MD
Professor and chairman
Department of Surgery
University of Saskatchewan
Saskatoon, SK
S7N 0X0

HEAD AND NECK PATHOLOGY. A
TEXT/ATLAS OF DIFFERENTIAL
DIAGNOSIS. Leon Barnes and Robert
L. Peel. 188 pp. Illust. Igaku-Shoin,
New York. 1990. Price not stated.
ISBN 0 -8 9 6 4 0 -1 7 2 -3

This book is divided into 11 sections
dealing with the most confusing head
and neck lesions — tumours, tumour
like lesions and infections affecting the
salivary glands, ear and sinonasal tract
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(nasopharynx, larynx, skin, soft tissue,
bone-odontogenic apparatus, nervous
system, endocrine system). The authors
selected 160 common and rare lesions
and included diagnostic problems for
discussion.
The text is concise, informative and
well written, with numerous high-qual
ity black-and-white photomicrographs
and a few important references selected
for the discussion of each lesion. The
book is arranged conveniently, with
text on one page and illustrations oppo
site. Readers can peruse the text and
have a quick glance at the figures. This
arrangement is unusual; the majority of
pathology atlases have the text at the
beginning of the sections and figures
accumulated at the end. Legends for
the figures are brief and specific. For
each lesion a succinct review of the
condition is presented followed by a
brief description of the histologic ap
pearance and differential diagnosis. Em
phasis is placed on the value and limita
tions of cytochemistry, immunocytochemistry and electron microscopy as
well as clinical data that are important
for an accurate diagnosis.
This book is written primarily for
practising pathologists and senior pa
thology residents. It may appear con
fusing to surgeons who have little inter

est in tissue diagnosis. However, it is
essential for general surgery and otolar
yngology academic departments that
have residency training programs. I find
this book useful in my everyday prac
tice and recommend it to practising
pathologists working in busy communi
ty hospitals.

Gia-Khanh Nguyen, MD
Department of Pathology
and Laboratory Medicine
University of Alberta Hospitals
8440 - 112 St.
Edmonton, AB
T6G 2B7

ILLUSTRATED TECHNIQUES IN
MICRONEUROSURGERY. Edited by
Haruhiko Kikuchi and Akira Hakuba.
282 pp. Illust. Igaku-Shoin Medical
Publishers, Inc., New York. Price not
stated. ISBN 0 -8 9 6 4 -1 9 0 -1

This surgical atlas, which illustrates
and describes techniques in mi
croneurosurgery, is the effort of five
continued on page 326
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5. Laparoscopic Cholecystectomy: Strategy
and Concerns
E.C. Poulin, MD, FRCSC;* J. Mamazza, MD, FRCSC;t D.E.M. Litwin, MD, FRCSC;$
A.G. Nagy, MD, FRCSC;§ M.J. Girotti, MD, FRCSCH
After briefly describing the first laparoscopic cholecystectomy performed by Philippe
Mouret, the authors review some of the differences in strategy, management and
concerns between conventional and laparoscopic cholecystectomy. They address the
problems relating to the required skills of triangulation and camera handling, the
presence of common-duct stones and concomitant disease, the issues of drainage,
hemostasis, access in difficult cases, iatrogenic trauma to the bile ducts and
pertinent differences in cardiorespiratory function.

Apres une breve description de la premiere cholecystectomie laparoscopique realisee
par Philippe Mouret, les auteurs passent en revue quelques unes des strategies,
demarches et preoccupations qui differencient les cholecystectomies classiques et
laparoscopiques. Ils s’interessent aux problemes relatifs aux habiletes requises pour
la triangulation et les manipulations de camera, a la presence de calculs dans le
choledoque et a celle de maladies associees, aux questions de drainage, d’hemostase,
d’acces dans les cas difficiles et de traumatismes iatrogenes des canaux biliaires, et
aux differences pertinentes a la fonction cardiorespiratoire.

n France the boundaries between
the surgical specialties are not
quite as rigid as in North America,
and it is not unusual to see visceral
surgeons, as they are called, per
form gastrointestinal, gynecologic
and other procedures that cross our
traditional specialty lines.
In that context, a skilled visceral
surgeon practising in Lyon had
been performing various laparo-

I

scopic procedures below and above
the pelvic rim for over 15 years and
gaining a wealth o f expertise. Then
one day in 1987 Philippe Mouret
attempted to remove the gallbladder
through the laparoscope in a select
ed patient. The 21/2-hour procedure,
performed with the instruments o f
the day, left him so exhausted that,
upon leaving the operating room,
he said to himself: “ This is my first
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and probably my last. . . .” (P.
Mouret: Personal communication).
However, the next day as he
showed up for rounds on the ward,
to his great surprise he was met in
the hallway by his patient who was
taking a leisurely walk, pain free.
That changed his mind.
Since then, we have been con 
fronted by the differences between
conventional and laparoscopic ch o
lecystectomy and forced to rethink
our approach to biliary problems
and their management.

Preoperative Concerns
Presence o f Common-Duct Stones

The preoperative detection o f
common-duct stones is important
because routine exploration and
safe extraction o f common-duct
stones laparoscopically are still in
their infancy. All the standard infor
mation derived from the patient’s
history and physical, laboratory and
radiologic investigations must be
noted precisely because the likeli
hood o f choledocholithiasis roughly
parallels the number o f positive
findings from the following: jaun
dice, pancreatitis, elevated enzyme
levels, common duct over 9 mm on
ultrasonography and length o f bili
ary tract disease.1
A decision will have to be made
on whether preoperative endoscopic
retrograde cholangiopancreatogra
phy (ERCP) or sphincterotomy, or
CJS, VOL. 35, NO. 3, JUNE 1992
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both, are necessary, taking into
consideration the efficacy and mor
bidity.
In the future, perioperative
ERCP, with or without sphinc
terotomy, will undoubtedly be com
pared to laparoscopic common-duct
exploration with respect to safety
and efficacy.
Concomitant Intra-abdominal
Disease
With the current technology, la
paroscopic exploration of the ab
dominal cavity probably suffers
when compared with manual explo
ration of all organs during open
laparotomy. Therefore the history
and physical examination for symp
toms and signs of associated intra
abdominal disease are especially im
portant, because the findings might
alter the indication for laparoscopic
surgery.2 For example, of our first
100 patients who underwent laparo
scopic cholecystectomy, 2 returned
months after their initial surgery.
One had a pancreatic mass, the
other had a carcinoma of the ce
cum. Both of these were missed at
initial exploration.

General Strategy

gery are camera handling and trian
gulation.
Camera-Handling Technique
For the purpose of this opera
tion, surgeons have had to borrow
camera-handling techniques well
known to the television and movie
industries. The principles are as
follows. First, the action should be
kept in the centre of the screen.
The camera should also be kept
stable at all times. A skilful camera
operator must be efficient at quickly
finding the operator or assistant
when they go off the screen, by
pulling back the camera rather than
by moving laterally. The camera
person should also respect the sur
geon’s focal zone of comfort, be
cause some surgeons prefer to be
closer or farther from the operative
field. All transitions, from wide
angle to close up, should also be
done smoothly, and, above all, the
camera handler should avoid panic
in an emergency situation because
there is absolutely nothing he can
do to help, other than clean blood
off the lens. Following these princi
ples will minimize the time wasted
looking for the surgeon and assis
tant and will permit hours of headache-free concentration on the mon
itor screen.

Coordinated Work
The surgeon, assistant and nurse
performing laparoscopic surgery
have to learn to perform proficiently
as a unit, akin to a forward line of
players in hockey. Only then will
routine cases seem easy and diffi
cult operations become possible
without misery. Never has poor
strategy and clumsy movement
been observed by so many in the
surgical suite or recorded on so
many videotapes as with this surgisurgical technique.
Basically, the two new skills re
quired to perform laparoscopic sur
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Triangulation (Surgeon and
Assistant)
For this operation, the surgeon,
and to a lesser degree the assistant,
looks away from the operating field
to watch a television monitor; the
surgeon’s hands are situated out
side the abdominal cavity at the tip
of long, delicate instruments. To
perform a surgical procedure, the
surgeon must assume the position
of the operating field by a process
referred to as triangulation (Fig.
I 3). The quickest way to learn how
to triangulate is to get tactile feed

back from the operative site. This is
achieved by touching or gently
bumping the liver or adjacent struc
tures with an instrument. The
human brain adapts once tactile
feedback is achieved, and the sur
geon can start to perform precise
gestures quite quickly. The assis
tant will make the surgery easier by
exposing the structures in Calot’s
triangle. For this purpose, the later
al grasper is used to lift up the
right lobe of the liver with the
fundus of the gallbladder, and this
grasper can be clipped to the drap
ing for most of the procedure. Time
is saved by avoiding unnecessary
movement of the graspers, letting
the surgeon perform all possible
dissection with a given exposure.
When exposure becomes necessary,
then the inside grasper is moved by
the surgeon or the assistant. Classi
cally, more creativity and more
movement are needed from both
graspers for the last couple of cen
timetres of dissection in the gall
bladder bed.

Concerns
Drainage
Although the controversy regard
ing the use of drains after elective
open cholecystectomy has been laid
to rest by numerous studies, espe-

F1G. 1. Triangulation: “A technique
for finding a specific position by divid
ing a region into a network of triangu
lar areas. . . ,”3

CONCERNS IN LAPAROSCOPIC CHOLECYSTECTOMY

dally that of Lewis and colleagues4
from the Queen Elizabeth Hospital
in Montreal, laparoscopic cholecys
tectomy presents new challenges,
which require new judgements.
For example the available literature
points to bile leaks as being an
important problem in laparoscopic
cholecystectomy.5
It would then be reasonable to
recommend drainage for the first 10
to 20 cases of a surgeon’s experi
ence so that a better appreciation or
feel for the surgery can be gained.
Drainage should be considered
when a bile leak is observed in the
liver bed and in difficult operations
in which previous upper-abdominal
surgery necessitates extensive lysis
of adhesions and more chance of
trauma. Drainage should follow op
erations for acute or gangrenous
cholecystitis in which hemostasis is
not perfect or pus is found, as well
as operations in which stones are
found at cholangiography. In this
last instance, distal obstruction
could foster a bile leak if ERCP the
next day is unsuccessful.
Anatomical Concerns
Most anatomical concerns in la
paroscopic cholecystectomy revolve
around access in difficult cases,
such as when the patient has under
gone previous surgery, especially
upper abdominal surgery. In these
situations, safe access under direct
vision can be achieved with the
Hasson cannula. Another technique
in which symmetrical pneumoperi
toneum is obtained with a Veress
needle inserted away from the previ
ous surgical scars can be consid
ered. The abdomen is then per
cussed at the needle site, and the
needle is gently rotated and palpat
ed against the peritoneum, as de
scribed by Philippe Mouret (person
al communication), to assess the
presence of adhesions. Then, a
5-mm sleeve-covered trocar is in

serted at the needle site, the status
of the abdomen is determined with
a 5-mm laparoscope and adhesions
are lysed as needed through anoth
er port for safe trocar access under
direct vision in the midline. We
should also insist on the distraction
of normal anatomical relationships
at the junction of the cystic and
common ducts caused by the lateral
grasper pulling up on the fundus of
the gallbladder. This should remind
us that before any clip application,
the infundibulum of the gallbladder
should be clearly dissected on all
sides to ascertain the nature of the
ductal structure exiting the gall
bladder.
Hemostasis
When the management of acute
cholecystitis is tackled laparoscopically, the quality and precision of
hemostasis is paramount.6 All the
blunt pulling down of gallbladder
adhesions frequently used in elec
tive surgery should be abandoned in
favour of cautery-controlled desic
cation, lest bleeding from these in
flamed adhesions be impossible to
locate or control safely. In doing so,
special attention should be paid to
the possibility of sparking adherent
organs, especially in the vicinity of
Calot’s triangle.
Incidents
Various incidents can complicate
laparoscopic cholecystectom y.
Spilled bile, especially if con
taminated with bacteria, is thought
by some to produce abdominal pain.
Therefore any spilled bile should be
aspirated and the area irrigated.
Spilled stones, although usually in
nocuous, should be picked up when
feasible. Although they are pre
sumed to become encased in fibrous
tissue, one of our patients present
ed 2 weeks after surgery with an
umbilical fistula through which

stones were expelled for weeks.
Common-Duct Stones
One of the two most debated
points in laparoscopic cholecystec
tomy concerns the use of operative
cholangiography. From the avail
able literature, it is estimated that
25% of surgeons perform cholangi
ography routinely and 75% selec
tively. This debate over the need for
operative cholangiography raged
for years in the days of open chole
cystectomy, before ERCP was intro
duced. Today the debate should be
tempered by our relative ignorance
of the natural history of small com
mon-duct stones and the important
contribution afforded by pre- or
postoperative ERCP, with or with
out sphincterotomy. Until credible
data are available, those who wish
to use cholangiography selectively
during laparoscopic cholecystecto
my should follow certain guidelines
suggested by the literature and
summarized in Table I. This as
sumes easy availability of ERCP.1'7
Iatrogenic Trauma to Bile Ducts
The Achilles’ heel of laparoscopic
cholecystectomy remains the rela
tively high rate of trauma to the
bile ducts reported in some initial
series.8 Whether this is the result of
a learning curve or is an obligatory
phenomenon remains to be con
firmed. However, for this new tech
nique to be recommended as the
primary surgical therapy for all pa
tients with symptomatic gallstones,
this 1% to 2% rate will have to
approach the 0.2% to 0.1% rate
estimated for initial experience with
open cholecystectomy.910 As has
been widely reported, special atten
tion should be paid to the first 30
cases of one’s experience because
the majority of trauma is reported
in this group. The most hazardous
cases involve thickened, chronically
CJS, VOL. 35. NO. 3. JUNE 1992
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inflamed gallbladder often contain
ing little or no bile and retracted on
stones.8-11'12 Chronic inflammation
retracts the gallbladder and short
ens the cystic duct. This is well
described in all recent editions of
Sabiston’s Textbook o f Surgery
(Fig. 2),13 where the legend reads:
“ . . . very short or absent cystic
duct, usually observed in severe,
chronic inflammation.”

Decrease in Cardiac Output
We have measured hemodynamic
parameters for 25 consecutive pa
tients who underwent laparoscopic
cholecystectom y. Measurements,
taken at 20 precise moments of the
perioperative course, have revealed
that between 60% and 80% o f pa
tients show a drop in cardiac output
at various points during the proce
dure. This drop is maximal at the
end o f insufflation when the patient
is placed in the Fowler position.
This affects 80% o f the patients for
an average of 26% of their cardiac
output. This clinically silent drop is
probably related to diminished ve
nous return secondary to increased
intra-abdominal pressure and its in
fluence on the ejection volume rath
er than the cardiac rate. It focuses
attention on the importance o f good
anesthetic monitoring of these pa
tients.14

1518 patients who had laparoscopic
cholecystectomy, reported by the
Southern Surgeons Club,12 only 2
patients had pulmonary complica
tions. In another study that we
conducted, pulmonary function was
evaluated in 54 consecutive patients
who underwent laparoscopic chole
cystectomy. There were no pulmo
nary complications. The next-day
decreases of forced expiratory vol
ume and forced vital capacity were,
on average, 22% and 21%, respec
tively, compared with 40% to 60%
T a b le 1. Criteria
No
cho lan g io g rap h y

Duct < 7 mm
Normal enzyme
levels
Few large stones
No jaundice or
pancreatitis
Disease of short
duration

in historical controls. Furthermore
there was no difference between
smokers and nonsmokers or be
tween patients older and younger
than 60 years, attesting to the
relative benignity of laparoscopic
cholecystectomy on pulmonary
function.18

Conclusions
So far, the outstanding benefits
observed worldwide with successful

for Selective Cholangiography

P re o p e ra tiv e ERCP

Duct > 9 mm ±
elevated enzyme
levels
Jaundice, pancreatitis
Common-duct stone
on ultrasonography

O p erative
ch o lan g io g rap h y

P o s to p e rative
ERCP

Duct between 7 and 9
mm
Elevated enzyme
levels
Small stones, large
cystic duct
Unclear anatomy

Failed operative
cholangiography
Stones at operative
cholangiography

ERCP = endoscopic retrograde cholangiopancreatography

More Advantages
Pulmonary complications are re
ported in 2% to 6% of patients who
undergo open surgery of the upper
abdomen. These patients suffer a
“ next-day” decrease of their vital
capacity and forced expiratory vol
ume o f 40% to 60%.15'16 Also, the
risk o f pulmonary complications is
estimated to be six times greater in
smokers than nonsmokers.17 How
ever, pulmonary complications ap
pear to be almost nonexistent after
laparoscopic cholecystectomy. Of
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FIG 2. Surgically significant variations in ductal anatomy. C shows shortened cystic
duct, which is due to chronic inflammation. Reproduced, with permission, from
Nahrwold DL.13

CONCERNS IN LAPAROSCOPIC CHOLECYSTECTOMY

laparoscopic cholecystectomy are
undeniable and confer on this tech
nique a preponderant role in the
treatment of symptomatic choleli
thiasis. However, some aspects war
rant improvement, notably the ini
tial rate of iatrogenic trauma to the
bile ducts, for which there are iden
tifiable anatomic and pathologic
warning signs. Surgeons should
also take note of the probable defi
ciency of laparoscopic surgery in
exploring intra-abdominal organs
compared with the hand revision of
open surgery. The impact of pneu
moperitoneum on cardiac output
should be appreciated. When severe
bradycardia, other arrhythmias and
the occasional cardiac arrest report
ed in the literature during surgery
under pneumoperitoneum occur,
one should remember the impor
tance of immediate decompression
as a first step to treat the cardiovas
cular emergency. Finally, the opti
mal management of common-duct
stones remains to be defined and
raises the issue of training surgeons
of the future in the skills of ERCP

with sphincterotomy and laparo
scopic common-bile-duct explora
tion.
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NOTICES
AVIS
Southern Ontario Surgical Society
The fall meeting of the Southern Ontar
io Surgical Society, held in conjunction
with the Association of Surgeons in
Jamaica, will take place Oct. 24 -3 1 ,
1992, at the Half Moon Club in Monte
go Bay, Jamaica. For more information
contact: Dr. J. Ian Macmillan, Ste. 100,
145 Queenston St., St. Catherines, ON
L2R 2Z9; phone: (416) 6 8 7 -3 4 1 1 .

New Orleans. The program includes 21
postgraduate courses, approximately
100 hours o f general and specialty
sessions, over 100 medical motion pic
tures, over 300 papers and scientific
and technical exhibits. For more infor
mation contact: Ms. Sally Garneski,
American College of Surgeons, 55 E
Erie St., Chicago, IL 6 0 6 1 1 -2 7 9 7 ,
USA; phone: (312) 6 6 4 -4 0 5 0 , Ext.
409.

Laparoscopic Surgery
American College of Surgeons
The Annual Clinical Congress of the
American College of Surgeons will con
vene Oct. 1 1 -1 6 , 1992, at the New
Orleans Convention Center and the New
Orleans Hilton Riverside and Towers in

The 2nd G.I.-Tract Laparoscopic Sur
gery International Meeting will be held
Oct. 8 -9 , 1992, in Liege, Belgium. The
meeting will include lectures, live proce
dures and video sessions. For more
information contact: Catherine Mariss-

iaux, Meeting coordinator, Clinique
Saint-Joseph, Rue de Hesbaye, 75, B 4 0 0 0 Liege, Belgium; phone: 0 4 1 - 2 4 8 0 -9 9 ; fax: 0 4 1 - 2 4 - 8 7 - 7 0 .

The International Federation of
Societies for Surgery of the Hand
The Grand Rapids 22nd Annual Interna
tional Symposium on Implant Surgery
for the Hand, Upper Extremity and Foot
will take place Oct. 2 2 -2 4 , 1992, in the
B lodgett Memorial Medical Center,
Grand Rapids, Michigan. For more in
formation contact: Dr. Alfred B. Swan
son, 2 9 0 Blodgettt Professional Bldg.,
1900 Wealthy St SE, Grand Rapids, MI
4 9 5 0 6 , USA.
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Prescribing Information
Classification
Antiandrogen

Action
Androcur (cyproterone acetate) is a steroid
which clinically demonstrates two distinct
properties:
a) Antiandrogenic: Cyproterone acetate
blocks the binding of dihydrotestosterone the active metabolite of testosterone to the specific receptors in the prostatic carci
noma cell.
b) Progestogenic/antigonadotrophic:
Cyproterone acetate exerts a negative feed
back on the hypothalamo-pituitary axis, by
inhibiting the secretion of LH leading to dimin
ished production of testicular testosterone.
The absorption of Androcur following oral ad
ministration is complete. Peak plasma levels
are reached 3-4 hours after administration.
Plasma levels fall rapidly during the first 24
hours as a result of tissue distribution and ex
cretion, and plasma half-life was 38 ± 5 hours.
Most of the cyproterone acetate is excreted
unchanged in the feces (60%) or urine (33%)
within 72 hours. Cyproterone acetate is
eliminated with the urine mainly in the form
of u n rn n u .notorf matahnlifpq and With the
bik
glucuronidized
metabo..
The principal metabolite identified was
158-hydroxy-cyproterone acetate.
Androcur Depot: Following intramuscular
Androcur Depot administration, mean maxi
mum blood levels were attained 3.4 days after
injection. The mean elimination half-life was
found to be 4 days.

Indications
Androcur (cyproterone acetate) is indicated
for the palliative treatment of patients with
advanced prostatic carcinoma.

Contraindications
Known hypersensitivity to the drug. Active liver
disease and hepatic dysfunction.
Renal insufficiency.

Warnings
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Liver Function: Cyproterone acetate has
been found at low doses o f 2-10 mg/kg to
cause liver abnormalities in dogs and rats in
the form o f proliferative liver changes including
increased liver weight, liver cell hypertrophy
with an increase in the smooth endoplasmic
reticulum and a rise in the serum glutamic
pyruvic transaminase (SGPT). At high doses
of 50-100 mg/kg, nodular hepatic hyperplasia
and hepatomas have also been observed.
Although cyproterone acetate has shown
good liver tolerance in man, liver function tests
including SGOT, SGPT and LDH should be
performed at least semi-annually during
Androcur therapy.
Inhibition of Spermatogenesis: The sperm
count and the volume of ejaculate are reduced
at oral doses of 50-300 mg per day. Infertility
is usual, and there may be azoospermia after
8 weeks of therapy, which is associated with
atrophy of seminiferous tubules. Follow-up
examinations on discontinuation of therapy
have shown these changes to be reversible.
Spermatogenesis usually reverts to its
previous level about 3-5 months after stopping
Androcur, or in some patients, after up to
20 months. Production of abnormal spermato
zoa during Androcur therapy has been
observed: their relationship to abnormal fertil

ization or malformed embryos is not known.
Gynecomastia: Benign nodules (hyperplasia)
of the breast have been reported; these gener
ally subside 1-3 months after discontinuation
o f therapy and/or after a reduction of dosage.
The reduction of dosage should be weighed
against the risk of inadequate tumor control.
Depression: Androcur therapy has occasionally
been associated with an increased incidence
of depressive mood changes, especially during
the first 6-8 weeks of therapy. Similar mood
changes have also been seen following surgi
cal castration and are considered to be due to
androgen deprivation. Patients with tendencies
to depressive reaction should be carefully
observed.

Precautions
Thromboembolism: Clinical investigations
have shown that when cyproterone acetate is
used alone, it has a minor effect on blood
clotting factors. However, when cyproterone
acetate was combined with ethinyl estradiol,
changes were found in increased coagulation
capability.
There is an inherent risk for those patients
with a history of thrombophlebitis or throm
boembolism for recurrence of the disease.
Cyproterone acetate should be discontinued
at the first sign o f thrombophlebitis or throm
boembolism.
The patient should be carefully re-evaluated
if manifestations of thrombotic disorders should
occur, e.g. thrombophlebitis, cerebro- vascular
complications, renal thrombosis or pulmonary
embolism.
Adrenocortical Function: Suppression of
adrenocortical function tests have occurred
in patients receiving high doses (100 mg/rr?)
of Androcur. Reduced response to endoge
nous ACTH was noted by the metyrapone test;
furthermore, reduced ACTH and cortisol blood
levels determined by the Mattingly method
were also found. It is therefore recommended
that adrenocortical function tests should be
monitored periodically by serum cortisol assay.
Diabetes: Androcur may impair carbohydrate
metabolism. Parameters of carbohydrate
metabolism, fasting blood glucose and glucose
tolerance tests, should be examined carefully
in all patients and particularly in all diabetics
before and regularly during therapy with
Androcur.
Hematology: Hypochromic anemia has been
observed rarely during therapy with Androcur.
Regular hematological assessment is
recommended.
Nitrogen Balance: A negative nitrogen
balance is usual at the start of therapy, but
does generally correct itself within 3 months
of continued therapy.
Metabolic Effects: Fluid retention, hypercal
cemia and changes in plasma lipid profile may
occur. Accordingly, Androcur should be used
with caution in patients with cardiac disease.
Skin: Androcur therapy may cause a reduction
of sebum production leading to dryness of the
skin, and transient patchy loss of body hair.
Concomitant Alcohol: Alcohol may reduce
the antiandrogenic effect of Androcur in hyper
sexuality. The relevance of this in prostatic
carcinoma is not known. However,
it would be prudent to inform the patients
that the use of alcohol during Androcur therapy
is not advisable.
Physical Performance: Patients should be in
formed that fatigue and lassitude are common
in the first few weeks of therapy,
but usually become much less pronounced
from the third month onwards. Marked lassi

tude and asthenia necessitate special care
when driving or operating machinery.

Adverse Effects
The most frequently recorded adverse effects
with Androcur (cyproterone acetate) are those
related to the hormonal effects of the drug.
These reactions usually disappear upon dis
continuation of therapy or reduction of dose.
Hormonal: inhibition o f spermatogenesis;
abnormal spermatozoa; impotence; breast ten
derness; breast enlargement; gynecomastia;
benign nodular hyperplasia; galactorrhea.
Central Nervous System: fatigue; lassitude;
weakness; depression; headache.
Gastrointestinal: diarrhea; nausea; vomiting;
constipation; indigestion.
Cardiovascular: edema; shortness of breath on
effort; thrombophlebitis.
Laboratory Function Tests: Abnormal values
have been found in the following tests:
Liver Function Test: SGPT and SGOT increase.
Adrenocortical Function test: decreased re
sponse to ACTH and lowered cortisol.
Hematology: hypochromic anemia. Negative
nitrogen balance initially and hypercalcemia.
Adverse reactions are rarely o f sufficient
severity to require dosage reduction or discon
tinuation of treatment. If reactions are severe,
it may be beneficial to reduce the dosage.

Symptoms and Treatment
of Overdosage
There have been no reports of fatal over
dosage in man with Androcur (cyproterone ac
etate). There are no specific antidotes, and
treatment should be symptomatic.
If oral overdosage is discovered within two
to three hours, gastric lavage can safely
be used if indicated.

Dosage and Administration
Oral Tablets: The usual daily initial and
maintenance dose of Androcur is 4-6 tablets
(200-300 mg) divided into 2-3 doses and taken
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recommended.
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Because of their pharmacokinetic properties,
Androcur (oral) and Androcur Depot (i.m.)
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treatment. The dosage may be reduced if
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Availability
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Androcur Depot (cyproterone acetate) 3 mL
(300 mg) ampoules. Each 3 mL ampoule
contains cyproterone acetate 100 mg/mL in
a castor oil solution.
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6. Laparoscopic Cholecystectomy:
Trans-Canada Experience With 2201
Cases
D.E.M. Litwin, MD, FRCSC;* M.J. Girotti, MD, FRCSC;t E.C. Poulin, MD. FRCSC;$
J. Mamazza, MD, FRCSC;§ A.G. Nagy, MD, FRCSCD
The authors carried out a prospective review of the initial and consecutive
experience with laparoscopic cholecystectomy of 58 surgeons from 31 teaching and
nonteaching institutions throughout Canada. The perioperative morbidity of 2201
cases is described, with special attention to iatrogenic complications. The data
suggest that complications, including bile-duct injury, are not frequent. Pneumonia
and wound infection rates appear lower than after open surgery. There were no
deaths. Laparoscopic cholecystectomy is replacing open cholecystectomy for the
management of symtomatic cholelithiasis.

Les auteurs revisent l’experience initiale et consecutive avec la cholecystectomie par
voie laparoscopique de 58 chirurgiens, provenant de 31 hopitaux universitaires et
non universitaires partout au Canada. La morbidite perioperatoire de 2201 malades
est revue prospectivement avec une attention speciale aux complications
iatrogeniques. Les complications, incluant les traumatismes aux voies biliaires, sont
peu frequentes. Certaines complications, comme la pneumonie et l’infection de plaie
apparaissent moins frequemment qu’en chirurgie ouverte. II n’y a pas eu de deces.
La cholecystectomie par voie laparoscopique remplace la cholecystectomie par voie
ouverte pour le traitement de la cholelithiase symptomatique.

he rapid acceptance of laparo
scopic cholecystectomy for un
complicated symptomatic choleli
thiasis and the widespread dissemi
nation of the technique are unprec
edented in recent surgical history.
Concerns have arisen because of
anecdotal reports of catastrophic
injury and patient death due, in
part, to inadequate training and

T

experience. However, laparoscopic
cholecystectomy has such over
whelming benefits for patients that
it must be considered as the treat
ment of choice for symptomatic
cholelithiasis.
As the published experience in
North America and Europe grows,
it is apparent that laparoscopic cho
lecystectomy can be carried out
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the Royal College o f Physicians and Surgeons o f Canada, Quebec, Que., Sept. 22, 1991
Accepted for publication Mar. 16, 1992
Reprint requests to: Dr. D.E.M. Litwin, Ste. 202, 610 Queen St., Saskatoon, SK S7K 0M8

safely in over 90% of patients with
symptomatic cholelithiasis.1"4 The
purpose of a national registry and
this review of surgeons’ experience
across Canada is to document as
accurately as possible the incidence
of complications associated with la
paroscopic cholecystectomy.

Methods

From June 1990 to July 1991
the combined experience of a large
group of surgeons across Canada,
from coast to coast, was collected
prospectively. There were 58 sur
geons from 31 institutions. All par
ticipating surgeons entered their
initial cases and their consecutive
experience thereafter. Therefore
data were collected in a prospective
fashion at all centres. A standard
ized database was used, and all data
were maintained and updated on a
spreadsheet devised for this pur
pose. If data were incomplete or the
potential for misinterpretation exist
ed, contact was made with the
surgeon for clarification.
Surgeons practised in small and
large hospitals and in solo and
group practices. They represented 8
teaching hospitals and 23 nonteach
ing hospitals. Similar numbers of
laparoscopic cholecystectom ies
were performed overall at teaching
and nonteaching hospitals.
Although the technique of lapa
roscopic cholecystectomy was not
standardized, all surgeons practised
CJS, VOL. 35, NO. 3, JU N E 1992
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a currently accepted method. The
majority adopted the American ap
proach of Reddick, Olsen and Dan
iel5 but some practised the French
technique.1 The use of cholangiog
raphy and postoperative drains
most closely mimicked the sur
geon’s routine with open cholecys
tectomy. Cautery was used in the
majority of cases for gallbladder
removal, and the routine use of the
Nd:YAG laser was confined to one
institution.
Invitations to participate in the
survey were given at training
courses across the country and sur
geons were reinvited subsequently
by letter. Contact was maintained
periodically by letter or telephone,
and participant motivation and en
thusiasm remained high through
out. Participants were encouraged
to report all complications and con
versions to open cholecystectomy.
The definition of a conversion was
that used by Meyers,4 but conver
sion was not regarded as a compli
cation per se. Because of the great
interest in complications of laparo
scopic surgery and to ensure that
no deaths, bile-duct injuries or
cases of deep vein thrombosis were
overlooked, all participating sur
geons were questioned about these
at the end of the study.

Findings
Patient Characteristics
The 2201 patients entered into
the registry underwent 2202 lapa
roscopic operations. One patient
underwent two procedures; the first
was a laparoscopic cholecystostomy
for an empyema of the gallbladder
and the second was a laparoscopic
cholecystectomy 4 months later.
Fourteen surgical groups performed
fewer than 20 procedures each, and
7 groups performed more than 100
procedures. Five groups performed
292
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from 20 to 50 procedures and five
performed between 50 and 100.
There were 482 (21.9%) men with a
mean age of 53.9 years and 1719
(78.1%) women with a mean age of
48.3 years. The patients ranged in
age from 7 to 94 years.
Indications
In 1974 patients (89.7%) the indi
cation for laparoscopic cholecystec
tomy was chronic cholecystitis,
which was responsible for either
biliary colic or chronic pain. Howev
er, there were 177 cases of acute
cholecystitis (8.0%). Other indica
tions for cholecystectomy included
pancreatitis (33 patients), jaundice
(6 patients), gallbladder polyps (4
patients), abnormal cholecystokinin
stimulation test result (2 patients),
chronic Salmonella carrier (1 pa
tient), previous laparoscopic chole
cystostomy (1 patient), acute volvu
lus (1 patient) and cancer of the
gallbladder (1 patient). Two patients
with asymptomatic gallstones were
operated on because of plans for
extensive travel or prolonged work
in a third-world country.
Operation
With respect to the conduct of
the operation, cholangiography was
done selectively in 277 (12.6%) pa
tients and was successful in 232
(83.8%) of them. Cautery was used
on most patients to detach the
gallbladder from the liver bed. The
Nd:YAG laser was used on 109
patients (5.0%), and scissors were
used on 104 patients (4.7%). The
most common tool used with cau
tery was the hook. Drains were
used in 313 (14.2%) cases, and 32
of them (10.2%) were left in place
for 48 hours or longer.
Conversion
Rates of conversion to open cho

lecystectomy ranged from 0% to
10%. Those centres that performed
more than 100 laparoscopic chole
cystectomies had a conversion rate
of 3.7% (57 of 1559) and those that
performed fewer than 100 had a
conversion rate of 5.9% (38 of 643).
The conversion rate overall was
4.3% (95 of 2202), and the group
with the largest series had a conver
sion rate of 2.8% (19 of 679). The
overall rate may be compared with
that of Meyers4 (Table I). In most
cases, conversion occurred because
of the technical inability to perform
the procedure, not because of com
plications. From the table one can
see that adhesions (26), acute
cholecystitis (14), common-bile-duct
stones (8), failed laparoscopic common-bile-duct exploration (1) and
obesity (8) accounted for more than
50% of conversions. These condi
tions presented technical challenges
for the laparoscopist that were re
lated in part to expertise. Complica
tions accounted for only 22 conver
sions.
A few conversions are of special
significance, however. Uncontrolla
ble bleeding occurred in six cases.
This was due to cystic-artery avul
sion (two), cystic artery transection
(one), bleeding from the liver bed
(one) and injury to the iliac artery
and vein (one), which occurred at
the end of a procedure when the
umbilical trocar was reintroduced
after extraction of the gallbladder in
the absence of pneumoperitoneum.
Two common-bile-duct injuries led
to immediate conversion. In one
instance, the common bile duct was
transected during cholecystectomy
in the presence of acute disease.
The injury was recognized, and re
pair was carried out by primary
anastomosis over a T tube. In the
other case, a small choledochotomy
was performed for insertion of a
cholangiography catheter, which
was clipped in position, and cholan
giography was done. The injury
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was recognized and the duct re
paired over a T tube. The only
other common-bile-duct injury was
unrecognized at the time of surgery
and was repaired 3 days postoperatively by hepatojejunostomy. The
common-bile-duct injuries occurred
within the first 30 cases of the
surgeon’s experience in every in
stance.
Mechanical problems led to con
version in eight cases. Among these
were five cases of extraperitoneal
insufflation. Also, in one instance
the surgeon was confronted with a
cystic duct larger than the stapling
device available, so open cholecys
tectomy was done to provide a
secure closure of the cystic duct.
Cautery failure and camera failure
each led to conversion. Conversion
was also necessary in two cases of
cystic-duct perforation, by dissec
tion or by the cholangiography
catheter distal to where it was con
sidered safe to place a clip without
tenting the common bile duct. In
sertion of a Veress needle into the
stomach was the only viscus injury
to result in conversion.

Intraoperative Complications

These were difficult to classify
since the majority were of no conse
quence (Table II), and many would
not be noted during open surgery.
Entry into the gallbladder and spill
age of stones were common but
appeared to be inconsequential.
Troublesome bleeding was relatively
common (88 patients [4%]) but rare
ly significant. Only six cases of
bleeding required conversion (Table
III). In the remainder bleeding was
controlled by clips, cautery, hemo
static agents or pressure; the cases
were often analogous to the situa
tion in open surgery where bleeding
from the liver bed is controlled by
pressure from an assistant’s retrac
tor with or without the use of a
hemostatic agent.
The definition of troublesome
bleeding is relative to the operator’s
experience and the laparoscopic
procedure in general. The Veress
needle injuries (five) included pene
tration of an ovarian cyst (one),
penetration of the small-bowel mes
entery with development of a hema

T a b le 1. R e a so n s fo r C o n v e rs io n o f L a p a ro s c o p ic C h o le c y s te c to m y to C o n ve n tio n a l
C h o le c y s te c to m y

R eason

M e y e r s ,* no. (% )
of c a s es

A cu te in fla m m a tio n
C h ro n ic in fla m m a tio n
A d h e s io n s
M e c h a n ic a l p ro b le m s
A b e rra n t a n a to m y
B le e d in g
B ile -d u c t la c e ra tio n
B ow e l in ju ry
T o rn g a llb la d d e r /s to n e s p illa g e (o r a n y v isc u s in ju ry )
N eed fo r d u c t e x p lo ra tio n
G a llb la d d e r c a rc in o m a
M a lig n a n t o b s tru c tio n o f b ile d u c ts
C h o le d o ch a l c y s t
O b e sity
C y s tic -d u c t p e rfo ra tio n
S m a ll-b o w e l o b s tru c tio n
P o ly c y s tic d is e a s e
M in ila p e x tra c tio n
L o s t g a llb la d d e r

8
20
8
6
6
5
4
4
5
2
2
1
1

T o ta l

7 2 (4 .7 4 )

* M e y e rs (S o u th e rn S u rg e o n s C lu b ) 1 5 1 8 p a tie n ts
tL it w in (T ra n s -C a n a d a se rie s ) 2 2 0 1 p a tie n ts

(0 .5 3 )
(1 .3 2 )
(0 .5 3 )
(0 .4 0 )
(0 .4 0 )
(0 .3 3 )
(0 .2 6 )
(0 .2 6 )
(0 .3 3 )
(0 .1 3 )
(0 .1 3 )
(0 .0 6 )
(0 .0 6 )
—
—
—
—
—

—

L itw in .t no. (% )
of cases
14 (0 .6 4 )
7 (0 .3 2 )
2 6 (1 .1 8 )
8 (0 .3 6 )
3 (0 .1 4 )
6 (0 .2 7 )
2 (0 .0 9 )
1 (0 .0 5 )
5 (0 .2 3 )
9 (0 .4 1 )
0 (0 )
0 (0 ).
0 (0 )
8 (0 .3 6 )
2 (0 .0 9 )
1 (0 .0 5 )
1 (0 .0 5 )
1 (0 .0 5 )
1 (0 .0 5 )
95 (4 .3 2 )

toma (one) and penetration of the
small bowel (one), colon (one), and
stomach (one). There were no com
plications among the four cases
managed conservatively. Of the four
trocar injuries, three were to liver
with no untoward sequelae and one
was to the iliac artery and vein
(already described). Two cases of
clip-applicator malfunction deserve
mention since jaw scissoring of the
clip applicator caused division of
the cystic duct close to the common
bile duct in two cases. The defect
had to be sutured because there
was not enough cystic-duct rem
nant to hold a clip without compro
mising the common duct. Cysticduct perforation has already been
described. The posterior wall of the
gallbladder was left in situ in one
case of acute cholecystitis. In one
case a duct of Luschka could not be
clipped after division in the liver bed
and this caused a bile leak, which
subsequently closed spontaneously.
Postoperative Complications

With respect to postoperative
complications (Table IV), infections
were uncommon and probably have
been underreported. Biliary compli
cations occurred in 22 patients. Bile

T a b le II. In tra o p e ra tiv e C o m p lic a tio n s
C o m p lic a tio n
E n try in to g a llb la d d e r
B le e d in g
M a jo r s to n e s p illa g e
E x tra p e rito n e a l
in s u ffla tio n
V e re s s n e e d le in ju ry
T ro c a r in ju ry
L o s t g a llb la d d e r
C o m m o n -b ile -d u c t in ju ry
C lip a p p lic a to r
m a lfu n c tio n
C y s tic -d u c t p e rfo ra tio n
P e riu m b ilic a l h e m a to m a
R e ta in e d p o s te rio r w a ll
D iv is io n o f d u c t o f
Luschka
B ra d y c a rd ia
In tra o p e ra tiv e
m y o c a rd ia l in fa rc tio n

N o. ( % ) of c a s e s
1 9 0 (8 .6 3 )
8 8 (4 .0 0 )
2 4 (1 .0 9 )
8 (0 .3 6 )
5 (0 .2 3 )
4 (0 .1 8 )
4 (0 .1 8 )
3 (0 .1 4 )
2
2
1
1

(0 .0 9 )
(0 .0 9 )
(0 .0 5 )
(0 .0 5 )

1 (0 .0 5 )
1 (0 .0 5 )
1 (0 .0 5 )
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leaks in 12 patients stopped sponta
neously in 7. All had been drained.
Of the remaining five patients two
required endoscopic retrograde cho
langiopancreatography (ERCP) with
papillotomy and stone extraction,
two had nasobiliary drainage and
one was explored and the cysticduct stump was retied. Bile perito
nitis occurred in five patients. In
three, this was suspected clinically
and from the presence of intra
abdominal fluid on ultrasonography
but was treated conservatively with
resolution. In two patients, laparot
omy was carried out. The cysticduct stump was retied in one and
the common bile duct explored and
a T tube placed in the other. Five
patients had bile collections in the
right subhepatic space. Of four
treated by percutaneous drainage,
two had infected collections; the
fifth was treated without drainage
and had gradual resolution of the
collection with antibiotic therapy.
There were seven cases of post
operative bleeding. Two of the pa
tients were explored by laparotomy
after observation, one 36 hours
after laparoscopic cholecystectomy
and one 3 days later. In both cases
no definite site of bleeding was
found, yet both patients had a sub
stantial drop in the hemoglobin
level. The other five patients had a
marked drop in hemoglobin level,
and three required transfusion.
Bleeding was from the abdominal

wall in three of the five patients.
There were two cases of bowel
perforation: in one patient a cautery
injury to the small bowel, which
perforated 8 days after surgery, was
treated by laparotomy with repair;
in the second patient retroduodenal
perforation of the duodenum oc
curred 2 to 3 weeks after laparo
scopic cholecystectomy secondary
to cautery injury. Open debridement
and drainage were carried out.
The majority of patients (70.4%)
had what we defined as mild abdom
inal pain, that is, the patient had no
need of a narcotic medication such
as Codeine or Demerol on the first
postoperative day and could be
maintained on acetaminophen only.
Moderate pain (narcotic medication
on day 1) was experienced by 24.1%
of the patients and severe pain
(narcotic medication beyond day 1)
by 5.4%. (In two patients [0.09%]
with severe abdominal pain, the
pain was classified as a postopera
tive complication and delayed the
patients’ discharge substantially
[Table IV].) Shoulder pain was ex
perienced by 12.2% and nausea by
14.3%.
Hospitalization

The length of hospital stay was
similar to that reported elsewhere.46
Most patients (96.1%) were operat
ed on as inpatients, and 57.3% were
discharged home the day after lapa

T a b le III. D ata o n 8 8 C a se s o f In tra o p e ra tive B le e d in g

No. of cases

No. converted to open
ch o le c y stec to m y

C y s tic a rte ry
L iv e r bed
T ro c a r site
M id lin e
L a te ra l
A d h e s io n s
G a llb la d d e r o r liver m e s e n te ry
F a lc ifo rm lig a m e n t
D iffu s e
Ilia c a rte ry o r vein
C y s tic d u c t

20
51

3
1

T o ta l/n o . converted

88

B le ed in g site
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5
2
3
1
1
3
1
1

1
1

6

roscopic cholecystectomy, 27%
were discharged home on the sec
ond postoperative day and 11.8%
remained in hospital for 3 or more
days.

Discussion
There can be little doubt that
laparoscopic cholecystectomy will
T a b le IV . P o s to p e ra tiv e C o m p lic a tio n s
C om plication
B ilia ry
Leak
P e rito n itis
C o lle ctio n
In fe c tio n
U rin a ry -tra c t in fe c tio n
U rin a ry re te n tio n
S u b c u ta n e o u s
em physem a
B leeding
A te le c ta s is
Ileus
A b d o m in a l-w a ll
h e m a to m a
C ardiac
A tria l fib rilla tio n
A n te ro s e p ta l is c h e m ia
C ardiac a rrh y th m ia s
M y o c a rd ia l in fa rc tio n
P u lm o n a ry
P n e u m o n ia
R e s p ira to ry a rre s t
R equired v e n tila tio n
P ro b a b le e m b o lis m
P n e u m o th o ra x
F ever
J a u n d ic e
D rug re a ctio n
C e fazo lin s o d iu m —
d iffic u lty in
b re a th in g
M o rp h in e — p ro fo u n d
h y p o te n s io n
S c o p o la m in e —
p s y c h o s is
P n e u m o s c ro tu m
P a n c re a titis
D elayed p e rfo ra te d
v is c u s
S m a ll b o w e l (d a y 8)
D u o d e n u m ( 2 - 3 wk,
re tro p e rito n e a l)
S eve re a b d o m in a l pain
S tro k e (w ith fu ll
re co v e ry)
H e m o b ilia
H ic cu p s
D eep ve in th ro m b o s is
S yn co p e
A o rto fe m o ra l o c c lu s io n
A s c ite s leakage

N o. ( % ) of cases

1 2 ( 0 .5 5 )
5 (0 .2 3 )
5 (0 .2 3 )
21 (0 .9 5 )
5 (0 .2 3 )
1 5 ( 0 .6 8 )
1 2 ( 0 .5 5 )
7 (0 .3 2 )
7 (0 .3 2 )
7 (0 .3 2 )
6 (0 .2 7 )
1
1
1
2

(0 .0 5 )
(0 .0 5 )
(0 .0 5 )
(0 .0 9 )

3 ( 0 .1 4 )
1 (0 .0 5 )
1 (0 .0 5 )
2 (0 .0 9 )
1 (0 .0 5 )
4 ( 0 .1 8 )
3 ( 0 .1 4 )

1 (0 .0 5 )
1 (0 .0 5 )
1 (0 .0 5 )
3 ( 0 .1 4 )
2 (0 .0 9 )

1 (0 .0 5 )
1 (0 .0 5 )
2 (0 .0 9 )
2
1
1
1
1
1
1

(0 .0 9 )
(0 .0 5 )
(0 .0 5 )
(0 .0 5 )
(0 .0 5 )
(0 .0 5 )
(0 .0 5 )
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become the method most frequently
used to treat cholelithiasis. In this
study the conversion rate among all
surgeons was 0% to 10% despite
the degree of experience. Therefore,
it is likely that, in the future, more
than 90% of patients with symptom
atic cholelithiasis will be treated
laparoscopically. This is consistent
with the results of all reports pub
lished so far.1-4 The low rate of
conversion due to selection criteria
is probably counterbalanced by the
relative inexperience of many of the
surgeons in this series. Certainly
the data from the most experienced
centre in this series would substan
tiate the low conversion rate. Of the
first 679 cases performed only 19
(2.8%) were converted. At that cen
tre, after their initial 30 cases,
laparoscopic cholecystectomy was
offered to all patients referred with
symptomatic cholelithiasis. With
experience, previous abdominal sur
gery and acute cholecystitis should
not be considered contraindications
to surgery.
In this series two patients were
operated on prophylactically for
asymptomatic cholelithiasis because
of the prospect of prolonged travel
abroad. Because of the perceived
noninvasiveness of the procedure by
both patients and physicians, the
prospect of prophylactic cholecys
tectomy for asymptomatic choleli
thiasis will continue to be raised.
In regard to the conduct of the
operation, the same intersurgeon
variability occurred as with open
surgery. It is clear that a number of
dissecting and cutting tools can be
successfully utilized, and there ap
pears to be no advantage of any one
modality.7 If properly taught, cho
langiography can be carried out
reliably with a high success rate
(83.8%), as demonstrated in this
series. Selective cholangiography
was practised by most. The practice
of selective drainage appears to be
the commonest and mimics the pat

tern of practice with open surgery.
The most common reason for
failure of laparoscopic cholecystec
tomy in this series was adhesions
secondary to either previous sur
gery or chronic disease. This does
not differ from the experience in
Meyers’ series4 and in some respects
is related to the experience of the
operating surgeon. Currently the
most experienced groups in this
series would attempt laparoscopic
cholecystectomy in all cases irre
spective of previous surgery or de
gree of disease. As expected, acute
cholecystitis was a common reason
for conversion, and that will always
remain an important option in acute
cholecystitis that is unmanageable
laparoscopically. However, in this
series, comprising a wide variety of
general surgeons, the conversion
rate in acute disease remained very
low (14 of 177 [8%]). Patients with
acute disease have the same bene
fits of diminished pain, shorter hos
pitalization and early return to
work. One patient with an empyema
of the gallbladder was treated with
laparoscopic cholecystostomy fol
lowed, 4 months later, by laparo
scopic cholecystectomy. It is con
ceivable that this could represent a
new algorithm in the management
of acute cholecystitis, namely, lapa
roscopic cholecystostomy followed
by interval laparoscopic cholecys
tectomy, which would make open
surgery even less likely. With both
operations the benefit to the patient
was early discharge and early re
sumption of normal activity.
Common-bile-duct stones were
the reason for conversion in nine
patients in this series. In one in
stance this followed failed transcystic common-bile-duct exploration.
There were, however, two success
ful transcystic common-bile-duct
explorations performed in combina
tion with electrohydraulic lithotrip
sy of the intraductal stones and
intraoperative ERCP. The use of

electrohydraulic lithotripsy in the
bile duct is not new,8’9 but the
approach with the laparoscope is
novel. Because of the low cost of
this modality it may prove to be
important as an adjunct to clearing
the common bile duct of stones,
particularly during transcystic ex
ploration, because there is a limit to
the size of stone that can be ex
tracted. Intraoperative ERCP in the
supine position has been criticized
but was successfully carried out in
two patients without much difficul
ty and with no complications. Papil
lotomy at the time of intraoperative
ERCP allowed stone fragments to
pass.
Of interest is that only 22 laparo
scopic procedures were converted
to open cholecystectomy because of
complications related to the laparo
scopic surgery. These complications
included bleeding (six cases), extraperitoneal insufflation (five
cases), gallbladder entry (five cases),
common-bile-duct injury (two
cases), perforation of the cystic duct
(two cases), lost gallbladder (one
case) and Veress-needle insertion
into the stomach (one case). Some
of these complications would not
lead to conversion in more experi
enced hands; therefore conversion
rates should remain low.
We found that many of the in
traoperative complications were of
no consequence. For example, entry
into the gallbladder or stone spill
age did not increase complications
or length of hospital stay. Most
surgeons would try to retrieve all
stones and suction up the bile.
Bleeding should be avoided when
using the laparoscopic technique,
because visualization is easily ob
scured and the ability to suction up
blood is limited. Bleeding of an
annoying nature was not uncom
mon (88 patients) but led to conver
sion in only 6 patients. In all six the
bleeding was easily controlled after
conversion. The only life-threatenCJS, VOL. 35, NO. 3, JUNE 1992
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ing injury was an inadvertent injury
to the iliac artery and vein. Al
though the potential for this kind
of injury will always exist, the pos
sibility will decrease with experi
ence.
In this series there were only
three common-bile-duct injuries.
This finding is particularly signifi
cant because of the large number of
surgeons who participated and be
cause of the large number of partic
ipating centres with fewer than 100
cases. The common-duct injuries
occurred early in the experience of
the surgeons represented, and this
is similar to what has been found
worldwide.2’4 Certainly, meticulous
technique, which includes delinea
tion of the anatomy, is the safest
way to avoid common-bile-duct in
juries. The incidence of commonduct injuries was low even though
cholangiography was seldom used.
This suggests that routine cholan
giography is not important in avoid
ing common-bile-duct injury. In
fact, in one case the bile duct was
mistaken for the cystic duct and a
choledochotomy carried out to
place a cholangiography catheter. It
may be argued, however, that al
though cholangiography does not
prevent common-bile-duct injury, it
identifies the injury and allows for
immediate correction.
Postoperative complications were
infrequent. Biliary complications
were the most common but were
easily treated in almost all cases.
The frequency of atelectasis and
pneumonia was very low, and this is
consistent with the findings of Mey
ers.4 Also, the frequencies of deep
vein thrombosis and pulmonary em
bolism were low. None of the post
operative complications were due to
the laparoscopic approach. Subcu
taneous emphysema and pneumos
crotum were innocuous problems.
There were occasional abdominalwall hematomas and two cases of
delayed perforation of a viscus, and
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there was one case of pneumotho
rax.
Although complications unique
to the laparoscopic approach do
occur, they are infrequent. As expe
rience is gained these are likely to
diminish. Conversely, there are
complications related to the open
approach, such as pneumonia, that
will be reduced by the laparoscopic
approach. In addition there are
clear-cut benefits to the health care
system and the health care consum
er from laparoscopic cholecystecto
my — reduction in pain, duration of
hospitalization and disability. These
factors weigh heavily in favour of
laparoscopic surgery. It is clear that
inadvertent injury to the common
bile duct will always be a potential
risk when surgeons perform biliarytract surgery by either the open or
the laparoscopic method.10-12 This
study does not show any increased
frequency with the laparoscopic ap
proach.
In conclusion, the data suggest
that laparoscopic cholecystectomy
as practised by a wide range of
surgeons in Canada is a safe proce
dure with acceptable mortality and
morbidity. Complications unique to
laparoscopic cholecystectomy are
not frequent, and common-bile-duct
injuries are no more frequent than
with conventional surgery. Patients
are in hospital for only a short time
and have minimal pain. Some com
plications such as infection and
pneumonia appear exceedingly low.
Laparoscopic cholecystectomy will
replace open cholecystectomy as
the “gold standard” for the man
agement of symptomatic choleli
thiasis.
We are indebted to the following sur
geons for their keen participation in
this study: B. Amson, C.P. Armstrong,
E. Bastien, G.A. Bell, G.K. Blair, A.N.
Boulos, M. Brie, M.G. Budzinski, J.
Castonguay, S. Chande, B.K. Cutler, D.
Denton, G. Dewar, F. Dias, J. Dooner,
W. Dunlop, W.A. Felix, C.L. Fortin, M.

Fortin, R.W. Friesen, R.W. Girard, G.
Helie, R.B. Higgins, J.B. Hurley, J.R.
Kirkpatrick, P. Kuechler. A. Kwan,
M.K. Macleod, E.C. MacMullin, P.A.
Makarewicz, M.B. McIntyre, H. McLachlin, J. Newell, F.A. Oleniuk, R. Pace,
C. Perreault, G. Porter, A.A. Rideout,
L. Rivers, J. Robert, L. Rossi, C. Rusnak, H. Scarth, W.G. Selman, D.A.
Sherrin, A.R. Stewart, J. Sundin, D.
Suresh, R.C. Tsang, A. Vaycner, S.K.
Warma, I. Weissglas, A.T. Whittaker.
We thank Ms. Sandra Blevins, RN,
BScN, for her expert assistance in data
coordination and management.
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7. Perceived Future of Laparoscopic
General Surgery
Karl A. Zucker, MD, FACS
The rapid and widespread acceptance of laparoscopic cholecystectomy is without
precedent in modern surgical history. Within a few years laparoscopic surgery has
all but replaced traditional open laparotomy in the management of routine
gallbladder disease. Recent reports of laparoscopically performed common-bile-duct
exploration, appendectomy, truncal and selective vagotomy, Nissen fundoplication,
colonic resection and other innovative procedures support the concept that, by the
end of the decade, laparoscopic surgery will become one of the most common
techniques used by general surgeons.

L’adoption rapide et elargie de la cholecystectomie laparoscopique est sans
precedent dans l’histoire de la chirurgie moderne. En quelques annees, la chirurgie
laparoscopique a tout simplement remplace la laparotomie ouverte traditionnelle
dans le traitement courant des maladies de la vesicule biliaire. Des articles recents
signalent la realisation par laparoscopie, d’explorations du choledoque,
d’appendicectomies, de vagotomies tronculaires et selectives, de fundoplicature de
Nissen, de resections coliques, ainsi que d’autres interventions innovatrices. Ceci va
a l’appui de l’hypothese qui veut, qu’a la fin de la decennie, la chirurgie
laparoscopique devienne une des techniques les plus souvent employees par les
chirurgiens generaux.

he rapid introduction and wide
spread adoption of therapeutic
laparoscopic techniques for biliarytract surgery are without precedent
in modern surgical history. In less
than 4 years tens of thousands of
general surgeons throughout the
world have returned to the animal
laboratory or spent long hours
working beside experienced col
leagues to learn the intricacies of
laparoscopic surgery. Even those

T

who at one time condemned this
technique have realized its tremen
dous advantages in both patient
care and surgical education. Many
investigators are now attempting to
expand the scope of therapeutic
laparoscopy. They believe that the
same benefits of diminished postop
erative pain, decreased hospitaliza
tion and rapid return to normal
activity will also accompany laparo
scopic procedures developed for dis
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orders outside the biliary tract.
What will the future uses of lapa
roscopy be?

Diagnostic Laparoscopy
Laparoscopy will likely become a
more popular therapeutic modality
for a variety of benign and malig
nant disorders. Although dramatic
advances in noninvasive imaging,
such as the use of ultrasonography,
computed axial tomography and
magnetic resonance imaging previ
ously diminished the popularity of
diagnostic laparoscopy, recent de
velopments in imaging capabilities
and instrumentation now allow a
laparoscopic exploration that mim
ics that achieved with a large lapa
rotomy incision. In the near future
devices such as semiflexible scopes
and ultrasound probes, designed
primarily for laparoscopic applica
tion, will become clinically available.
For these reasons clinicians are now
finding laparoscopy helpful in situa
tions as diverse as the problematic
case of a patient with signs of
peritoneal irritation and individuals
with various intra-abdominal malig
nant disease, as well as in determin
ing the source of acute or chronic
abdominal pain and in assessing
selected patients after blunt or
sharp abdominal trauma.1-5
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tectomy is now a popular and readi
ly available procedure in many com
munities, it is evident that its role in
the management of biliary-tract dis
ease will continue to expand. Indi
cations for attempting laparoscopic
cholecystectomy will soon include
nearly every patient with document
ed gallbladder disease. In medical
centres with extensive laparoscopic
experience this procedure is already
being offered routinely to patients
presenting with complex acute
cholecystitis, to those who have
already had upper abdominal sur
gery and to morbidly obese pa

tients. There are now reports that
laparoscopic cholecystectomy may
be the safest option during early
pregnancy.6 The most important
co n sid eratio n s in d eterm in in g
whether such patients can safely
undergo laparoscopic cholecystecto
my appear to be the experience of
the surgical team and the ability to
convert quickly to open laparotomy
if the operative conditions do not
favour the laparoscopic approach.
Currently at our institution the only
absolute contraindications to at
tempting laparoscopic cholecystec
tomy are generalized abdominal

Cystic
duct

FIG. 1. Introduction of flexible choledochoscope through cystic duct.
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sepsis or peritonitis and irreversible
coagulopathy.
Management of choledocholithiasis in this era of laparoscopic sur
gery has forced surgeons to alter
their approach to such patients.
Patients with strong evidence of
common-bile-duct (CBD) stones will
generally undergo preoperative or
postoperative endoscopic retrograde
ch o la n g io p a n crea to g ra p h y and
sphincterotomy. Alternatively the
laparoscopic procedure can be
aborted in favour of an open lapa
rotomy and CBD exploration if an
abnormal cholangiogram is ob
tained. In the very near future,
however, surgeons will be capable
of handling both the gallbladder
and the CBD during laparoscopic
surgery. Preliminary reports of la
paroscopic CBD exploration have
recently supported the safety and
feasibility of this approach.7'8 At
present two methods of gaining
access to the CBD have been re
ported. The most popular approach
is to use the cystic duct. The duct is
gradually dilated to 3 .0 or 4.0 mm,
and a flexible choledochoscope is
introduced through one of the later
al cannulas and guided into the
cystic duct and CBD (Fig. 1). A
working channel within the chole
dochoscope allows the surgeon to
grasp the stone and remove it. In
most circumstances stones are
grasped tightly and removed from
the ductal lumen along with the
choledochoscope (Fig. 2). In some
patients the cystic duct lumen may
not dilate enough to accommodate
the choledochoscope or the sur
geon may not be able to manipulate
the scope into the more proximal
common hepatic or intrahepatic bile
ducts. In such cases it may be
preferable to perform an choledochotomy by continuing the cysticduct opening down to the CBD or
by making a separate opening (Fig.
3). The choledochotomy then al
lows the surgeon to introduce vari-
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ous biliary catheters as well as the
choledochoscope. After completing
the CBD exploration a T tube is
inserted and secured with sutures
placed laparoscopically. Successful
laparoscopic treatment of choledocholithiasis would, in many cases,
eliminate the need for a second

uncomfortable and expensive biliary
endoscopic procedure.

Acute Appendicitis
Laparoscopic removal of the ap
pendix actually predates its use in

FIG. 2. Extraction of common-bile-duct stones with choledochoscope.

dim inutive c y s tic
_ict r e q u i r e s e n l a r g e 
m e n t f o r p a s s a g e of
c h o le d o c h o s c o p e

biliary-tract disease.9 Although still
less popular than laparoscopic cho
lecystectomy, this approach to
acute appendicitis appears to offer a
number of potential advantages
over traditional open surgery. Re
cent reports by Pier, Gotz and
Bacher,10 who performed 625 con
secutive laparoscopic appendecto
mies in adults, and Valla and col
leagues,11 who described this proce
dure in 465 children, have con
firmed the feasibility and safety of
this approach. Their studies showed
that laparoscopic surgery allowed
the removal of very inflamed or
ruptured appendices as well as
those located in atypical locations
(retrocecal, pelvic, etc.). Laparo
scopic appendectomy requires a
minimum of three trocars and can
nulas, although patients with in
flammatory adhesions or other com
plicating factors may require a
fourth sheath (Fig. 4). The appen
dix is mobilized until its juncture
with the cecum is accessible. The
vessels of the mesoappendix may be
ligated with sutures or clips and
individually divided, or secured with
a laparoscopic stapling device (Fig.
5). The base of the appendix may be
controlled with pre-tied laparoscop
ic sutures or with a stapling device.
With either technique the base of
the appendix is left everted from the
cecum. Although a laparoscopic in-

Epigastric
Vasculature
Canula Site for
Retrocecal
Appendix
McBurney
(Lateral)
Cannula Site

FIG. 3. Extension of cystic-duct opening proximally to provide
direct access to common bile duct.

Umbilical
Cannula Site
Midline-Bikim Line
Cannula Site
Suprapublic
Cannula Site

FIG. 4. Trocar and cannula placement for laparoscopic appen
dectomy.
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verting suture is feasible, previous
prospective controlled trials have
shown no advantage with either an
inverted or an everted appendiceal
stump during open surgery.12
Laparoscopic appendectomy ap
pears to cause less postoperative
discomfort and results in a more
rapid return to normal activity than
traditional surgery. Laparoscopy al
lows the surgeon to perform a more
complete examination of the abdo
men without enlarging the opera
tive incision(s). This is especially
important when a patient with peri

tonitis has a normal-appearing ap
pendix. Although not examined
prospectively, these reports also
suggest that the wound infection
rate for the laparoscopic procedure
is much lower than for open sur
gery because the contaminated tis
sues can be removed completely
from the peritoneal cavity without
coming in contact with the abdomi
nal wall.10'11 As surgeons become
more experienced in manipulating
the large and small bowel, placing
laparoscopically guided sutures and
dissecting tissue planes in the lower

A p p e n d ic u la r v e s s .
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abdomen, laparoscopic appendecto
my will undoubtedly become rou
tine in most medical centres.

Laparoscopic Management of
Peptic Ulcer Disease
Peptic ulcer disease continues to
be one of the most frequently diag
nosed digestive disorders. The in
troduction of multiple potent phar
macologic agents that decrease acid
secretion or promote mucosal heal
ing, or both, has severely dimin
ished the role of surgery in most
patients with uncomplicated ulcer
diathesis. As a result, many patients
with so-called “intractable ulcer dis
ease” are now being managed with
lifelong medical therapy. Although
relief of symptoms is often incom
plete and the medications are ex
pensive, most physicians and pa
tients have been content to contin
ue indefinite drug therapy when the
only alternative was major abdomi
nal surgery. A laparoscopic ap
proach associated with minimal
postoperative pain and disruption of
lifestyle appears to be a viable alter
native.
One of the first clinical investiga
tors to address this disease process
using modern rigid endoscopes (i.e.,
laparoscopes) was Professor Fran
cois Dubois from the Universite de
Paris. He developed a thoracoscopic
approach through the left chest to
perform a bilateral truncal vagoto
my. To avoid subsequent problems
with gastric emptying he also per
forms an endoscopic balloon pyloromyotomy, which results in a patent
pyloric channel. Other surgeons
have recommended a transabdomi
nal approach to complete the trun
cal vagotomy (Fig. 6). A few inno
vative investigators have even re
ported performing laparoscopic
truncal vagotomy combined with
antrectomy and Billroth-II anasto
mosis in patients with gastric-outlet
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obstruction. There also appears to
be an important role for laparoscop
ic intervention in patients who pres
ent with acute duodenal-ulcer perfo
ration. Mouret and colleagues13 and
Mouiel and Khatkhouda14 have re
cently reported the safety and effi
cacy of managing such patients
with currently available laparoscop
ic instrumentation. In their series
the abdominal cavity was irrigated
copiously, and the perforation was
successfully closed with an omental
patch. The greatest enthusiasm has
centred around the concept of per
forming selective vagotomy in pa
tients with intractable ulcer disease.
Two procedures have proven
popular in Europe and North Amer
ica. Professors Khatkouda and
Mouiel,15 from the Universite de
Nice, were the first to report a
laparoscopic selective vagotomy
procedure in 1991. They described
performing a posterior truncal va
gotomy and anterior highly selec
tive vagotomy in more than 30
patients with intractable duodenal
ulcer disease. Their technique was
similar to that popularized earlier
by Taylor, Gunn and Macleod in
England.16 Under laparoscopic guid
ance Khatkouda and Mouiel mobi
lized 3.0 to 5.0 cm of esophagus
and then divided the posterior

FIG. 6. Laparoscopic truncal vagotomy
combined with endoscopic balloon pyloromyotomy.

vagus nerve near the hiatus (Fig.
7). The seromyotomy interrupted
the individual branches of the ante
rior vagus nerve as they course
obliquely through the wall of the
stomach before reaching the gastric
mucosa (Fig. 8). The long seromyo
tomy was then closed with an over
lapping suture to avoid bleeding
and adhesion formation postoperatively. Taylor, Gunn and Macleod16
and others have shown that if the
anterior vagal innervation to the
distal antrum and pylorus was left
intact, gastric emptying would func
tion normally despite the perfor
mance of a complete posterior trun
cal vagotomy. An alternative proce
dure has been reported by investiga
tors from the University of Mary
land.1417 In their technique the pos
terior vagus nerve was also divided
near the hiatus, but the individual

branches of the anterior vagus were
dissected individually along the
lesser curvature of the stomach and
divided between clips or sutures
(Fig. 9). Each branch of the anterior
vagus nerve was divided, beginning
at the distal esophageal nerve and
continuing down to and including
the most proximal branch of the
nerve of Laterjet. The remaining
vagal fibres to the antrum and
pylorus were left intact. Although
both groups have reported only
preliminary results, their work is
encouraging; acid secretion was
dramatically decreased and nearly
all patients reported excellent relief
of symptoms. Longer follow-up
studies are necessary to evaluate
fully the results of these two proce
dures. If future investigators con
firm the effectiveness of one or both
of these procedures laparoscopic

FIG. 7. Mobilization of posterior vagus nerve during laparoscopic selective
vagotomy.
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surgery will surely play a more
important role in the management
of peptic ulcer disease.

Laparoscopic Management of
Esophageal Reflux
The same pharmacologic agents
used to treat patients with peptic
ulcer disease have also been suc
cessfully employed in the manage
ment of symptomatic esophageal
reflux. As a result surgery is often
recommended only after life-threat
ening complications have devel
oped. As with peptic ulcer disease, a
laparoscopic procedure that could
effectively control esophageal reflux
with only minimal pain and disrup
tion in lifestyle would offer a rea
sonable alternative to lifelong drug
therapy.

Recently two laparoscopic proce
dures that restore esophageal
sphincter tone have been reported.
Nathanson, Shimi and Cuschieri18
described the use of the ligamentum teres (round ligament) as a
sling to lengthen the abdominal
segment of the esophagus and fix
the angle of the gastroesophageal
junction. Five abdominal cannulas
were used, and the procedure re
quired specially designed curved
grasping forceps and a siliconized
cannula. Preliminary results in five
patients showed that this procedure
significantly raised the tone of the
lower esophageal sphincter and re
lieved symptoms of chronic reflux.
A second antireflux procedure, in
corporating a Nissen-like gastric

FIG. 8. Anterior selective vagotomy with seromyotomy.
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fundoplication, has been reported
by Dallemagne and associates from
Belgium.19 Five cannulas were also
required, but no special instruments
were necessary. Laparoscopic Nissen fundoplication was performed in
a fashion similar to the open proce
dure, with the surgeon mobilizing
the distal esophagus and proximal
stomach, dividing the short gastric
vessels, wrapping the gastric pouch
around the distal esophagus and
fixing the fundoplication in place
with a 00 silk suture (Figs. 10 and
11). Of the first 12 patients on
whom Dallemagne and associates
attempted this procedure, 3 re
quired conversion to open laparoto
my for failure of the light source or
bleeding encountered during dissec-

FIG. 9. Selective ligation and division of branches of the
anterior vagus nerve.
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tion of the short gastric vessels.
The remaining nine patients report
ed complete relief of symptoms.
Postoperative x-ray films demon
strated that the fundoplication was
intact, and esophageal manometry
revealed an increase in lower-esophageal-sphincter tone.19'20 Recently
this group reported their results in
over 30 patients with a similar
excellent outcome.20 Antireflux pro
cedures appear to be ideally suited
to laparoscopic surgery because the
disorder is nonmalignant and there
is no large specimen to remove.
Previous prospective studies with
Nissen fundoplication have shown
that 85% to 90% of patients report
long-term control of their symp
toms.21 Therefore, if the laparoscop
ic approach achieves similar results,
it will inevitably replace open sur
gery for this disease and will proba
bly increase the role of surgery in
those patients who would otherwise
remain on lifelong drug therapy.

Laparoscopic-Assisted
Intestinal Surgery
Several surgeons have already re
ported the successful use of lapa
roscopy for both large- and smallbowel surgery.22-25 The latter is
more ideally suited for laparoscopic
surgery because of its smaller diam
eter and greater mobility. There are
very few disorders of the small
bowel that require surgical inter
vention. Therefore, most of the pro
cedures performed to date have
been for enteral nutrition. This in
cludes jejunostomy-tube placement
and Roux-en-Y enterocutaneous jejunostomy for long-term nutritional
support. For both procedures four
cannulas are used to mobilize the
small bowel. At present actual jejunostomy-tube placement or Rouxen-Y formation is performed with
the small bowel eviscerated through
a minilaparotomy or a larger laparo

scopic cannula (30 or 40 mm) (Fig.
12).

Laparoscopic Inguinal Hernia
Repair

Far more controversial is laparo
scopic colonic resection for benign
or malignant disease. Jacobs, Verdeja and Goldstein22 recently report
ed a series of 20 patients who
underwent laparoscopic colonic re
section. They demonstrated the
safety and efficacy of this tech
nique.22 Their series included 10
patients with adenocarcinoma, 4
with diverticular disease and 1 each
with cecal volvulus, sigmoid endometrioma, inflammatory bowel
disease and a large cecal villous
adenoma. The vessels of the mesen
tery were controlled by individual
ligation with either surgical clips
and sutures or a recently developed
laparoscopic intestinal stapling in
strument (Endo-GIA; Auto Suture
Co., Norwalk, Conn.). Their tech
nique required the use of a 5.0- to
7.0-cm minilaparotomy for speci
men removal and anastomosis (Figs.
13 and 14). For lesions requiring a
distal left-sided anastomosis, a transanal intestinal stapling device was
used. Unfortunately their series was
too small to compare the results
with traditional surgery. However,
18 of the 20 patients had return of
normal bowel function within 24
hours of surgery. It seems likely
that laparoscopy will be indicated in
certain patients with colonic disor
ders, especially those with nonma
lignant lesions.

FIG. 13. Cannula placement for laparo
scopic right hemicolectomy.

FIG. 12. Evisceration of small bowel
through 30-mm cannula in preparation
for Roux-en-Y feeding jejunostomy.

FIG. 14. Evisceration of right colon in
preparation for colectomy and ex
tracorporeal anastomosis.

The current operations recom
mended for inguinal hernia repair
seem unlikely to be challenged by
laparoscopy because most hernia
repairs are performed under local or
regional anesthesia with patients
rarely staying in the hospital for
more than a few hours. The clinical
investigators advocating laparo
scopic herniorrhaphy believe that
this approach will diminish the inci
dence of neuralgias, ischemic orchi
tis and epididymitis and allow pa
tients to return to normal activity
within days rather than weeks. Var
ious methods of laparoscopic repair
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have been described, nearly all of
them requiring the use of a pros
thetic mesh. The largest experience
so far has been that of Corbitt from
Florida.24 With his technique the
hernial sac is reduced into the peri
toneal cavity and opened, and the
cord structures are reduced back
into the canal. A prosthetic plug,
approximately 5.0 to 7.0 mm in
diameter and 30 to 40 mm long, is
inserted through the internal ring
into the canal. The prosthetic mate
rial invokes an inflammatory reac
tion, obliterating any space that
may predispose to recurrent hernia
formation. A second mesh, 5.0 by
10.0 cm, is placed beneath the
peritoneum and over the internal
ring. The indirect hernial sac is
then ligated near the internal ring
with a Roeder loop or a laparoscop
ic stapling device. The second piece
of mesh scars to the abdominal wall
and minimizes the risk of direct
hernia recurrence. Corbitt’s results
have been mixed: excellent results
for indirect inguinal hernia but a
recurrence rate of 5% or more for
direct inguinal hernias (personal
communication, 1991). An alterna
tive approach is under study by
Salerno, Fitzgibbons and Filipi in
Nebraska.25 In their procedure the
hernial sac is not reduced; instead a
much larger mesh is sutured or
stapled over the internal ring and
lower abdominal wall. A prospec
tive, randomized trial is currently
under way, but no preliminary re
sults are available. Unfortunately
the most common complication of
inguinal repair is early or late recur
rence, and this problem will often
not manifest itself for several years
after the initial repair. Thus it may
be years before the true effective
ness of laparoscopic herniorrhaphy
is known and if there are any
significant advantages over existing
repairs. Until then laparoscopic her
nia repair should remain an investi
gational procedure.
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Conclusions
The overwhelming advantages in
patient care realized with laparo
scopic cholecystectomy will contin
ue to be the driving force to adopt
laparoscopy in the management of
other abdominal disorders. Soon la
paroscopic cholecystectomy will be
offered even to patients with acute
cholecystitis or choledocholithiasis.
Recent advances in imaging equip
ment and instrumentation have re
sulted in a renewed interest in diag
nostic laparoscopy for a variety of
benign and malignant diseases. Pre
liminary reports have also shown
the potential of laparoscopy for
managing esophageal reflux, peptic
ulcer disease, acute appendicitis and
bowel disorders.
Figs. 1 to 9 and 12 to 14 are repro
duced from Zucker KA, Bailey RW,
Reddick EJ (eds): Surgical Laparoscopy,
Quality Med Pub. St. Louis, Mo, 1991:
2 1 9 -3 0 8 . Figs. 10 and 11 are repro
duced from Dallemagne B, Weerts JM,
Jehaes C et al: Surg Laparosc Endosc
1991: 1 (3): 1 3 8 -1 4 3
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Prosthetic Replacement of the Superior
Vena Cava With a Custom-Made
Pericardial Graft: an Experimental Study
Carlos Del Campo, MD, FRCSC;* James Love, BVMS, PhD, MRCVS;t Frank Bowes, MD, FRCPCJ
Prosthetic replacement of the vena cava has been disappointing, mainly because of
the hemodynamic characteristics of the venous system and the physical properties of
the prostheses used. Spiral grafts constructed with autogenous saphenous vein have
been the most successful prostheses to date, but their use is limited to replacement
of short segments, and intraoperative construction is time consuming. The authors
report their experience with a graft constructed of extra-thick bovine pericardium
(PX) and surgical staples. Externally stented polytetrafluoroethylene (PTFE) was
used as a control. The superior vena cava was replaced in 13 ewes; PTFE was used
in 6 (group 1) and PX in 7 (group 2). Mean follow-up was 15 ± 8 months for group
1 and 13 ± 8 for group 2. Cumulative graft follow-up totalled 4612 graft-days.
There was one graft occlusion in each group. Patency rates (80%) were similar for
the two groups.
Histologic changes in pericardial grafts were more marked but did not influence
patency. This study reports the longest experimental follow-up (maximum 23
months) and graft patency to date for replacement of the superior vena cava. Both
types of graft performed excellently.

Le remplacement prothetique de la veine cave s’est avere desappointant, surtout a
cause des caracteristiques hemodynamiques du systeme veineux et des proprietes
physiques des protheses utilisees. Des greffes en spirale construites a partir de
saphenes autogenes ont ete les meilleures protheses a ce jour mais leur utilisation
se limite au remplacement de courts segments et l’operation de reconstruction est
longue. Les auteurs decrivent leur experience d’un greffon construit de tissu
pericardique bovin extra epais (PX) et d’agrafes chirurgicales. Comme temoin on a
utilise du polytetrafluoroethylene expanse (PTFE). La veine cave superieure fut
remplacee chez 13 brebis; 6 re^urent du PTFE (groupe 1) et 7, du PX (groupe 2).
La periode moyenne de surveillance des suites therapeutiques a ete de 15 ± 8 mois
pour le groupe 1 et de 13 ± 8 pour le groupe 2. Le suivi cumulatif du greffon
totalise 4612 jours-greffons. On a enregistre une occlusion de greffon dans chaque
groupe. Le taux de permeabilite (80 %) a ete le meme pour les deux groupes.
Les changements histologiques des greffons pericardiques ont ete plus marques
mais ceci n’a pas affecte la permeabilite. Cette etude decrit la plus longue
surveillance experimentale (maximum 23 mois) et fait etat de la permeabilite du
greffon a ce jour, suite au remplacement prothetique de la veine cave superieure.
Les deux types de greffons ont donne d’excellents resultats.

rosthetic replacement of veins
has lingered far behind arterial
revascularization. Although autoge
nous veins and various prosthetic
materials are satisfactory for arteri
al reconstruction, when used in the
venous system their success has
been limited.1 Replacement of the
superior vena cava (SVC) to date
has not been uniformly accom
plished. Its long segment and large
diameter prevent the utilization of
autogenous grafts. Spiral vein
grafts have been successful clinical
ly in isolated cases.2 Attempts at
venous replacement with a variety
of prostheses have been associated
with low patency rates in the exper
imental setting. Fiore and associ
ates3 obtained better results in dogs
with externally supported polytetra
fluoroethylene (PTFE) grafts than
with glutaraldehyde-fixed and pre
served porcine pericardium. Follow
up was limited to 30 days and is not
sufficient to draw conclusions for
clinical application.
We hypothesized that better
long-term patency would be
achieved if thicker bovine pericardi
um with a different preservation
technique was used. The graft
would be less thrombogenic and
collapsible. In this paper we de
scribe our experience.

P
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Thirteen ewes, weighing 38 to 60
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kg, were randomly separated into
two groups. They were kept away
from rams throughout the study to
prevent pregnancy.
All animals received humane care
in compliance with the Canadian
Guide to the Care and Use o f Exper
imental Animals* and the United
States Guide for the Care and Use
o f Laboratory Animals.5
Grafts
A commercially available 19-mm,
microporous, PTFE, externally
stented graft (IMPRA-FLEX, Impra
Inc. Tempe, Ariz.) was implanted
into six ewes (control, group 1). A
bovine pericardial graft (PX) was
constructed for seven ewes assigned
to group 2.
Technique of Pericardial Graft
Construction
From Shiley Laboratories (Irvine,
Calif.) we obtained 8 X 8-cm
sheaths of pericardium that was
thicker (0.25 to 0.5 mm) than that
commercially available (less than
0.25 mm). The sheaths were fixed
with glutaraldehyde and preserved
in formaldehyde. At the time of
surgery the bovine pericardium was
rinsed three times in separate con
tainers for 20 minutes with 0.9 N
saline solution. A tube approximate
ly 19 mm in diameter was con
structed with the epicardial side of
the patch toward the inside. The
CIA surgical stapler (Auto Suture
Canada Ltd., Montreal) was used to
apply a double row of 1.5-mm sta
ples to the free edges (Fig. 1) to
complete the tube. We did not use a
mandrel to minimize graft manipu
lation.

tubation. Anesthesia was conducted
with halothane and oxygen. Central
venous pressure was measured by
direct puncture of the jugular vein.
A short indwelling catheter was
used so its tip would not lie in the
superior vena cava. Arterial pres
sure was measured by direct punc
ture. The heart rate and electrocar
diogram were monitored by contin
uous display. The superior vena
cava was exposed through a right
thoracotomy in the third intercostal
space. The superior vena cava was
dissected free in its whole length
from the right atrium to the thorac
ic inlet. The phrenic nerve was
dissected free and retracted lateral
ly. The azygos vein was ligated.
Heparin, 100 units/kg, was given
intravenously. The superior vena
cava was clamped and removed in
its entire length. A shunt was not
used. Group 1 ewes received PTFE
and group 2 PX grafts. Anastomo
ses were constructed with a 6-0
polypropylene suture. The grafts
were carefully vented for air. Air
was evacuated from the chest cavity
with a temporary water seal that
was removed upon chest closure.
Heparinization was not reversed.
The ewes were allowed to stand up
at 2 hours postoperatively and
drink fluids. Anticoagulants or anti

platelet agents were not used post
operatively.
Follow-up
On postoperative day 7 the ewes
were taken to a farm and kept
separate from the rams. They were
checked daily by the farm personnel
and periodically by the authors.
One animal from each group under
went superior venacavography with
real-time fluoroscopy during the
early postoperative period. Twentythree months from the start of the
study the ewes were given 10 000
units of heparin intravenously and
put to death with a lethal dose of
thiopental sodium. The grafts were
removed, including cuffs or native
tissue at both ends, measured, visu
ally inspected for clots and calcifica
tion and fixed in formalin. Ewes
that died earlier were brought to
the laboratory and an autopsy was
done within 24 hours. All the speci
mens were submitted to the pathol
ogist (F.B.) without any information
about the graft or animal condition
at the time of removal.
Statistical Evaluation
Patency rates for group 1 versus
group 2 were determined by life-

Surgical Technique
Anesthesia was induced with thi
opental sodium. A single-lumen
tube was used for endotracheal in
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FIG .l. Pericardium has been folded to appropriate diameter. Stapler is used to
construct graft. Note that staples will remain on outside.

PERICARDIAL GRAFT FOR SUPERIOR VENA CAVA

table analysis and compared by sta
tistical inference of the standard
error of the means.

Results
The mean weight of the ewes was
48.4 ± 5.9 kg for those in group 1
and 49.5 ± 5.4 kg for those in
group 2. One animal in group 1
died 2 hours postoperatively from
acute aspiration. The graft was re
moved and found to be intact. One
animal in group 2 died 4 hours
postoperatively as a result of techni
cal error. Both animals were exclud
ed from the study. Intraoperatively
there was a decrease of 15 mm Hg
in mean arterial pressure during
venous clamping. The central ve
nous pressure increased by a mean
of 28 cm H20 . All pressures re
turned to normal after placement of
the graft. These changes were simi
lar for both groups and did not
have any clinical repercussions (Ta
ble I). One ewe in group 2 had
weakness of her right foreleg, but
this resolved after 1 week. One ewe
in group 1 died at 4 months from
an upper respiratory tract infection;
at autopsy the graft was intact and
showed no histologic difference
from the other grafts in the same
group.
The mean follow-up was 15 ± 8
months for group 1 animals and 13
± 8 months for group 2 animals.
Cumulative graft follow-up totalled
4612 graft-days. There was one
graft occlusion in each group dur
ing the first month. All other grafts
remained patent to the conclusion
of the study. Patency rates were
similar for both groups (p = 0.98)
(Fig. 2).
Examination of the specimens
(Figs. 3 to 5) revealed no shorten
ing of any graft. Wall thickness of
the grafts was similar in both
groups. Endothelialization had oc
curred in all grafts. The pseudoin-

Table 1. O p e ra tiv e C h a ra c te ris tic s fo r E w e s W ith P o ly te tra flu o ro e th y le n e G ra fts (G ro u p 1) a n d W ith
B ov in e P e ric a rd ia l G ra fts (G ro u p 2)

Characteristic

Group 1

W e ig h t, kg
G ra ft le n g th , cm
C ro s s -c la m p tim e , m in
In cre a se in c e n tra l v e n o u s p re ss u re d u rin g
c la m p in g , c m H20
D ecre a se in m e a n a rte ria l p re ss u re d u rin g c la m p in g ,
m m Hg

Group 2

4 8 .4 ± 5 .9
3 .3 ± 0 .4
4 5 .0 ± 1 3 .5

4 9 .5 ± 5 .4
3 .4 ± 0 .3
4 1 .0 ± 5 .8

3 0 .0 ±

5 .0

3 5 .0 ± 3 .0

1 5 .0 ±

4 .0

1 8 .0 ± 3 . 0

P A TE N C Y R A TES

FIG. 2. Comparison of patency rates between groups. PTFE = polytetrafluoroethylene graft, PX = thick bovine pericardial graft.

FIG. 3. Macroscopic appearance of grafts. Left: early thrombosis of PTFE graft.
Note thrombus occluding lumen. Middle: PTFE graft well endothelialized with
smooth transition at both anastomotic sides where native superior vena cava and
graft endothelialization are almost indistinguishable. Right: PX graft with tissue
reaction around external portions of graft. The intimal characteristics are similar to
those of PTFE graft with unnoticeable suture lines. Both grafts have same length
and diameter.
CJS, VOL. 35. NO. 3, JUNE 1992
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tima was smooth with mild to mod
erate fibrosis beneath it. Endothelialization in humans seldom occurs
through the entire graft. Human
grafts are longer, thus making mi
gration of cells much more difficult.
The wall of both grafts was affected
by focal calcification, which was
more serious in the PX group. It
did not affect the luminal diameter.
Foreign-body giant cells were dis
tributed throughout the PX graft
but mainly around the anastomoses
in the PTFE grafts.

Discussion
There has been no acceptance to
date of a standard approach for
replacement of the superior vena
cava. Different conduits have been
tried, but the results are mostly
anecdotal. Emergency thrombecto
my has been successful in cases of
acute thrombosis.67 Over 90% of
patients with obstruction of the
superior vena cava have advanced
malignant disease, and chemothera
py or radiotherapy can be used for
palliation.8-10 Benign obstructions
usually occur over a long time, thus
allowing venous collaterals to devel
op. In most of these cases operation

is avoided.11 Those patients requir
ing replacement of the superior
vena cava usually have a good life
expectancy because of the benign
nature of the disease. Thus, it is
crucial that a prosthesis with poten
tial for long-term patency be im
planted. Cases of successful re
placement with either PTFE
grafts12-13 or spiral saphenous vein
grafts2 have been reported. Either
their follow-up has been short or
there has been a disparity in the
results obtained; therefore, the
choice of graft remains empirical.
Comparison between grafts has
been attempted in the experimental
setting. Fiore and associates3 com
pared autologous veins, knitted Da
cron, glutaraldehyde-fixed porcine
pericardium and unsupported and
supported PTFE grafts implanted in
the superior vena cava and inferior
vena cava of dogs. Their follow-up
was limited to 1 month.
The experience of one of us
(C.D.C.)14 with bovine pericardium
in the replacement of heart valves
and as a pericardial substitute in
humans formed the basis for the
construction of the experimental
graft described here.
Menus and colleagues15 reported
a low incidence of tissue reaction

FIG. 4. Cut surface of PTFE graft. Note graft texture at
bottom left and well-developed intima with subintimal fibrosis
and intact lumen (hematoxylin-eosin, orginal magnification X
80).
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12 months after implantation when
bovine pericardium was implanted
as a pericardial substitute. This
reaction was much more marked
when PTFE patches were used. We
selected thicker pericardium than
what is commercially available (0.25
mm to 0.5 mm) to add rigidity to
the venous graft. The superior vena
cava in sheep has a total length of 4
to 4.5 cm. The average length of
our grafts was 3.7 cm for both
groups. So if we subtract the width
of the vascular clamps at both ends
and the length of the cuffs needed
for the anastomoses, our grafts had
the maximum possible length. Pre
vious publications3 have shown that
grafts this long are adequate in this
setting. Smaller grafts, 2 to 2.5 cm
long, when implanted in the superi
or vena cava and treated with and
without antiplatelet agents16
showed a significant difference (p <
0.001) in occlusion rates between
control and study groups. Replace
ment of the inferior vena cava
would have provided a longer graft,
but these results cannot be extrapo
lated to the superior vena cava
because of the effect of intra
abdominal pressure and gravity.
Fiore and associates3 had patency
rates of 50% at 30 days with por-

FIG. 5. Cut surface of PX graft. Note uniformity of intima and
well-established continuity with graft (hematoxylin-eosin,
original magnification X 200).

PERICARDIAL GRAFT FOR SU PERIO R VENA CAVA

cine pericardium from a different
manufacturer, preserved in glutaraldehyde. Our pericardium had been
fixed in glutaraldehyde but pre
served in formaldehyde. This tech
nique has been reported to be bene
ficial in cardiac valve replacement.17
Staplers were used to provide a
uniform suture line without inva
sion of the graft’s internal surface
in an attempt to minimize thrombogenicity and as a longitudinal
stent to provide orientation and to
prevent kinking. Externally stented
PTFE grafts were used in the con
trol group because they had shown
the best patency rate in short-term
reports.3'12
Graft patency for groups 1 and 2
at 30 days was 83% and 80% re
spectively and remained unchanged
at 23 months. This represents an
improved result and the longest
experimental follow-up available to
date. These data suggest that long
term patency could be achieved
with either graft in humans. PX
grafts are very easily constructed at
the time of operation, and their
diameter can be modified according
to the size of the patient’s vena
cava. Thus, it is not necessary to
store several graft sizes for a proce
dure that is uncommon. The saphe
nous vein can be spared for other
bypass procedures.
The decision as to which graft to
use may remain unanswered until
the results of clinical trials are
available. The situation is similar to
that of the indications for use of
mechanical versus tissue heart
valves, for which each patient is
now considered individually. It is
our impression that the stented
PTFE graft may be the graft of
choice in patients with occlusion of
the superior vena cava due to exter
nal compression (i.e., fibrosis) be

cause a more rigid graft may pre
vent reocclusion caused by progres
sion of the underlying disease. The
PX graft may be beneficial in pa
tients with chronic intraluminal oc
clusion (i.e., secondary to indwell
ing catheters).
We elected not to use antiplatelet
agents in order to minimize the
number of variants. Recent studies16
have shown better patency when
these agents are used.
Our report has a follow-up period
much longer than that of any other
experimental study available to
date, with improved patency rates
for both types of graft. We must
emphasize that with these results
we cannot advocate the use of one
graft over the other; each patient
must be considered separately. Fur
ther research is needed before the
use of this thick bovine pericardial
graft can be recommended in loca
tions other than the superior vena
cava.
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DIFLUCAN
(fluconazole/pfizer)

AN OPPORTUNISTIC WAY
TO TREAT FUNGAL INFECTION
PRODUCT INFORMATION
NAME OF DRUG
DIFLUCAN TABLETS
DIFLUCAN INTRAVENOUS INFUSION 2 mg/mL in 0.9% SODIUM CHLORIDE
(fluconazole)
THERAPEUTIC CLASSIFICATION Antifungal
ACTIONS: Fluconazole is a highly selective inhibitor of fungal cytochrome P-450 sterol C-14alpha-demethylation. Mammalian cell demethylation is much less sensitive to fluconazole
inhibition. The subsequent loss of normal sterols correlates with the accumulation of 14-alphamethyl sterols in fungi and may be responsible for the fungistatic activity of fluconazole.
INDICATIONS AND CLINICAL USE: DIFLUCAN (fluconazole) is indicated for the treatment of:
1. Oropharyngeal and esophageal candidiasis. DIFLUCAN is also effective for the treatment of
serious systemic candidal infections, including urinary tract infection, peritonitis, and
pneumonia. 2. Cryptococcal meningitis. 3. Prevention of the recurrence of cryptococcal
meningitis in patients with acquired immunodeficiency syndrome (AIDS).
Specimens for fungal culture and other relevant laboratory studies (serology, histopathology)
should be obtained prior to therapy to isolate and identify causative organisms. Therapy may
be instituted before the results of the cultures and other laboratory studies are known; however,
once these results become available, anti-infective therapy should be adjusted accordingly,
CONTRAINDICATIONS: DIFLUCAN (fluconazole) is contraindicated in patients who have shown
hypersensitivity to fluconazole, to any of its excipients, or other azole related compounds.
WARNINGS: Patients with baseline abnormal liver function tests and those who develop
abnormal liver function tests during DIFLUCAN (fluconazole) therapy should be monitored for
the development of more severe hepatic injury. Although serious hepatic reactions have been
rare and the causal association with DIFLUCAN uncertain, if clinical signs and symptoms
consistent with liver disease develop that may be attributable to fluconazole, DIFLUCAN
should be discontinued, (see ADVERSE REACTIONS).
Immunocompromised patients, especially those with AIDS, who develop rashes during
treatment with DIFLUCAN should be monitored closely and the drug discontinued if lesions
progress, (see ADVERSE REACTIONS).
In rare cases, as with other azoles, anaphylaxis has been reported.
PRECAUTIONS
Use in Pregnancy: There are no adequate and well-controlled studies in pregnant women.
DIFLUCAN (fluconazole) is not recommended in pregnant women unless the potential benefit
outweighs the potential risk to mother and fetus.
Use in Nursing Mothers: Fluconazole is secreted in human breast milk at concentrations
similar to plasma, hence its use in nursing mothers is not recommended.
Use in Children: The clinical use of DIFLUCAN in children below 13 years of age has not been
established.
Use in Elderly: DIFLUCAN was well tolerated by patients aged 65 years and over.
Drug Interactions
Cimetidine and Antacids Absorption of orally administered DIFLUCAN does not appear to be
affected by gastric pH. Cimetidine did not affect oral bioavailability of fluconazole to a
clinically meaningful extent; reduction of about 13% in ADC (area under the plasma
concentration-time curve) and 21% in peak plasma concentration (Cmax) was observed.
Administration of magnesium/aluminum hydroxide formulation, just prior to DIFLUCAN
administration had no clinically relevant effects on the absorption or elimination of fluconazole
in normal volunteers.
Cyclosporine DIFLUCAN administered at 100 mg daily dose does not affect cyclosporine
pharmacokinetic levels in patients with bone marrow transplants. There have been several
reports in the literature associating concomitant administration of high doses of DIFLUCAN with
an increase in cyclosporine plasma concentrations in renal transplant patients with or without
impaired renal function. Therefore, when DIFLUCAN and cyclosporine are coadministered,
cyclosporine levels should be monitored and cyclosporine dose accordingly adjusted.
Warfarin DIFLUCAN increased the prothrombin time after warfarin administration in healthy
males. Though the magnitude of change was small (12%), careful monitoring of prothrombin
time in patients receiving coumarin-type anticoagulants is recommended.
Hydrochlorothiazide Concomitant administration of multiple doses of DIFLUCAN and
hydrochlorothiazide was associated with increases in fluconazole plasma levels which were
not considered to be clinically significant.
Sulfonylurea-Oral Hypoglycemics The potential for hypoglycemia due to decreased elimination
and increased blood levels of sulfonylurea oral hypoglycemics (glibenclamide, glipizide and
tolbutamide) has been demonstrated with concomitant administration of DIFLUCAN. Blood
glucose levels should be monitored closely and the dose of the hypoglycemic agent should be
adjusted as necessary.
Phenytoin Concomitant administration of DIFLUCAN at steady state and phenytoin at steady
state resulted in an increase of up to 75% in AUC of phenytoin. Since phenytoin has a low
therapeutic ratio, phenytoin plasma levels should be closely monitored when DIFLUCAN is
coadministered. The dose of phenytoin should be adjusted to maintain therapeutic levels.
Rifampin Concomitant administration of DIFLUCAN and rifampin resulted in a 25% decrease
in the AUC and a 20% shorter half-life of fluconazole. The dosage of fluconazole should be
increased by 25% when fluconazole is administered with rifampin.
Zidovudine (AZT) and/or Pentamidine Isethionate Though no formal interaction studies have
been completed for DIFLUCAN and concomitant zidovudine and/or pentamidine isethionate,
these drugs have been used together in patients with AIDS with no clinically important
difference in the pattern of adverse events.
Theophylline Concomitant administration of DIFLUCAN and theophylline resulted in an 18%
decrease in the mean plasma clearance of theophylline. Patients who are receiving high doses
of theophylline or who are otherwise at increased risk for theophylline toxicity should be
observed for signs of theophylline toxicity while receiving fluconazole, and therapy modified
appropriately if signs of toxicity develop.
Oral Contraceptives In pharmacodynamic studies, single and multiple 50 mg oral doses of
DIFLUCAN had no clinically significant effects on ethinyl estradiol or levonorgestrel
pharmacokinetics in healthy women taking oral contraceptives. However, at 200 mg daily, the
AUCs of ethinyl estradiol and levonorgestrel were increased. 40% and 24%, respectively.

Drug/Drug Interaction Interaction studies with other medications have not been conducted, but
such interactions may occur.
Drug/Laboratory Test Interactions: None known.
ADVERSE REACTIONS: Sixteen percent of over 4000 patients treated with DIFLUCAN
(fluconazole) in clinical trials of 7 days or more experienced adverse events.
Treatment was discontinued in 1.5% of patients due to adverse clinical events and in 1.3% of
patients due to laboratory test abnormalities.
Adverse clinical events were reported more frequently in HIV infected patients (21%) than in
non-HIV infected patients (13%). However, the patterns of adverse events in HIV infected and
non-HIV infected patients were similar. The proportions of patients discontinuing therapy due
to clinical adverse events were similar in the two groups (1.5%). The two most serious
adverse clinical events noted during clinical trials with DIFLUCAN were: 1. Exfoliative skin
disorders 2. Hepatic necrosis Because most of these patients had serious underlying disease
(predominantly AIDS or malignancy) and were receiving multiple concomitant medications,
including many known to be hepatotoxic or associated with exfoliative skin disorders, the causal
association of these reactions with fluconazole is uncertain. Two cases of hepatic necrosis
and one exfoliative skin disorder (Stevens-Johnson syndrome) were associated with a fatal
outcome.
The following treatment-related clinical adverse events occurred at an incidence of 1% or
greater in 4,048 patients receiving fluconazole for 7 or more days in clinical trials: Nausea 3.7%
Headache 1.9% Skin Rash 1.8% Vomiting 1.7% Abdominal Pain 1.7% Diarrhea 1.5% Other
treatment-related clinical adverse events which occurred less commonly (0.2 to <1%) are
presented by organ system below:
Skin and Appendages: pruritus.
Musculoskeletal: myalgia.
Central and Peripheral Nervous System: convulsions, dizziness, paresthesia, tremor, vertigo.
Autonomic Nervous System: dry mouth, increased sweating.
Psychiatric: insomnia, somnolence.
Gastrointestinal: anorexia, constipation, dyspepsia, flatulence.
Liver and Biliary System: cholestasis, hepatocellular damage.
Special Senses: taste perversion.
Hematopoietic: anemia.
General: fatigue, malaise, asthenia, fever.
In rare cases, anaphylaxis has been reported.
LABORATORY TEST ABNORMALITIES
Liver Function: Clinically significant increases were observed in the following proportions of
patients: AST (SGOT) 1%, ALT (SGPT) 1.2%, Alkaline Phosphatase 1.2%, Total bilirubin
0.3%. The incidence of elevated serum transaminases was independent of age or route (p.o.
or i.v.) of administration but was greater in patients taking DIFLUCAN concomitantly with one
or more of the following medications: rifampin, phenytoin, isoniazid, valproic acid, or oral
hypoglycemic agents. Clinically significant increases also were more frequent in patients
who: 1) had SGOT or SGPT elevations greater than three times the upper limit of normal
(>3xULN) at the time of entering the study (baseline), 2) had a diagnosis of hepatitis at any
time during the study and, 3) were identified as alcohol abusers. The overall rate of serum
transaminase elevations of more than 8 times the upper limit of normal was approximately
1% in patients treated with DIFLUCAN during clinical trials. (See table below)
Number*
Percent
Number
Percent
Lab
of
Percent
Drugof
Percent
DrugParameter
Patients
Abnormal
Related
Patients
Abnormal
Related
Baseline >3xULN
Baseline < 3xULN
SGOT
53
9.4
3.8
3007
4.2
0.8
SGPT
2874
65
3.1
0.0
4.8
1.0
Non-Hepatitis Patients
Hepatitis Patients
SGOT
160
10.6
1.9
2900
3.9
0.8
SGPT
11.4
2.1
2799
140
4.4
1.0
Alcohol Abuse
Non-Alcohol Abuse
SGOT
42
4.2
0.9
9.5
2.4
3018
SGPT
40
10.0
2.5
4.7
1.0
2899
Never
Received
Received
I.V. Fluconazole
I.V. Fluconazole
144
SGOT
5.6
1.4
2916
4.2
0.9
SGPT
5.0
0.7
4.7
1.0
139
2800
>65 Years Old
<65 Years Old
SGOT
277
4.3
1.1
2783
4.3
0.9
SGPT
258
3.9
1.2
4.8
1.0
2681
‘ Note: Only patients who had measurements at baseline and during therapy were included.
Renal Function: Clinically significant increases were observed in the following proportions of
patients: blood urea nitrogen (0.4%) and creatinine (0.3%).
Hematological Function: Clinically meaningful deviations from baseline in hematologic
values which were possibly related to DIFLUCAN were observed in the following proportions
of patients: hemoglobin (0.5%), white blood cell count (0.5%), and total platelet count
( 0. 6% ) .
SYMPTOMS AND TREATMENT OF 0VER00SAGE
Symptoms: There has been one reported case of overdosage with DIFLUCAN. A 42-year-old
patient infected with human immunodeficiency virus developed hallucinations and exhibited
paranoid behavior after reportedly ingesting 8200 mg of DIFLUCAN. The patient was admitted
to the hospital, and his condition resolved within 48 hours.
Treatment: In the event of overdosage, symptomatic treatment (with supportive measures
and gastric lavage if necessary) may be adequate. Fluconazole is largely excreted in urine. A
three hour hemodialysis session decreases plasma levels by approximately 50%.
Mice and rats receiving very high doses of fluconazole, whether orally or intravenously,
displayed a variety of nonspecific, agonal signs such as decreased activity, ataxia, shallow
respiration, ptosis, lacrimation, salivation, urinary incontinence and cyanosis. Death was
sometimes preceded by clonic convulsions.
DOSAGE AND ADMINISTRATION
Oral and Intravenous Treatment: Fluconazole is well absorbed and excreted predominantly
unchanged in urine following oral administration in man. The oral bioavailability is essentially
complete (greater than 90%), and is independent of dose. Peak plasma concentrations after
oral administration are attained rapidly, usually within 2 hours of dosing. Since oral absorption
is rapid and almost complete, the daily dose of DIFLUCAN (fluconazole) is the same for
oral and intravenous administration. The term inal plasma elimination half-life is
approximately 30 hours (range 20-50 hours).
The daily dose of DIFLUCAN and the route of administration should be based on the infecting
organism, the patient's condition and the response to therapy. Treatment should be
continued until clinical parameters and laboratory tests indicate that an active fungal infection

SESAP VII Critique / Critique SESAP VII
Item 263
Malignancy is the most common cause of superior vena caval obstruction and accounts for over 95% of cases. In
adults, bronchogenic carcinoma accounts for over 80% of malignancies, whereas lymphoma accounts for only
10%. Inflammatory mediastinitis resulting in severe fibrosis is a rare cause of superior vena caval obstruction.
Superior vena caval syndrome presents with facial swelling, shortness of breath, cough, and orthopnia. Physical
signs include facial and glossal swelling, neck and upper extremity vein distention, and changes in mentation.
Venography is often helpful in determining the extent of the superior vena caval obstruction and the presence of
collateral circulation. However, only patients with benign disease benefit from bypass with autogenous vein
graft. In the remainder, treatment usually consists of radiation therapy to the upper mediastinum. Most patients
with lymphoma respond favorably to such treatment, whereas the response is variable at best in those with
bronchogenic carcinoma. Although the syndrome may be alleviated quickly, long-term prognosis is based on the
histology of the underlying malignancy.
___
E
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has been cured or has subsided. An inadequate period of treatment may lead to recurrence of
active infection. Patients with AIDS and cryptococcal meningitis or recurrent oropharyngeal
candidiasis usually require maintenance therapy to prevent relapse.
Recommended Adult Dosages
Loading Dose: Administration of a loading dose on the first day of treatment, consisting ol
twice the usual daily dose, results in plasma concentrations close to steady state by the
second day. Patients with acute infections should be given a loading dose equal to twice
the daily dose, not to exceed a maximum single dose of 400 mg. on the first day of
treatment.
Oropharyngeal Candidiasis: 100 mg once daily. Treatment should be continued for at least 2
weeks to decrease the likelihood of relapse.
Esophageal Candidiasis: 100 mg to 200 mg once daily. Patients should be treated for a
minimum of 3 weeks and for at least 2 weeks following resolution of symptoms.
Systemic Candidiasis: 200 mg to 400 mg once daily. These patients should be treated for a
minimum of 4 weeks and for at least 2 weeks following resolution of symptoms.
Cryptococcal Meningitis: 200 mg to 400 mg once daily. Although the duration of therapy for
cryptococcal meningitis is unknown, it is recommended that the initial therapy should last a
minimum of 10 weeks.
Prevention of Recurrence of Cryptococcal Meningitis in AIDS: 200 mg once daily.
DIFLUCAN (fluconazole) may be administered either orally or by intravenous infusion. The
intravenous infusion of DIFLUCAN should be administered at a maximum rate of approximately
200 mg/hour given as a continuous infusion. See Directions for Use .
Dosage in Patients With Impaired Renal Function
Fluconazole is cleared primarily by renal excretion as unchanged drug. In patients with impaired
renal function, an initial loading dose of 50 to 400 mg should be given. After the loading
dose, the daily dose (according to indication) should be based on the following table:
Creatinine Clearance (mL/min)
Percent of Recommended Dose
>50
100%
21-50
50%
11-20
25%
Patients receiving
one recommended
regular hemodialysis
dose after each dialysis
When serum creatinine is the only measure of renal function available, the following formula
(based on sex, weight, and age of the patient) should be used to estimate the creatinine
clearance.
Males:
Weight (kg) x (1 4 0 -age)
72 x serum creatinine (mg/100 mL)
Females:
0.85 x above value
Composition: DIFLUCAN Tablets (pink) contain 50. 100 or 200 mg fluconazole Also
contains the following non-medicinal ingredients: microcrystalline cellulose, dibasic calcium
phosphate anhydrous, povidone, croscarmellose sodium, FD & C Red No. 40 aluminum lake
dye, and magnesium stearate.

DIFLUCAN I.V. for infusion is a sterile solution of fluconazole in saline at a concentration of
2 mg/mL which is made iso-osmotic with sodium chloride 9 mg/mL.
Directions for Use: Inspect visually for particulate matter or discoloration prior to
administration. Do not use if cloudiness or precipitation is evident.
Reject the contents as unsterile if the metal seal is broken. NOT INTENDED FOR MULTIDOSE
USE: discard any portion not used when the seal is first broken.
Connect an intravenous giving set to the bottle of DIFLUCAN (fluconazole) intravenous
solution and also insert a venting set through the bung. Infuse DIFLUCAN intravenous
solution at a maximum rate of 200 mg/hour. Flush DIFLUCAN intravenous solution remaining
in the giving set with sterile normal saline.
Because fluconazole is available as a dilute saline solution, in patients requiring sodium or
fluid restriction, consideration should be given to the rate of fluid administration.
Incompatibility: It is recommended that DIFLUCAN I.V. be infused separately.
Compatibility: Administration sets (“giving” sets).
DIFLUCAN I.V. infusion is compatible with (i.e. not susceptible to absorption) sets constructed
of a delivery tube (PVC) luer lock (modified phenylene oxide), flash ball (latex) drip chamber
(polypropylene) and piercing spike (polypropylene).
DOSAGE FORMS
Availability: DIFLUCAN TABLETS are available as pink tablets containing 50 mg. 100 mg.
and 200 mg of fluconazole.
Supplied in bottles (opaque polyethylene) of 50 or 100 tablets.
DIFLUCAN I.V. is available as a sterile aqueous solution for direct infusion. Each mL contains
2 mg fluconazole and 9 mg sodium chloride. Supplied in clear glass bottles of
100 mL and 200 mL. affording doses of 200 mg and 400 mg fluconazole respectively, sealed
with a rubber bung.
STORAGE
DIFLUCAN TABLETS (fluconazole) 50,100, and 200 mg: Store below 30°C.
DIFLUCAN I.V. (fluconazole) 2 mg/mL: Store below 30-C. Do not freeze.
References: 1. DIFLUCAN new drug submission. Data on file. Pfizer Canada Inc.
2. Product monograph-DIFLUCANT

DIFLUCAN
(fluconazole/pfizer)

© Pfizer Canada Inc. 1992
Kirkland. Quebec
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Scalp as a Donor Site for Grafts to Facial
and Neck Burns in Children
Howard J. Silverman, MD;* Ronald M. Zuker, MD, FRCSC, FACS;t Steven Morris, MDJ
In facial and neck burns, attention to cosmetic details, in addition to preservation of
function, is crucial. The authors describe use of the scalp as a graft donor site for
such burns. The advantages include excellent colour match of the graft and minimal
morbidity at the donor site. The technique for graft harvest is outlined, and the
potential pitfalls are described. Based on their experience with this technique, the
authors believe the scalp should be considered as a donor graft site during the acute
phase of facial and neck burns.

Pour les brulures du visage et du cou, il est crucial de prefer attention au details
cosmetiques tout en preservant les fonctions. Les auteurs decrivent l’utilisation du
cuir chevelu comme zone de prelevement de greffons pour de telle brulures. On
compte parmi les avantages, un excellent appariement du teint et une morbidite
minime de la zone de prelevement. La technique de prelevement est soulignee et on
decrit les ecueils possibles. De leur experience avec cette technique, les auteurs
concluent que le cuir chevelu doit etre considere comme zone de prelevement de
greffons durant la phase aigu des brulures du visage et du cou.

he use of the scalp as a skingraft donor site in burn treat
ment has been well established.
Originally the scalp was chosen
when burns were so extensive that
they precluded the use of other
donor sites.1-2 In the procedure de
scribed in this paper a split-thick
ness skin graft (STSG) harvested
from unburned scalp is chosen pre
ferentially to cover facial and neck
burns. The graft thickness selected
is such that the dermis remaining at

T

the donor site contains sufficient
epidermal elements to re-epithelialize the resulting wound, yet the
graft is thick enough to provide
stable closure of the wound itself.
These epidermal elements consist of
the hair follicles and sweat glands,
so that hair growth will be pre
served at the donor site but will not
occur in the graft, which is har
vested superficial to the majority of
hair-follicle roots. The potential for
this technique is gradually being

From the Division o f Plastic Surgery, Department o f Surgery, The Hospital for Sick Children,
University o f Toronto, Toronto, Ont.
*Medical student, Faculty o f Medicine, University o f Toronto
fChief, Division o f Plastic Surgery, The Hospital fo r Sick Children, University o f Toronto
fS e n io r resident, Division o f Plastic Surgery, The Hospital for Sick Children, University o f
Toronto

realized, and some centres report
that the scalp is the donor site of
choice in certain situations.3-5
The scalp is usually easily acces
sible during surgery. The donor site
heals rapidly3 and can be reharvest
ed within a short time1-2-4 Also there
is a lower incidence of hypertrophic
scarring in the scalp compared with
more traditional donor sites.2-5 Esthetically, the scalp provides a supe
rior colour match in face and neck
burns, and with subsequent hair
growth the donor site is hidden.3-4-6
Finally graft harvest from the scalp
results in less donor-site discomfort
than at other sites.3-5
The disadvantages to using the
scalp are few. Persistent alopecia at
the donor site and hair growth at
the graft site are rare.1-3-5 The
major drawback to this procedure
in children is that they fear mutila
tion, baldness and pain, which they
feel will accompany the harvesting
of a scalp graft. This has been
carefully studied by Kloti and Pochon,5 who indicated that 90% of
children who have had a graft taken
from the scalp would willingly un
dergo a second similar procedure if
necessary. It was shown that many
of these fears were allayed by ade
quate preoperative discussion and
contact with patients who had al
ready undergone scalp grafting.

Technique
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Children, 5 55 University Ave., Toronto, ON M5G 1X8
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Under general anesthesia the
scalp is shaved with a safety razor,

SCALP AS DONOR SITE

prepared with Betadine solution and
draped. A regional subcutaneous
injection of saline is given to facili
tate harvesting. The surface is then
washed with saline solution and
lubricated with mineral oil. An
STSG is harvested with a Padgett
dermatome (Padgett Instruments
Inc., Kansas City, Kan.) set at
0.012-in (0.3-mm) thickness passed
in an anterior to posterior direction
(Fig. 1). The donor site is then cov
ered with thrombin-epinephrinesoaked sponges until hemostasis is
achieved, followed by a scarlet red
dressing, which may be stapled into
place. Bulky gauze and a head
dressing are applied after the burn
wound has been grafted and
dressed. Attention is now turned to
the burn. It is gently debrided until
pinpoint bleeding is recognized. He
mostasis is achieved with throm
bin-epinephrine-soaked sponges
and point electrocoagulation. The
graft is then laid down, ensuring
adequate coverage of any open
areas (Fig. 2). Chlorhexidine acetate
(Bactigras; Smith and Nephew Inc.,
Whitby, Ont.) and saline-soaked
sponges are applied, and a tie-over
stent dressing is fashioned with 4-0
Prolene sutures. This is then cov

FIG. 1. Harvesting scalp graft.

ered with saline-soaked burn gauze,
dry burn gauze and a soft collartype dressing. These should remain
undisturbed for 8 days postoperatively to allow adequate time for
graft incorporation. Standard dress
ings of burn gauze with silver sulfa
diazine (Flamazine; Smith and
Nephew Inc.) and polymyxin Bgramicidin (Polysporin; Burroughs
Wellcome Inc., Kirkland, Que.) may
then be used and should be
changed regularly.

Case Reports
Case 1
A 6-year-old boy sustained a
flame burn covering 18% of his
total body surface after his clothes
accidentally ignited while he was
playing with matches. The affected
areas were the neck, right shoulder,
right arm and left hand. The burns
to his chest and shoulder were
judged to be full thickness ones,
whereas that to the anterior neck
appeared to be a deep partial-thick
ness burn. The boy was resuscitat
ed, and his wounds were dressed
upon admission. The chest, shoul

der and arm were debrided and
grafted with STSGs harvested from
the buttocks and posterior thighs
bilaterally 3 and 4 days after the
injury. The neck burn was treated
twice daily with normal-saline baths
and dressing changes consisting of
burn gauze and Flamazine in the
hope that the wound would re-epithelialize spontaneously. However,
the burn eventually proved to be of
full thickness and required a skin
graft. On day 26 an 8 X 20-cm
STSG was harvested from the right
parietal area by the technique previ
ously described. The graft bed con
sisted of debrided granulation tis
sue, and the operation proceeded
without incident with full coverage
of the wound.
After the operation there was
some difficulty in maintaining the
neck dressing in place because the
young patient was very restless.
Nine days after the procedure the
dressings were removed and the
graft was examined. The graft
“take” was judged to be fair to
moderate because there was some
patchy “take” centrally and poor
“ take” on the right lateral border
of the wound. However, the neck
graft was nursed scrupulously over
the following days, resulting in
moderate graft “take” in all but the

FIG. 2. Scalp graft in place.
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right lateral region, which remained
open. Eleven days after harvesting,
the scalp donor site was completely
healed. The open areas on the neck
healed spontaneously over the next
week. The child was then dis
charged from hospital wearing an
elastic compression neck splint.
Four months after the original
injury the colour match and func
tion of the graft itself were good;
however, the surrounding scar dem
onstrated hypertrophic activity and
some degree of contraction, as ex
pected.
C ase 2

A 2V2-year-old boy sustained a
hot fuel burn to the face, involving
8% of the total body surface area,
after a restaurant accident with hot
oil. He was brought immediately to
hospital where he was resuscitated,
and the burn wound was dressed.
The burns were assessed to be of
partial thickness on the forehead,
eyelids and both ears and full thick
ness over the chin, submandibular
area and anterior neck. For the next
14 days the patient was treated
conservatively twice daily with nor
mal-saline baths and gentle debride
ment of loose eschar. The face was
kept well greased with Polysporin
ointment and was soaked with nor
mal saline every 4 hours while the
patient was awake. By day 14 after
the injury, the partial-thickness
wounds had re-epithelialized, and
treatment consisted of lanolin mas
sage to the healed areas and con
tinued Polysporin administration to
the chin and neck, which were
covered by granulation tissue. On
day 18, these areas were surgically
debrided, and an STSG was har
vested from the occiput and used to
cover these open areas.
Postoperatively, the dressings
were left undisturbed for 8 days,
during which normal-saline face
soaks were continued. Examination
314
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of the graft and donor sites after
the dressings were removed showed
that the skin graft had taken well,
yet two small areas remained open
on the right side of the chin. The
scalp donor site was well healed.
For the next 3 days the donor site
was kept greased with lanolin, and
Polysporin and Bactigras were ap
plied to the chin until the patient
was discharged.
An elastic compression face mask
and inserts for compression to the
neck and submandibular region
were used. The skin graft settled
well, but despite these efforts con
siderable hypertrophy was noted in
the grafted area and on the conser
vatively treated cheek and forehead
6 months after the injury. The scalp
donor site appeared to have healed
well.

with lanolin and the graft with
Polysporin.
At follow-up 1 week later, the
patient was given an elastic com
pression face mask to be worn at all
times. The mask, however, did not
cover the right ear. Over the next 9
months hair grew back fully at the
donor site, and the graft settled in
beautifully with excellent colour
match and contour; however, there
was some antehelical irritation dur
ing this time, and some local hyper
trophic scarring developed (Fig. 6).
After 9 months compression thera
py was discontinued, and, upon
reassessment 16 months after the
injury, the donor site was unrecog
nizable, and the graft had blended
well with the adjacent skin (Fig. 7).
There was some scarring in the
preauricular region and ear.

Case 3

Discussion
A 3V2-year-old girl suffered a
full-thickness burn of the right
cheek and ear after contact with a
hot stove. The burn covered 5% of
her total body surface area (Fig. 3).
She was treated twice daily with
normal-saline baths and dressing
changes with light debridement.
The facial burn was dressed with
Flamazine and burn gauze, and the
ear was greased with Polysporin
and left open. This was continued
until day 17 when the patient un
derwent debridement and grafting.
The cheek wound was debrided and
resurfaced with an STSG that was
obtained from the right temporal
region of the scalp because there
were two small defects on the ear.
Nine days postoperatively the dress
ings were removed to reveal that
the graft had taken completely, and
the scalp donor site had healed
(Figs. 4 and 5). Due to the social
situation, the child could not be
discharged from hospital for an
additional 2 weeks, during which
time the donor site was kept greasy

Several conclusions can be ex
trapolated from each of the cases
reported. In the first case, noncom
pliance was a problem in the imme-

FIG. 3. Initial full-thickness burn.
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diate postoperative period. The sur
viving grafted tissue was a success
both functionally and cosmetically,
yet the surrounding denuded area
that healed spontaneously became
hypertrophic and hyperemic. This
illustrates that optimal results can
be obtained only if graft “take” is
adequate, and that ensuring this

postoperatively is imperative to the
ultimate success of the procedure.
In the second case hypertrophic
scarring occurred in grafted as well
as nongrafted areas despite accept
able graft “take.” This suggests
that in areas difficult to compress,
such as the submandibular region
in this case, use of a scalp graft
cannot prevent the development of
hypertrophic scarring, which may
negate the benefits of good colour
match. The third case demonstrated

a very favourable result. The graft
“take” was excellent, and the loca
tion of the burn allowed easy com
pression. In maximizing these two
factors, the outcome in this patient
was the best of the three cases
described.
No donor-site morbidity was en
countered. Specifically, there was
no alopecia or hair growth in the
grafts, and the patients did not
complain of excessive pain due to
the harvesting of the graft. There
was evidence of superior colour
match in two of the three cases.
Each patient had some degree of
hypertrophic scarring, and there is
no indication that the incidence of
hypertrophic scarring is reduced
with this approach.

Conclusions

FIG. 4. Graft and donor site 9 days
postoperatively.

FIG. 6. Graft site 9 months postopera
tively.

The use of the scalp as a donor
site for treating facial and neck
burns is effective. The technique’s
major advantages are minimal site
morbidity and a superior cosmetic
result in burns that can readily be
compressed.
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lOmg TABLETS & 30mg IM INJECTIONS

(ketorolac tromethamine)

NARCOTIC EFFICACY WITHOUT NARCOTIC DRAWBACKS
TORADOL (ketorolac tromethamine) 10 mg tablets
TORADOL IM (ketorolac tromethamine) 15 mg/mL and 30 mg/mL intramuscular injections
THERAPEUTIC CLASSIFICATION
Analgesic Agent
ACTION
Toradol (ketorolac tromethamine) is a non-steroidal anti-inflammatory drug that exhibits analgesic activity. Its mode of
action is to inhibit the cyclo-oxygenase enzyme system, thereby inhibiting the synthesis of prostaglandins, and is consid
ered to be a peripherally acting analgesic. At analgesic doses it has minimal anti-inflammatory and antipyretic activity.
Ketorolac tromethamine is rapidly and completely absorbed when administered by both the oral and intramuscular routes,
and pharmacokinetics are linear following single and multiple dosing.
Steady state plasma levels are attained after one day of Q.I.D. dosing. Based only on pharmacokinetic principles, a faster
attainm ent of the steady state plasma level might be achieved with a loading dose of about twice the maintenance
dose. This occurs when the dosing interval is approximately equal to the drug's half-life.
Following oral administration, peak plasma concentrations of 0,52 to 1.31 mcg/m l occurred 35 minutes after a single 10 mg
dose. The terminal plasma elimination half-life ranged between 4.1 and 6.1 hours in healthy adults, while in elderly sub
jects (mean age: 72 years) it ranged between 3.0 and 6.1 hours. A high fat diet decreased the rate but not the extent
of absorption of oral ketorolac tromethamine, while antacid had no effect.
Following intramuscular administration, peak plasma concentrations of 2.2 to 3.0 m cg/m l occurred an average of 50
minutes after a single 30 mg dose, The terminal plasma half-life ranged between 3.8 and 6.3 hours in young adults and
betw een 4.4 and 8.6 hours in elderly subjects (mean age: 72).
The primary route of excretion of ketorolac tromethamine and its metabolites (conjugates and the p-hydroxy m etabo
lite) is in the urine (91.4%) and the remainder is excreted in the feces.
More than 99% of the ketorolac in plasma is protein bound over a wide concentration range.
INDICATIONS
Orally administered Toradol (ketorolac tromethamine) is indicated for the short-term management of mild to moderately
severe pain, including post-surgical pain (such as general, orthopedic and dental surgery), acute musculoskeletal
trauma pain and post-partum uterine cramping pain.
Intramuscular injection of Toradol is indicated for the short-term management of m oderate to severe pain, including pain
following major abdominal, orthopedic and gynecological operative procedures.
CONTRAINDICATIONS
Toradol (ketorolac tromethamine) should not be used where there is a known or suspected hypersensitivity to the drug,
Because of the possibility of cross-sensitivity, ketorolac tromethamine should not be used in patients in whom acetylsalicylic acid (ASA) or other non-steroidal anti-inflammatory agents induce acute asthmatic attacks, urticaria, rhinitis or other
allergic manifestations. Fatal anaphylactoid reactions may occur in such individuals.
Toradol (ketorolac tromethamine) also should not be used in patients with peptic ulcer or active inflammatory disease
of the gastrointestinal system.
WARNINGS
Long-term administration of ketorolac tromethamine oral formulation has shown th a t this drug shares the risks that other
non-steroidal anti-inflammatory drugs pose to patients when taken chronically. Peptic ulceration, perforation and gas
trointestinal bleeding, sometimes severe and occasionally fatal have been reported during therapy with non-steroidal
anti-inflammatory drugs and may occur with ketorolac tromethamine, both in the presence or absence of previous symp
toms. Elderly and debilitated individuals are most susceptible to these complications, the incidence of which increases
with dose and duration of treatment. Close medical supervision is recommended in patients prone to gastrointestinal
tract irritation, particularly those with a history of peptic ulcer, diverficulosis or other inflammatory disease of the gastrointestinal
tract. In these cases the physician must weigh the benefits of treatment against the possible hazards.
Patients taking any non-steroidal anti-inflammatory drug including ketorolac tromethamine should be instructed to con
tact a physician immediately if they experience symptoms or signs suggestive of peptic ulceration or gastrointestinal bleeding.
These reactions can occur at any time during the treatment. If peptic ulceration is suspected or confirmed, or if gastrointestinal
bleeding occurs, ketorolac tromethamine should be discontinued and appropriate treatment instituted and the patient
closely monitored.
Ketorolac tromethamine is not recommended for routine use with other non-steroidal anti-inflammatory drugs because
of the potential for additive side effects.
Use in pregnancy, lactation and labour: The administration of ketorolac tromethamine is not recommended during preg
nancy or lactation.
Ketorolac tromethamine is not recommended for use as an obstetrical preoperative medication or for obstetrical anal
gesia because of the known effects of non-steroidal anti-inflammatory drugs on uterine contraction and fetal circulation.
Use in children: Safety and efficacy in children have not been established. Therefore, Toradol is not recommended for
use in children under age 16.
Use in the elderly: Because ketorolac is cleared somewhat more slowly by the elderly (See PHARMACOKINETICS) who
are also more sensitive to the renal effects of non-steroidal anti-inflammatory drugs, extra caution and the lowest effec
tive dose should be used.
PRECAUTIONS
Renal effects: As with other drugs that inhibit prostaglandin biosynthesis, elevations of blood urea nitrogen (BUN) and cre
atinine have been reported in clinical trials with ketorolac tromethamine. Since ketorolac tromethamine and its metabolites
are excreted primarily by the kidney, patients with significant impairment of renal function (serum creatinine values greater
than 5 mg/dL) should not receive ketorolac tromethamine unless the expected benefits outweigh the risks. In patients
with moderately impaired renal function serum creatinine values ranging from 1.9 to 5.0 mg/dL, the rate of ketorolac
clearance was reduced to approximately half of normal. The total daily dose of ketorolac tromethamine should be reduced
by half in such patients. The disposition of ketorolac in dialysis patients has not been studied.
Patients who are volume depleted because of blood loss or severe dehydration may be dependent on renal prostaglandin
production to maintain renal perfusion and therefore glomerular filtration rate. In such situations the use of drugs which
inhibit prostaglandin synthesis might be expected to further decrease renal blood flow, Caution is advised if ketorolac
tromethamine is used in such circumstances, Close monitoring of urine output, serum urea and serum creatinine is rec
om m ended until the patient is normovolemic.
Hepatic effects: Meaningful elevations (greater than 3 times normal) of serum transaminases (glutamate pyruvate (SGPT
or ALT) and glutamic oxalacetic (SGOT or AST)) occurred in controlled clinical trials in less than 1% of patients. If clinical
signs and symptoms consistent with liver disease develop, or if systemic manifestations occur (e.g., eosinophilia, rash, etc.),
ketorolac tromethamine should be discontinued. Patients with impaired hepatic function from cirrhosis do not have any
clinically important changes in ketorolac tromethamine clearance. Studies in patients with active hepatitis or cholesta
sis have not been performed.
Fluid and electrolyte balance: Fluid retention and edema have been observed in patients treated with Toradol. Therefore,
as with many other non-steroidal anti-inflammatory drugs, the possibility of precipitating congestive heart failure in
elderly patients or those with compromised cardiac function should be borne in mind. Toradol should be used with cau
tion in patients with cardiac decompensation, hypertension or other conditions predisposing to fluid retention.
Hematologic effects: Ketorolac tromethamine inhibits platelet function and may prolong bleeding time. It does not affect
platelet count, prothrombin time (PT) or partial thromboplastin time (PIT). Patients who have coagulation disorders or
are receiving drug therapy that interferes with hemostasis should be carefully observed when ketorolac tromethamine
is administered. Unlike the prolonged effects from aspirin, the inhibition of platelet function by ketorolac tromethamine
is normalized within 24 to 48 hours after the drug is discontinued.
Blood dyscrasias associated with the use of non-steroidal anti-inflammatory drugs are rare, but could occur with
severe consequences.
Infection: In comm on with other anti-inflammatory drugs, ketorolac tromethamine may mask the usual signs of infection.
Drug Interactions: Toradol (ketorolac tromethamine) is highly bound to human plasma protein (mean 99.2%) and bind
ing is independent of concentration.

Prothrombin time should be carefully monitored in all patients receiving oral anticoagulant therapy concomitantly with
ketorolac tromethamine.
Ketorolac tromethamine does not alter digoxin protein binding.
In vitro studies indicated that at therapeutic concentrations of salicylates (300 mcg/mL), the binding of ketorolac
tromethamine was reduced from approximately 99.2% to 97.5%. Therapeutic concentrations of digoxin, warfarin,
acetaminophen, phenytoin, tolbutamide and piroxicam did not alter ketorolac tromethamine protein binding. Since ketoro
lac tromethamine is a highly potent drug and present in low concentrations in plasma, it would not be expected to displace
other protein-bound drugs significantly.
There is no evidence in animal or human studies that ketorolac tromethamine induces or inhibits the hepatic enzymes
capable of metabolizing itself or other drugs. Hence, it would not be expected to alter the pharmacokinetics of other
drugs due to enzyme induction or inhibition mechanisms,
Ketorolac tromethamine mildly reduces the diuretic response to furosemide in normovolemic subjects. Inhibition of renal lithium
clearance leading to an increase in plasma lithium concentration and potential lithium toxicity has been reported with some
non-steroidal anti-inflammatory drugs. The effect of ketorolac tromethamine on lithium plasma levels has not been studied,
Concomitant administration of methotrexate and some non-steroidal anti-inflammatory drugs have been reported to
reduce the clearance of methotrexate, enhancing the toxicity of methotrexate. The effect of ketorolac tromethamine
on methotrexate clearance has not been studied.
There is limited experience on concurrent administration with morphine. Available information shows no evidence of adverse
interactions. The extent of a possible narcotic-sparing effect of ketorolac tromethamine is currently under investigation.
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ADVERSE EFFECTS
Toradol tablets: The incidence of adverse reactions in approximately 600 patients and subjects receiving short-term oral
therapy (lessthan 2 weeks) with Toradol (ketorolac tromethamine) are listed below. The most common adverse effects include:
Gastrointestinal: dyspepsia (2%), gastrointestinal pain (2%), nausea (2%). Central nervous system: headache (2%), dizzi
ness (2%).
The following adverse events are rare but have been reported (less than 1%): Gastrointestinal: flatulence, gastritis.
Respiratory: dyspnea. Dermatologic: urticaria, rash, pruritus. Metabolism/nutritional: edema. Body as a whole: asthenia.
Hemic and lymphatic: purpura. Musculoskeletal: myalgia.
Toradol IM: The adverse reactions listed below were reported to be probably related to Toradol IM in clinical trials in which
patients received up to 20 doses of 30 mg of intramuscularly administered Toradol over a period of up to five days.
Incidence between 3 and 9%: Gastrointestinal: nausea, dyspepsia, gastrointestinal pain. Central nervous system: drowsiness.
Incidence between 1 and 3%: Gastrointestinal: diarrhea. Central nervous system: dizziness, headache, sweating. Body as
a whole: edema. Injection site pain was reported by 2% of patients in multi-dose studies (vs. 5% for morphine control group).
Incidence 1% or less: Gastrointestinal: constipation, flatulence, gastrointestinal fullness, liver function abnormalities,
melena, peptic ulcer, rectal bleeding, stomatitis, vomiting. Body as a whole: asthenia, myalgia. Cardiovascular: vasodi
latation, pallor. Hemic and lymphatic: purpura. Nervous system: dry mouth, nervousness, paresthesia, abnormal thinking,
depression, euphoria, excessive thirst, inability to concentrate, insomnia, stimulation, vertigo. Respiratory: dyspnea,
asthma. Urogenital: increased urinary frequency, oliguria. Dermatologic: pruritus, urticaria. Special senses: abnormal taste,
abnormal vision.
OVERDOSAGE
The absence of experience with acute overdosage precludes characterization of sequelae and assessment of antido
tal efficacy at this time. In a gastroscopic study of healthy subjects, daily doses of 360 mg given over an 8-hour interval
for each of five consecutive days (3 times the highest recommended dose) caused abdominal pain and peptic ulcers
which recovered after discontinuation of dosing,
DOSAGE AND ADMINISTRATION
Adults: Dosage should be adjusted according to the severity of the pain and the response of the patient.
Oral: The usual oral dose of Toradol (ketorolac tromethamine) is 10 mg every 4 to 6 hours for pain as required. Doses exceed ing 40 mg per day are not recommended.
Toradol is recommended for short-term use only i.e. for a maximum of a few weeks.
Parenteral: The recom mended usual initial dose is 30 mg. Subsequent dosing may be 10 mg to 30 mg every 4-6 hours as
needed to control pain. A lower initial dose may be suitable for patients under 50 kg in body weight, over age 65 years
and/or with less severe pain at baseline. In the initial post-operative period, more frequent dosing (e.g., every 2 hours)
may be employed, but the total daily dose should not exceed 120 mg. Dose above 120 mg could cause drug toxicity
(see Warnings & Precautions). If supplemental analgesia is required, a concomitant low dose of opiate can be used.
The administration of continuous multiple daily doses of Toradol IM should not exceed 5 days for Injection dosing. There
has been limited experience with dosing for more than 5 days since the vast majority of patients have transferred to oral
medication or no longer required analgesic therapy after this time.
Directions for use: Insert the plunger into the syringe barrel and thread it onto the screw. WITHOUT REMOVING THE NEEDLE GUARD,
apply quick, firm pressure to the plunger to break the inner seal (you will feel it let go). Pull back on the plunger slightly to relieve
pressure, Remove the needle guard by twisting as you pull. Use the unit as you would a normal syringe. Dispose of properly.
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CONVERSION FROM PARENTERAL TO ORAL THERAPY
Toradol tablets may be used either as monotherapy or as follow-on therapy to parenteral ketorolac. In the latter case,
the total combined daily dose of ketorolac should not exceed 120 mg on the day the change of formulation is made,
this includes a maximum of 4 of the 10 mg tablets.
Toradol (ketorolac tromethamine) is a Schedule F drug.
COMPOSITION
Toradol Tablets: Each Toradol tablet contains ketorolac tromethamine, the active ingredient, with microcrystalline cel
lulose, lactose and magnesium stearate. The coating suspension contains hydroxy-propyl-methylcellulose, titanium
dioxide and polyethylene glycol.
Toradol IM: Toradol IM is available for intramuscular administration as: 15 mg in 1 mL (1.5%), or 30 mg in 1 mL (3%) of ketoro
lac tromethamine in sterile solution. The 15 mg/mL solution contains 10% (w/v) alcohol, USP, and 6.68 mg sodium chloride
in sterile water. The 30 mg/mL solution contains 10% (w/v) alcohol, USP and 4.35 mg sodium chloride in sterile water. The
pH is adjusted with sodium hydroxide or hydrochloric acid, The sterile solutions are clear and slightly yellow in colour.
STABILITY AND STORAGE RECOMMENDATIONS
Toradol Tablets: Store at room temperature. The blister package tablets should be protected from light.
Toradol IM: Store at room temperature with protection from light.
AVAILABILITY OF DOSAGE FORMS
Toradol (ketorolac tromethamine) is available as 10 mg white round film coated tablets with one side printed in red with
TORADOL inside a bold T and the other side with Syntex. Toradol (ketorolac tromethamine) 10 mg tablets are available
in bottles of 100 and 500 tablets.
Toradol IM is available in 1 mL syringes containing 15 or 30 mg/mL of ketorolac tromethamine.
Product Monograph available on request.
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1. TORADOL Product Monograph, Syntex Inc., Feb. 1991.2. Compendium of Pharmaceuticals and Specialties, 26th
Edition, 1991.3.Yee JP et al. Pharmacother 1986; 6(5): 253-61.4. Brown CR et al. Pharmacother 1990; 10(6 Pt 2): 45S-49S.
5. O'Hara DA et al. Clin Pharm Ther 1987; 41(5)556-61.6. Fragen RJ. Data on File, Syntex Inc., Document CL3837,1987.
7. Cherry C et al. Data on File, Syntex Inc., Document CL3835,1987,8. Stanski DR et al. Pharmacother 1990; 10(6 Pt 2):
40S-44S. 9. Data on File, Syntex Inc., Document #90027-1,1989.10. Forbes JA et al. Pharmacother 1990; 10(6 Pt 2): 77S93S. 11. Forbes JA et al. Pharmacother 1990; 10(6 Pt 2): 94S-105S. 12. Mehlisch D et al„ Data on File, Syntex Inc., Document
CL3686,13. Data on File, Syntex Inc., Document #90027-3,1989.14, Rooks IIWH et al. Pharmacother 1990; 10(6 Pt 2): 30S32S. 15. Rubin P et al. Clin Pharmacol Ther 1987; 41(2): 182.16. Bravo BUC et al. EurJClin Pharmacol 1988; 35:491-4.17. Toradol
Cost Effectiveness Report. Data on File, Syntex Inc. 18. Oosterlinck W et al. J Clin Pharmacol 1990; 30:336-341.19. Cutting CJ
et al. Data on File, Syntex Inc., Document C L4740,1989.20. Diebschlag W, Nocker W, Data on File, Syntex Inc.,
Document CL5468,1989.21. Molinie J et al. Data on File, Syntex Inc., Document CL4624,1988.22. Herrera JMC et al. Data
on File, Syntex Inc., Document CL4886,1989.
Toradol Information Line: 1-800-561-5481,

©

SYNTE><]®

Syntex Inc.* Mississauga, Ont./Montreal (Que.)
‘ Registered user of all ©trademarks.

Upjohn ]®
IpaabI
Ic c p p |

The Upjohn Company of Canada
Don Mills, Ontario

f

“1

ORIGINAL ARTICLES

Laparoscopic Cholecystectomy: a Review
of 258 Patients
Yves-Marie Dion, MD, MSc, FACS, FRCSC; Jacques Morin, MD, FRCSC
Between Apr. 18, 1990, and Apr. 26, 1991, 258 patients were treated for
symptomatic cholelithiasis by laparoscopic cholecystectomy. In 252 patients the
diagnosis was chronic calculous cholecystitis, in 3 acute cholecystitis and in 3
hydrops of the gallbladder. There were no deaths. Major complications occurred
early in the study — one patient suffered a cardiac arrest because of gas embolism
and one had leakage from the stump of the cystic duct, which was treated by
percutaneous drainage. Both patients recovered without further complications. The
hospital stay averaged 2.9 days. The authors discuss important technical points for
the safe performance of laparoscopic cholecystectomy and consider the results
obtained by leading groups in the field and by one multicentre survey in the United
States. Almost 25 000 cases of laparoscopic cholecystectomy are evaluated.

Entre le 18 avril 1990 et le 26 avril 1991, 258 patients ont ete traites pour
cholelithiase symptomatique, par cholecystectomie laparoscopique. On avait
diagnostique chez 252 de ces patients une cholecystite calculeuse chronique, chez 3
autres, une cholecystite aigu et 3 souffraient d’hydropisie de la vesicule biliaire.
Aucune mortality n’a ete enregistree. Des complications majeures sont survenues tot
durant l’etude; un patient a souffert d’un arret cardiaque consecutif a une embolie
gazeuse et un second presenta une fuite du moignon du canal cystique, ce qui fut
traite par drainage percutane. Les deux patients se sont retablis sans autres
complications. La duree du sejour a l’hopital a ete en moyenne de 2,9 jours. Les
auteurs commentent les points techniques importants qui permettent de reussir une
cholecystectomie laparoscopique securitaire et passent en revue les resultats
obtenus par les principaux groupes dans le domaine, et ceux d’une enquete
multicentrique realisee aux Etats-Unis. Pres de 25 000 cas de cholecystectomie
laparoscopique ont ete evalues.

aparoscopic cholecystectomy
has become the procedure of
choice for the treatment of symp
tomatic cholelithiasis. Over a period
of 12 months, we treated 258 pa
tients. Since we reported on our
first 60 patients1 we have noted a
low complication rate and a high
patient satisfaction rate.

L

Patients and Methods
From Apr. 18, 1990, to Apr. 26,
1991, 258 patients (192 women

and 66 men) underwent laparoscop
ic cholecystectomy.
The technique and instruments
used have been described else
where.1
Our present indications for lapa
roscopic cholecystectomy include
the following:2 symptomatic choleli
thiasis; asymptomatic persons in
whom acute cholecystitis might be
difficult to treat, such as diabetics,
persons travelling in regions where
medical care is inadequate and
women planning pregnancy; and se
lected cases of acute cholecystitis.

From the Department o f Surgery, Hopital Saint-Franqois d'Assise, Quebec, Que.
Accepted fo r publication Aug. 6, 1991
Reprint requests to: Dr. Yves-Marie Dion, Hopital Saint-Franqois d ’Assise, 10 de I ’Espinay,
Quebec, PQ G IL 3L5

Contraindications to the perfor
mance of the procedure can be
classified in the following two cate
gories:2 absolute — patients who
cannot tolerate general anesthesia
or laparotomy, such as those with a
severe cardiac or pulmonary prob
lem or those with a blood dyscrasia,
patients with severe cirrhosis and
portal hypertension and pregnant
patients; relative — acute cholecys
titis, jaundice or cholangitis, acute
pancreatitis, morbid obesity, previ
ous upper abdominal surgery.

Findings
Follow-up of patients extended
from 12 to 367 days postoperatively
(Table I). We contacted 224 (87%)
patients for evaluation of late com
plications. The patients’ ages
ranged from 14 to 82 years (aver
age 44 years). Their weights ranged
from 41 to 109 kg (average 65 kg).
The postoperative hospital stay var
ied from 1 to 18 days (average 2.9
days) (Table II).
Most revealing is the average
number of times patients took par
enteral analgesics such as Demerol
(Winthrop Pharma, Aurora, Ont.),
intramuscularly, or Dilaudid (Knoll
Pharmaceuticals, Markham, Ont.),
subcutaneously, to relieve their pain
(Table III). Sixty-eight (26%) pa
tients took parenteral analgesics
only once, and 128 (50%) patients
took such medication twice. Thir
teen (5%) patients took no pain
medication, and 11 (4%) took only
enteral analgesia (Empracet; Bur
roughs Welcome Inc., Kirkland,
Que.).
Of the 258 patients 252 were
operated on for chronic calculous
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cholecystitis, 3 for acute cholecysti
tis and 3 for a mucocele of the
gallbladder.
Complications were few (Table
IV). One leak from the cystic-duct
stump occurred early in the series
and the fluid was drained percutaneously by the radiologist. One
subphrenic hematoma, occurring
early in the series, was aspirated
percutaneously. One cardiac arrest
also occurred early. It lasted only a
few seconds and, with the agree
ment of the anesthetist, the proce
dure was completed. There was no
bile-duct trauma, bowel injury, he
morrhage, pulmonary embolism,
acute pancreatitis or death.
No case of injury to the biliaryduct system or deep vein thrombo
Table 1. Patient Characteristics
Characteristic

No.

Total no. of patients
Sex
Female
Male
Age, yr
Range
Mean
Weight, kg
Range
Mean
Diagnosis
Chronic cholecystitis
Acute cholecystitis
Hydrops
Operative cholangiography,
no. of patients
Postoperative stay, d
Range
Mean
No. of patients followed up
Length of follow-up, d
Range
Mean

258
192
66
14-82
44
41 - 109
65
252
3
3
35
1 -1 8
2.9
224
12-367
163

Table II. Postoperative Stay
Length of stay, d

318

No. of patients

1
2
3
4
5
6
7
> 8

3
137
73
21
10
4
2
8

Total

258
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sis was noted. One inflamed gall
bladder was recovered from the pel
vis through a mini-Pfannenstiel in
cision without any subsequent com
plication. Two patients had an um
bilical wound infection treated with
conventional incision, drainage and
antibiotics.
No cases of acute pancreatitis,
acute peritonitis or intra-abdominal
abscess developed, and there were
no injuries related to the use of the
Veress needle or the trocars. No
deaths were recorded.
Thirteen patients complained
postoperatively of abdominal pain
similar to biliary colic. In one case
endoscopic retrograde cholangio
pancreatography (ERCP) identified
a common-duct stone, which was
removed during endoscopic sphinc
terotomy. Five patients had normal
findings on ERCP and, at the time
of writing, seven were awaiting
ERCP. We obtained 35 operative
cholangiograms. One cholangiogram was positive for a commonduct stone, but postoperatively the
findings on ERCP were normal.
The rate of conversion to open
cholecystectomy was 2% (five
cases), owing to difficulty in defin
ing the anatomy (presence of dense
adhesions or small retracted gall
bladder with a virtually nonexistent
Calot’s triangle) in four cases and
to obesity combined with a con
tracted gallbladder in another case.

Discussion
Laparoscopic cholecystectomy
has become the procedure of choice
for uncomplicated chronic calculous

cholecystitis. Of the relative con
traindications to laparoscopic chole
cystectomy stated by Ponsky,2 two
merit comment. For instance, jaun
dice or cholangitis, if caused by
stones, could be treated by prelaparoscopic ERCP and endoscopic
sphincterotomy. As well, biliary
pancreatitis can be treated, after the
acute phase, by laparoscopic chole
cystectomy, once ERCP has shown
that there is no stone in the com
mon duct.
Many series3-5 attest to the safety
of the procedure (Table V3-7). How
ever, from a review of a series of
22 204 collected cases of laparo
scopic cholecystectomy performed
by 2386 surgeons in the United
States,6 it is evident that dramatic
injuries can occur to the bile ducts,
bowel and vascular structures such
as aorta, vena cava or portal vein
(Table V). Airan6 believed that the
data underestimated the real com
plication rate.
We think that to avoid complica
tions, the surgeon should first mas
ter insertion of the Veress needle
and the trocars.
The one cardiac arrest in an
otherwise healthy 30-year-old
woman early in our series, which
was preceded by ventricular ex
trasystoles and ventricular fibrilla
tion, was likely caused by gas em
bolism possibly from puncture of an
omental vein. When a similar situa
tion occurs and the patient does not
respond promptly to treatment, in
tra-abdominal or retroperitoneal he
morrhage should be suspected. As
no trocar has been inserted usually,
immediate laparotomy should be
performed.

Table III. Patients Receiving Analgesia*
No. of times/d
Route of analgesia

1

2

3

> 4

Enteral
Parenteral

4
68

4
128

1
22

2
16

*13 patients received no analgesia.

LAPAROSCOPIC CHOLECYSTECTOMY

It is false to assume that the
protective sheath covering dispos
able trocars will prevent all injuries.
Injuries have occurred despite prop
erly inserted trocars.8 When bowel
injury occurs because of an improp
erly placed Veress needle, the site
can be examined after cholecystec
tomy and usually there will be no
indication for intervention at this
site. A trocar injury mandates that
the bowel be repaired through a
laparotomy.
Dissection of the cystic duct
should always begin at its junction
with Hartmann’s pouch, and the
surgeon should work carefully to
ward the common bile duct. We and
others3 do not fear leaving a fairly
long cystic duct in situ. If any
doubt exists concerning local anato
my, cystic-duct cholangiography (or
cholangiography performed via the
gallbladder) should be done. The
cystic artery should be divided close
to the gallbladder. Whether to carry
out routine or selective operative
cholangiography is debatable.9’10 It
is suggested, however, that if a
policy of selective cholangiography
T a b le IV.

Complications

Type

No.

Umbilical wound
infection
Ileus
Cardiac arrest
Cystic-duct leak
Symptomatic common-duct
stones on postoperative
endoscopic sphincterotomy
Subphrenic hematoma
Wound hematoma

2
2
1
1
1
1
1

is adopted, cholangiography should
be carried out in the first few
patients so that the surgeon can
master the technique and verify the
integrity of the biliary system.
Using monopolar electrocautery
is safe,11 provided one is careful not
to overdesiccate tissue close to a
structure that electrical current can
damage. Bowel perforation and
common-bile-duct injury have been
caused by electrocautery that was
not directly applied to the site of
the lesion. The actual perforation
may occur up to the third postoper
ative day, when necrotic tissue
sloughs.
In attempts to extract a swollen
gallbladder, it is preferable to open
the fascia in the umbilical region to
allow easy delivery of the gallblad
der. This avoids the risk of ruptur
ing the gallbladder and having to
deal with stones lying between
loops of small bowel. Removal of
stones in such a location is often
more difficult than when a spill
occurs in the subhepatic region.
There, most of them can be suc
tioned out through a no. 28 thorac
ic catheter passed through a 10-mm
trocar with irrigation provided
through a 5-mm port. Larger
stones are extracted with appropri
ate grasping forceps, sometimes
withdrawing the trocar at the same
time. The trocar is then reinserted
to remove other stones. The sur
geon should remove most of the
stones because retained stones
could lead to an intra-abdominal
abscess.12
T a b le V.

Soper, Deanna and Dunnegan13
evaluated bile leaks from the gall
bladder during laparoscopic chole
cystectomy. They noted that 81
(32%) of the 254 patients they
treated had bile leakage during sur
gery. However, there was no in
crease in the infection rate (intra
abdominal abscess or wound infec
tion). The mean postoperative stay
of 1 day was similar to that of
patients who did not have bile leak
age. Operative time was slightly
longer because of irrigation and
suctioning in the subphrenic and
subhepatic spaces. As many stones
as possible were removed from
these spaces. Patients received se
cond-generation cephalosporins perioperatively. When the perforation
in the gallbladder wall is located
away from its attachment to the
liver bed, we insert an Endoloop
(Ethicon, Montreal) to limit loss of
bile and gallstones.
The fascia is closed only when
the 10-mm trocar incision is en
larged. Hernias are not likely when
the umbilical trocar has been direct
ed during insertion slightly off the
midline into the rectus sheath, be
cause the point of entry in the
anterior rectus sheath is not direct
ly overlying the exit site in the
posterior sheath.12 However, when
there is no tunnelling of the trocar
in the rectus sheath and only the
linea alba is entered, the fascia
should be closed.14
Our policy is to remove all muco
celes by laparoscopic cholecystecto
my. However, it seems that, at

Complications Reported From Various Series
C o m p lic a tio n s

S erie s

Reddick and
Olsen3
Perissat et al4
Dubois et al5
Airan6
Berci7

No. of c ases

B iliary
tra u m a

C ystic-duct
le a k

V is c e ra l
tra u m a

H e m o rrh a g e

500
300
877
22 204
850

1
1
1
119
3

1
1
4
200
1

1
1
0
40
1

1
4
4
107
—

A bscess

—

3
1
1
—

P u lm o n a ry
e m b o lis m

1
—
—
—

1
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0
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1
16
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present, the patient who suffers
from acute cholecystitis (elevated
leukocyte count, fever, Murphy’s
sign) could be offered open surgery.
As an alternative one could use the
laparoscope to evaluate the feasibili
ty of laparoscopic cholecystectomy).
Also difficult and dangerous to re
move is a small contracted gallblad
der, which may be adherent to the
common bile duct. Excision of a
portion of the common bile duct en
bloc with the gallbladder has been
reported even during open surgery
in such situations.
The conversion rate is often con
sidered to be a reflection of good
judgement on the part of the sur
geon. It is certainly the case when
open surgery is undertaken for the
following reasons: uncertain biliary
anatomy; discovery of another and
more serious condition; choledocholithiasis. However, open surgery
is more often performed after a
complication (bleeding, bowel injury
or biliary injury) or a technical
failure (failure to create a pneu
moperitoneum, which can nearly
always be achieved by grabbing the
peritoneum with hemostats and
opening it before introduction of
the trocar). The conversion rate
should not exceed 5%.
Our patients stayed in hospital an
average of 2.9 days after laparo
scopic cholecystectomy. Most of
those who stayed 3 to 5 days did so
for personal reasons (e.g., distance
from home or alone at home). Only
10 stayed more than 6 days. Two of
them suffered an ileus from which
they recovered without complica
tion. One woman had a neurogenic
bladder that kept her longer in
hospital. The others had concurrent
disease that was investigated or
treated.
Now that laparoscopic cholecys
tectomy has been found safe in the
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hands of properly trained surgeons,
new questions are being raised and
should be answered with the help of
improving technology. Commonbile-duct stones could eventually be
treated by a cystic-duct approach
(using flexible choledochoscopy or
fluoroscopy) or a formal laparoscop
ic common-bile-duct exploration. It
has to be remembered that endo
scopic sphincterotomy has, in the
best hands, a failure rate of 5% to
22%, a morbidity rate of up to 9%
and a mortality ranging from 0.5%
to 1.5%.15
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Cemented Ceramic Acetabular
Component: a 7-Year Review
H.U. Cameron, MB, ChB, FRCSC
A 7-year review of 30 cases of cemented ceramic acetabular components has shown
that all components rapidly become surrounded by a lucent zone between the cement
and bone that appears to be nonprogressive. Although these prostheses have
functioned well, some separation interiorly between the ceramic cup and the cement
suggests that “creep” of the cup within the cement occurs and that the cup should
be modified to provide greater “pull out” resistance from the cement. This study has
failed to substantiate some of the theoretical advantages of ceramic cups.

meaningful are the results. Howev
er, because cemented components
are used mainly in the elderly, the
longer a study runs, the fewer pa
tients survive. Hence the decision
was made to review the results now.

La revue d’une experience de 7 ans avec les composantes acetabulaires de ceramique
cimentees a montre qu’elles s’entourent toutes, rapidement, d’une zone translucide
entre le ciment et l’os, laquelle ne semble pas evolutive. Bien que ces protheses
aient toutes bien fonctionne, une separation observee a la partie inferieure entre la
cupule de ceramique et le ciment indique que la cupule se retracte du ciment, et que
la cupule devrait etre modifiee de fa^on a assurer une plus grande resistance a
<d’eloignement» du ciment. Cette etude n’a pas permis de confirmer certains des
avantages theoriques des cupules de ceramiques.

Materials, Patients and
Methods

he loosening rates for cement
ed acetabular components in
crease with time. The standard ace
tabular component is plastic, and
considerable concern has arisen
about the liberation of polyethylene
wear debris, which has the capacity
to induce osteolysis at a quiescent
bone-implant interface.1"3
A ceramic acetabular component
may offer some advantages. Ceram
ic is very stiff and should therefore
reduce peak stresses on the sur
rounding cement mantle.4 Ceramic
is also a better “heat sink” than
plastic, and could reduce the ther
mal damage produced by methylme
thacrylate.5

T

Ceramic is very hard and can be
highly polished. This not only re
duces the frictional torque on the
acetabulum but also significantly
reduces the volume of wear debris
generated.6 The wear debris that
does occur seems relatively innocu
ous,7 although there has been one
report of osteolysis8 and one of a
tumour adjacent to a ceramic pros
thesis.9
For these reasons it seemed
worthwhile to carry out a clinical
trial with a cemented ceramic ace
tabular component. Because loosen
ing of the cemented acetabular
component is a late phenomenon,
the longer the follow-up, the more
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The Mittelmeier ceramic hip sys
tem (Richards Manufacturing Co.,
Memphis, Tenn.) consists of a co
balt chrome stem with a ceramic
head locked onto a trunnion by
means of a Morse taper. It is neces
sary to use a ceramic head with a
ceramic acetabular component be
cause a metal head would rapidly be
destroyed. All stems used in this
study were cemented. The acetabu
lar component was ceramic, the
cemented version resembling a con
ventional acetabular cup. Occasion
ally, particularly if there was an
eroded acetabulum with a large ca
vitary defect, the threaded truncat
ed cone version designed for use
without cement appeared to give
better fill and was cemented in place
(Fig. 1). The ceramic is fully dense
aluminum oxide from Feldmuhle
AG, Stuttgart, Germany. The ce
ramic heads and acetabula are made
independently — they are not
“ matched pairs.”
The indications for cemented
components were based mainly on
patient age (i.e., over 70 years in
cases of primary placement) and on
unsuitability for noncemented
CJS, VOL. 35, NO. 3, JU N E 1992
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threaded components in cases of
revision.
Acetabular preparation was car
ried out in standard fashion with
brushing, pressure lavage and ce
ment pressurization before cup in
sertion. The cement used was Sur
gical Simplex (Howmedica Inc.,
Rutherford, NJ).
The patients were assessed annu
ally by the Harris Hip Score.10 Rou
tine x-ray films of hip and pelvis
were obtained and analysed after
DeLee and Charnley.11 The acetabu
lum is divided into three zones on
the anteroposterior film: zone 1 —
the upper third, zone 2 — the
central third and zone 3 — the
lower third. A type 1 radiolucency
is that seen only in zone 1, and a
type 3 radiolucency is seen in all
three zones. Grading depends on
the depth of the radiolucent line
(grade I — less than 1 mm, grade II
— greater than 1 mm and grade III
— greater than 2 mm).
A cemented ceramic socket was
used in 30 patients (7 men, 23
women). The mean age at the time
of implantation was 73 years. Sev
enteen implantations were primary,
and 13 were revisions. Thirteen
patients died during the study, 6
having had a follow-up of less than
3 years and 7 less than 4 years.
Nine of the 13 died of causes
unrelated to hip surgery. In these,
the hip was functioning at the time
of death.
Two patients underwent revision
for acetabular pain at 6 and 7 years,

FIG. 1. Grooves on cementable ceramic
cup are quite shallow compared with
those on threaded cup.
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leaving 15 cases for review at 7 to 9
years.

Results
Of the surviving 15 patients 4
were men and 11 were women. The
mean age was 77.9 years (range
from 72 to 85 years) at the time of
the last follow-up. Twelve patients
scored good or excellent (more than
80 points on the Harris Hip Score)
and 3 scored fair (70 to 80 points).
No patient had groin pain. No stem
showed complete radiolucency.
Twelve nonthreaded cemented
cups remained, of which 4 were
revisions and 8 were primary place
ments. The three cemented thread
ed components were revisions.
Within 2 to 3 years all components,
whether primary or revision, devel
oped a Charnley type 3, grade I
acetabular radiolucency (i.e., a zone
of radiolucency completely sur
rounding the cement mantle). This
had not been progressive and there
had been no obvious migration of
the acetabular-cement complex.
Of the 12 nonthreaded cups, 8
(67%) showed some separation be
tween cement and implant in zone
3, and 5 (42%) showed separation in

FIG. 2. X-ray film 4 years after place
ment of ceramic cup shows Charnley
type 3, grade I acetabular radiolucency
with some separation of cup from ce
ment in zones 2 and 3.

zone 2 also (Fig. 2). This was first
noted at 2 years, but progressed
little over the following 5 years.
This phenomenon was not noted
with the threaded cups.
The two cases in which revision
was required both involved cement
ed, threaded components. The pa
tients began to complain of groin
pain and "grating” at 5 and 6 years
respectively. The acetabular radiolu
cency was not appreciably different
from the others, and at revision the
components were not obviously
loose. The stems were tight. Both
sockets were changed. Because the
pain disappeared after surgery, it
likely arose from the acetabulum.
The cement was firmly adherent to
the component. No gross wear of
the ceramic bearings was noted.
In one case, the sleeve of the
ceramic head cracked during high
speed trauma. Two loose pieces of
ceramic were present within the
joint and the crack in the head
could be seen. The implant, howev
er, survived for 4 years with no
further deterioration.

Discussion
Many of the patients had revision
of previously cemented compo
nents. The rapid appearance of ra
diolucency surrounding the new ce
ment was therefore to be expected.
However, the same observations
were made in patients who had
primary implantation.
Because ceramic is a better “heat
sink” (i.e., has a greater capacity to
absorb heat) than plastic, it should
theoretically reduce the risk of ther
mal bone necrosis caused by heat
release during cement curing. Al
though no data comparing the ef
fects of outer cement temperatures
on different socket materials are
available, this study suggests that
this factor is not of major impor
tance.

CEMENTED CERAMIC ACETABULAR COMPONENT

Similarly the increased socket
stiffness of the ceramic has not
slowed down the early development
of radiolucency between cement and
bone. Studies comparing metalbacked sockets with purely plastic
sockets have also shown that an
increase in socket stiffness does not
appear to confer any advantage.12
No obvious wear of the ceramic
sockets or heads has been noted,
even in the component with the
cracked head. In the long term this
may be a decisive factor in favour of
ceramic bearings, because the vol
ume of wear debris is reduced and,
with the exception of the two cases
mentioned earlier, wear particles
seem relatively innocuous.
What is of interest in this study
is the separation of the ceramic cup
from the cement bed in zone 3 and
occasionally in zone 2. The simple
explanation for this is failure of the
cement bed, but when such failure
is present, cement fractures are
usually readily identifiable. Because
that was not the case in this study,
it suggests that “creep” or plastic
deformation of the cement oc
curred, allowing the stiff ceramic
cup to migrate superiorly into the
cement. Why the migration arrested
remains unknown. Perhaps as the
ceramic cup approached the acetab
ular bone superiorly the cement
mantle became sufficiently stiffened
that migration ceased. The actual
migration, if it occurred, was too
small to measure. This is not seen
with plastic cups, suggesting that it
might be a function of cup stiffness.
The grooves in the ceramic cup
designed for use with cement are
quite shallow and not undercut,
thereby producing little resistance
to cup “pull out” of the cement
mantle inferiorly. The fact that sep
aration was not seen when a thread
ed cup was cemented in place sug

gests that deep or undercut grooves
do resist tensile loads and this
“creep” phenomenon. This finding
might be transferable to the stiffer
metal-backed cup (i.e., surface po
rosity or undercut grooves for ce
ment attachment).
Not only was there a difference in
component geometry between
threaded and nonthreaded cups in
this series, one being a truncated
cone and the other hemispherical,
but also there was a difference in
overall stiffness, the larger-threaded
components being somewhat stiffer.
This study also showed that a
threaded component can be cement
ed in and the threads do not appear
to act as stress risers in the cement.
The 7-year results with these
cemented ceramic cups are quite
acceptable. There does not appear
to be any major disadvantage in
their use. Some of the theoretical
advantages have not been demon
strated clinically in this study. The
results are similar to those obtained
with plastic cups, and the price of
the plastic components is so much
lower that the author has aban
doned the use of ceramic compo
nents in the elderly. However, the
problem with plastic wear debris in
the young patient is such that ce
ramic remains a very attractive
bearing surface, especially if a ce
ramic liner could be placed inside
the current noncemented metallic
acetabular components.
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(0.1-1.0%); thrombophlebitis (<0.1%). aPain on intramuscular injection
is usually mild and less frequent when the drug is administered in sterile
1% Lidocaine solution Laboratory Abnormalities: Hematologic:
Eosinophilia (4.6% ), throm bocytosis (5.1%), leukopenia (2.0%);
neutropenia, lymphophenia, thrombocytopenia, increase or decrease
in hematocrit, prolongation of prothrombin tim e and decrease in
hemoglobin (0.1 -1.0%); leukocytosis, lymphocytosis, monocytosis,
basophilia and decrease in prothrombin time (<0.1%). Hepatic: Increase
in AST (SGOT) (4.0%)t>, ALT (SGPT) (4.8%)b, increase in alkaline
phosphatase (1.0%); increase in bilirubin (0.1 -1.0%) Urinary: Increase
in BUN (1.1%)c increase in creatinine, erythrocyturia, proteinuria and
presence of casts in urine (0.1 -1.0%); glycosuria (<0.1%). ^Incidence
is more frequent in patients less than one year old. coincidence is more
frequent in patients less than one year old and over 50 years old.
SYMPTOMS AND TREATMENT OF OVERDOSAGE
Ultrasonographic shadows suggesting precipitations in the kidneys
accompanied by calcium ceftriaxone precipitate in the urine was observed
in one patient dosed with Rocephin* (ceftriaxone sodium) at 10 g/day
(2.5 times the maximum recommended dose). No other case of overdosage
has been reported to date with Rocephin * . No specific information on
symptoms or treatment is available. Excessive serum concentration of
ceftriaxone cannot be reduced by hemodialysis or peritoneal dialysis.
Treatment should be symptomatic.
DOSAGE AND ADMINISTRATION
Rocephin* (ceftriaxone sodium) may be administered intravenously or
intramuscularly after reconstitution. Dosage and route of administration
should be determined by the severity of infection, susceptibility of the
causative organisms, and condition of the patient. The intravenous route
is preferable for patients with septicemia or other severe or life-threatening
infections. DOSAGE Adults: Moderate and Severe Infections: Total daily
I.M. or I.V. dose 1 or 2 g daily. The daily dose may be given as 0.5 or 1 g
q12h, or 1 or 2 g q24h. There is limited experience with daily doses of
3-4 g administered as a single dose or two equally divided doses. The
total daily dose should not exceed 4 g. Uncomplicated Gonorrhea: Single
dose of 250 mg I.M. Infants and Children (one month to 12 years of age)
Serious Miscellaneous Infections: Total daily I.M. or I.V. dose 50 or
75 mg/kg administered as 25 or 37.5 mg/kg q12h. The total daily dose
should not exceed 2 g. If body weight is 50 kg or more the adult dose
should be used. M eningitis: Total daily I.M. or I.V. dose-100 m g/kg
administered as 50 m g/kg* q12h. *W ith or without a loading dose of
75 mg/kg. The total daily dose should not exceed 4 g. With the exception
of gonorrhea, which is treated with a single dose, the administration of
Rocephin* should be continued for a minimum of 48 to 72 hours after
the patient defervesces or after evidence of bacterial eradication has
been obtained, usually 4 to 14 days. In bone and joint infections the
average duration of treatment during clinical trials was 6 weeks, with a
range of 1 to 13 weeks, depending on the severity of the infection. When
treating infections caused by beta-hemolytic Streptococcus, it is
recommended that therapy be continued for at least 10 days. The average
duration of therapy for infections associated w ith beta-hemolytic
Streptococcus during clinical trials was 2 weeks, with a range of 1 to
5 weeks, depending on the site and severity of the infection. Prophylaxis
For preoperative use as prophylaxis before vaginal or abdominal hyster
ectomy, coronary artery bypass surgery, or biliary tract surgery in patients
at risk of infection, a single dose of 1 g administered 1/2 to 2 hours before
surgery is recommended. Impairment of Renal and/or Hepatic Function
In patients with mild to moderate renal impairment, changes in the dosage
regimen are not required, provided liver function is intact. In cases of
preterminal renal failure (creatinine clearance less than 10 mL/min),
periodic monitoring of serum ceftriaxone concentrations is recommended.
The daily dosage should be limited to 2 g or less. In patients w ith liver
damage, there is no need for the dosage to be reduced provided renal
function is intact. In cases of coexistent renal and clinically significant
hepatic insufficiency, close monitoring of serum ceftriaxone con
centrations, at regular intervals, is recommended. If there is evidence

of accumulation, dosage should be decreased accordingly.
ADMINISTRATION Intramuscular: The reconstituted solution of
Rocephin® should be administered by deep intragluteal injection.
It is recommended that not more than 1 g be injected at a single site.
Pain on intramuscular injection is usually mild and less frequent when
Rocephin* is administered in sterile 1% Lidocaine solution. Intravenous
(bolus) Injection: The reconstituted solution should be administered over
approximately 5 minutes. If the distal port of an intravenous administration
set is used, stop the primary flow, inject the reconstitued ‘Rocephin®’
solution and then restart the primary flow. This w ill prevent mixing with
the primary fluid and possible incompatibilities Short Intravenous
Infusion: The further diluted intravenous solution should be given over
a period of 10 to 15 minutes in infants and children and 20 to 30 minutes
in adults. NOTE: Rocephin* solution should not be physically mixed
with aminoglycoside antibiotics nor adm inistered at the same site
because of possible chemical incompatibility.
PHARMACEUTICAL INFORMATION
Reconstitution
For Intramuscular Use
Reconstitute Rocephin* powder with the appropriate diluent:
• Sterile Water for Injection
• Bacteriostatic Water for Injecton
• 0.9% Sodium Chloride Injection • 1% Lidocaine Solution
• 5% Dextrose Injection
Reconstitute as follows:
___________________ Reconstitution Table (IM )
Approximate
Approximate
Volume to be
available
average
Vial
added to vial
concentration
volume
Size
mL
mL
g/mL
1
0.25
0.25 g
0.9
4
0.25
1 .0 Q
3.6
0.25
7.2
8
2.0 g
Shake well until dissolved.
NOTE: SOLUTION PREPARED FOR INTRAMUSCULAR USE OR ANY
SOLUTION CONTAINING LIDOCAINE OR BACTERIOSTATIC WATER
FOR INJECTION SHOULD NEVER BE ADMINISTERED INTRAVENOUSLY
For intravenous Use
Reconstitute only with Sterile Water for Injection.
Reconstitute as follows:
Reconstitution Table (IV)
Approximate
Approximate
Volume to be
average
available
Vial
added to vial
concentration
volume
Size
mL
g/mL
mL
2.4
2.5
0.1
0.25 g
0.1
10.0
9.6
1.0 g
0.1
19.2
20.0
2.0 g
Shake well until dissolved. The prepared solution may be further diluted
to the desired volume with any of the “ Solutions for IV Infusion” listed
below.
Solutions for IV Infusion
0.9% Sodium Chloride Injection
5% Dextrose Injection
Dextrose and Sodium Chloride Injection
0.9% Sodium Chloride Injection in ADD-VANTAGE (Abbott) flexible
diluent container, 50 mL and 100 mL
5% Dextrose Injection in ADD-VANTAGE (Abbott) flexible diluent container,
50 mL and 100 mL.
Pharmacy Bulk Vial Reconstitution for Preparation of Intravenous
Infusion Solutions
The closure of the pharmacy bulk vial shall be penetrated only one time
after reconstitution, using a suitable sterile transfer device or dispensing
set which allows measured dispensing for the contents.
Reconstitution Table for Bulk Pharmacy Package
Approximate
Approximate
Volume to be
average
available
Vial
added to vial
concentration
volume
Size
mL
g/mL
mL
0.1
95
100.0
10 g
Shake well until dissolved. Withdraw the required amount and dilute
with one of the "Solutions for IV Infusion". Any unused solution remaining
within a period of 8 hours should be discarded.
Stability of Solutions - Storage
For complete stability and storage information, consult the Product
Monograph.
Incompatibility:
Rocephin* should not be physically mixed w ith other antimicrobial
agents.
Rocephin* should not be added to blood products, protein hydrolysates
or amino acids.
Rocephin* should not be added to solutions containing calcium.
DOSAGE FORM
Availability:
1. Rocephin* Vials containing sterile powder equivalent to 0.25 g, 1 g
and 2 g of ceftriaxone.
2. Rocephin® Vials containing sterile powder equivalent to 1 g and 2 g
of ceftriaxone for use only with Abbott Laboratories Limited ADDVANTAGE (Abbott) 0.9% Sodium Chloride Injection U.S.P. or 5%
Dextrose Injection U.S.P. in 50 mL and 100 mL containers.
3. Rocephin® Pharmacy Bulk Vials containing sterile powder equivalent
to 10 g ceftriaxone (not for direct administration).
The availability o f the pharmacy bulk vial is restricted to hospitals with a
recognized intravenous admixture programme.
Storage:
Rocephin* sterile powder should be stored at a controlled room
temperature (between 15° and 30°C) and protected from light.
Product Monograph available on request.
Hoffmann-La Roche Limited
2455 Meadowpine Boulevard
Mississauga. Ontario L5N 6L7
Original Research in Medicine and Chemistry
® Registered Trade Mark © Copyright 1992
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Priapism in the Newborn
Lynn Stothers, MD; Brian Ritchie MD, FRCSC
The authors describe a rare case of priapism in a newborn infant. Treatment with
intravenous ketamine hydrochloride produced rapid detumescence. The literature is
reviewed with respect to priapism in the newborn and its management, and the
authors propose injection of ketamine hydrochloride as an alternative method of
management for this condition in newborn infants.

Les auteurs decrivent un evenement rare, soit un cas de priapisme chez un
nouveau-ne. Un traitement par chlorhydrate de ketamine intraveineux a provoque
une detumescence rapide. La litterature portant sur le priapisme du nouveau-ne et
son traitement est passee en revue et les auteurs proposent Tinjection de
chlorhydrate de ketamine comme alternative pour traiter cette affection.

riapism is defined as a persis
tent erection of the penis in the
absence of sexual stimulation or
desire. In newborn infants it is
extremely rare. Concern in regard
to impotence remains a valid one.
The authors describe the case of an
infant whose priapism was success
fully managed by injection of keta
mine hydrochloride.

P

Case Report
A white male infant, weighing
3.6 kg, was born to a 26-year-old
primigravida at 39 weeks’ gesta
tion. The mother’s antenatal course
and medical history were unremark
able. She had not been taking any
medications. The onset of labour
was spontaneous, and the child was
delivered vaginally. The Apgar
scores were 8 at 1 minute and 8 at
5 minutes. The mother’s VDRL test
was negative. Her blood type was 0

positive, as was the infant’s. An
erect penis was noted during exami
nation of the infant immediately
after delivery. The erection persist
ed and was again noted 36 hours
after birth. The infant voided small
amounts of urine. At 72 hours of
age the child was examined by the
urology staff. There were no ab
dominal masses and no palpable
spleen. Both testes were descended.
Rectal examination revealed some
meconium in the rectum, but no
other abnormality. An uncircum
cised erect penis was noted. It was
nontender. Catheterization with a
small feeding tube gave 3 mL of
urine, which was sterile upon cul
ture. The penis remained erect after
catheterization.
The hemoglobin level was 228
g /L (normal range from 165 to
200 g/L) and the hematocrit was
0.654 volume fraction (normal
range from 0.570 to 0.680 volume
fraction). The leukocyte count was
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normal; the platelet count was 279
X 109/ L (normal range from 84 to
478 X 109/L ). The child had not
received any blood transfusions,
and a subsequent sickle cell test
gave negative results.
Under anesthetic supervision in
the operating room, 0.3 mL of a 1%
solution of ketamine hydrochloride
was injected intravenously. Prompt
detumescence resulted. Over the
next 48 hours there was no recur
rence of erections except when
voiding. The urinary stream re
mained excellent. There was no
lingering induration of the penis.
The child was discharged in good
health and was normal at subse
quent follow-up and investigation at
3 years of age.

Discussion
Priapism is extremely rare in
newborns. Six cases have been de
scribed in the literature.1-4
In newborns the causes of pria
pism vary from sickle cell anemia to
trauma to the central nervous sys
tem. In 1978 Leal, Walker and
Egan2 described a case of idiopathic
priapism in an otherwise normal
newborn. The cause of priapism in
the case we report may have been
related to an abnormally high he
moglobin level, possibly from ma
ternal fetal transfusion before
clamping of the umbilical cord.
Management of priapism in the
newborn has varied from prolonged
observation to intent to treat as a
surgical emergency. In 1977 Amlie,
Bourgeois and Huxtable1 observed
CJS, VOL. 35, NO. 3, JUNE 1992
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a persistent erection in a 37-day-old
premature infant for 12 days until
the patient was discharged. Sha
piro3 described a case of newborn
priapism of 3 days' duration. He
intended to perform a shunt, but
the erection resolved spontaneous
ly. In the case reported by Leal,
Walker and Egan2 the newborn’s
erection was observed for 6 days
until spontaneous detumescence oc
curred. Although long-term follow
up is lacking in reports of newborn
priapism, priapism in childhood has
been reported to result in impo
tence. Mykulak and Glassberg5 re
cently described a 23-year-old impo
tent man with sickle cell disease
whose priapism had been treated
conservatively for 8 days when he
was 8 years of age.
We administered ketamine hydro
chloride after 72 hours of persistent

erection because of concern about
impotence and because of infre
quent voiding. Ketamine hydrochlo
ride is a nonbarbiturate general
anesthetic that produces a dissocia
tive type of general anesthesia. It is
believed to produce somesthetic
sensory blockade by blocking asso
ciation pathways in the brain. This
may be the mechanism of action
that results in detumescence. Keta
mine hydrochloride was chosen be
cause it has been successful in
causing penile detumescence during
hypospadias repairs.6 Other benefi
cial features of this drug include a
general lack of respiratory depres
sion and maintenance of pharyngeal
and laryngeal reflexes.
Priapism in the newborn is an
extremely rare medical emergency.
Long-term results are not available.
The concern with regard to impo

tence, however, remains a valid one.
Ketamine hydrochloride is suggest
ed as an alternative to observation
in priapism in the newborn.

the procedure progresses.
Thirty-four surgical procedures are
illustrated in some detail under the
general headings of cerebrovascular dis
ease, brain tumour and diseases of the
spinal cord, and two miscellaneous pro
cedures are covered under decompres
sion of cranial nerves. All the high-qual
ity diagrams are by Dr. Mokoki Baba, a
well-known neurosurgeon, and they
complement the combined experience of
the distinguished editors.
The illustrations are accompanied by
a brief and appropriate text describing
the necessary steps for the successful
completion of each procedure. Al
though no new or innovative proce
dures are documented, the atlas depicts
the advantages and the pitfalls of stan
dard procedures very effectively.

There is a brief, but complete, refer
ence list covering the standard bibliog
raphy for the procedures, and a good
index and table of contents direct the
reader to a procedure of interest.
I believe the authors have succeeded
very well in providing the young neuro
surgeon with the steps necessary for
the successful completion of some very
complex surgical procedures. Every
neurosurgical department should have
this volume in its library, and many
“old hands” would benefit from perusal
of its pages.
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BOOK REVIEWS
continued from page 284

expert Japanese neurosurgeons. It has
been designed to provide surgical guid
ance to young neurosurgeons and ful
fills this objective remarkably well. In
the opening pages the text outlines the
training neurosurgeons need to become
competent in microneurosurgery and
details the basic operative techniques,
the set-up of the operating microscope
and the instruments necessary to com
plete these procedures. Perhaps even
more interesting, the authors have at
tempted to describe the philosophy and
psychology necessary for the successful
completion of complex surgical proce
dures, emphasizing the operative plan
ning, the need to review the anticipated
intraoperative anatomy and the value of
rehearsing in the mind the various
situations that might be encountered as
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The Canadian Journal o f Surgery is pleased to accept classified advertisements. The deadline is 1 month before issue date. Classified rates: $58
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SCOTT & WHITE
The Division o f Neurological Surgery o f
White Clinic and Texas A&M University
o f Medicine is seeking a Neurosurgeon
clinical/faculty position as Director
Division o f Neurological Surgery.

CARDIOVASCULAR SURGEON
Scott &
College
to fill a
o f the

Scott & White is located in Temple, Texas,
approximately 60 miles north o f Austin and 120
miles south o f Dallas/Ft. Worth. Tem ple is a
family oriented city o f 50,000 with numerous
nearby lakes and outdoor activities.
Scott & White provides an exceptionally
attractive salary and benefits package to include
4 weeks vacation and 3 weeks C.M.E.
Tor more information, please call Barry Harper
at 1-800-725-3627 or send curriculum vitae to:
D ennis J. Lynch, M.D.
Chairman, Department o f Surgery
Scott & White Clinic, Texas A&M
University College o f Medicine
2401 South 31st Street
Temple, 'IX 76508
—S91-83

Victoria Hospital
London, Ontario

The Department of Surgery at Victoria Hospital, Lon
don, is seeking a dedicated professional to join our
team of adult academic cardiac surgeons. This is a
full-time position associated with the Department of
Surgery, University of Western Ontario.
The successful candidate will possess an Ontario
medical licence, certification by the Royal College of
Physicians and Surgeons of Canada, and the demon
strated ability to be an integral part of a multidiscip
linary team dedicated to the provision of high quality
cardiac care.
Victoria Hospital is a member of the Provincial
Cardiac Care Network. As a tertiary care teaching
facility associated with the University of Western
Ontario, we offer a comprehensive range of adult
and children’s cardiac services to families within
southwestern Ontario.
Please respond with CV before the closing date of
JULY 3, 1992 to:
Dr. Murray Girotti
Chief of Surgery
Victoria Hospital
375 South Street
London, Ontario
N6A 4G5
Tel: (519) 667-6778
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CLASSIFIED ADVERTISING Unlike a tabloid or newspaper that is read today and discarded tomorrow, an adver
tisement in the Classified Advertising section of CJS is read today and reread tomorrow.
CJS is the only Canadian publication exclusively for surgeons. No other Canadian surgical publication reaches over 9000
subscribers every 2 months, giving wide coverage for your advertising dollar.
Average issue readership of CJS (81%) is among the highest of any medical journal in Canada, the latest readership studies confirm the best and most cost efficient way to reach Canadian surgeons is through the pages of CJS.
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CHIEF OF SURGERY: PQ - The Sir Morti
mer B. Davis - Jewish General Hospital, a
628-bed tertiary care teaching hospital of
McGill University is inviting applications for
the position of Chief of Surgery. The Depart
ment comprises the divisions of cardiovascu
lar and thoracic, colorectal, general and plas
tic surgery. Potential candidates should be
certified by the Royal College of Physicians
and Surgeons of Canada (or equivalent) and
have significant academic and research expe
rience in teaching hospitals. The successful
candidate will be offered a university appoint
ment commensurate with his/her qualifica
tions. In accordance with Canadian immigra
tion requirements, this advertisement is initial
ly directed to Canadian citizens and perma
nent residents of Canada. Interested candi
dates should send a copy of their curriculum
vitae to: Dr. P.L. Heilpern, Associate Exec
utive Director, Professional Services,
S.M.B.D. - Jewish General Hospital, 3 755
Cote Ste-Catherine Rd., Montreal, PQ H3T
1E2.
-S 92-116

Cover

Roussel Canada Inc.
Proctosedyl HC 245
Saskatoon City Hospital
270
Syntex Inc.
Toradol 246, 247, 316
3M Canada Inc.
Steri-Strip Inside Back Cover

HOTEL-DIEU
OF
ST-JOSEPH

Northern Carleton
Hospital

GENERAL SURGEON
Hotel-Dieu of St-Joseph, Perth-Andover, and Northern Carleton
Hospital, Bath, New Brunswick, are looking for a second surgeon.
These two hospitals are located in small communities in the
Upper Saint John Valley, about 20 minutes apart. They plan to
join surgery services to cover the needs of this area.
Both hospitals are extremely well equipped. The Perth Hospital
is a 65-bed acute care facility with a concentrated care unit and
a full-time surgeon. The surgical services are varied and the
volume is too much for a solo surgeon. The Bath Hospital is a
36-bed acute care facility, with a close observation unit, and the
present surgeon is about to retire. There should be an excellent
jo in t p ra ctice b e tw e e n th e tw o c o m m u n itie s w ith an
above-average income. The position qualifies for a guaranteed
income for the first year of practice.
Enquiries are welcome.
For further information, please contact:
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Please submit a curriculum vitae
and the names of three references
by June 30. 1992.to:

Dr. R.Y. McMurtry
Professor and Head
Department o f Surgery'
The University o f Calgary
1403 - 29 Street N.W.
Calgary, Alberta
T2N 2T9

SURGEON-IN-CHIEF
ST. MICHAEL’S HOSPITAL

NCH

Dr. Brian Sykes
Hotel-Dieu of St-Joseph
Perth-Andover, NB
EOJ 1V0
Tel: (506) 273-2201 (work)
(506) 273-6767 (home)
or
Bath, NB
Mr. Roger Jones,
Tel: (506) 278-5231 (work)
(506) 328-4884 (home)

The University of Calgary
Department of Surgery and
Foothills Hospital invite
applications for a clinical
academic appointment as a
Urologist. Academic interest
and ability are essential
qualifications; renal transplant
experience is an asset. Starting
date is negotiable.

St. Michael’s Hospital, a 456-bed acute care, general
teaching hospital, fully affiliated with the Faculty of
Medicine, University of Toronto, requires a Surgeonin-Chief.
The Department of Surgery consists of six major divi
sions: cardiovascular surgery, general surgery, neuro
surgery, orthopedic surgery, plastic surgery and urology.
The department has an active undergraduate and post
graduate teaching program, and an active research
program.
The successful candidate will have an FRCSC or
equivalent; be eligible to practise medicine in Ontario; be
recognized as a skilled surgeon and an outstanding
teacher; have a background in research; and will have
superior leadership qualities and planning abilities, with
previous experience in a senior administrative position.
In accordance with Canadian immigration regulations,
this advertisement is directed to Canadian citizens and
permanent residents of Canada.
Applications for this position will close July 31, 1992.
Interested candidates should forward their curriculum
vitae to:

-S 9 1 -8 6

Dr. John C. Platt
Secretary, Search Committee
Surgeon-in-Chief
St. Michael’s Hospital
30 Bond Street
Toronto, Ontario
M5B 1W8

— S92-114

The simplest way to bring a
i laparoscopic procedure to a close

If

All you need now is the new “Steri-Strip”
laparoscopic wound closure system from 3M.
This all-in-one system combines two products
that, for years, have been highly-regarded by
health care professionals: “Steri-Strip” skin
closures and “Tegaderm” transparent dressing.
You will appreciate it because it’s specially
sized and shaped for laparoscopic incisions. You
can close and dress a wound quickly, without ever

MF11589201E

®

having to cut strips or dressings again.
Your patients will like it, too, because they can
wear it for up to 7 days without changing it. They
can even shower with it on.
In short, the new “Steri-Strip” laparoscopic
wound closure system works for you and your
patients. It’s as simple as that.
For a free sterile sample, call 1-800-563-2921.
Medical/Surgical Products

Official Mark of the Canadian Olympic Association

3MIQS&

Worldwide Sponsor 1992 Olympic Games

Taking suture technology
to new heights
NEW

□

r*
(BRAIDED SYNTHETIC ABSORBABLE SUTURE)

9827-61

75 cm (30” )

V'.uwde, Srtm ii. MSOMBABie Surgical Suluie. IS P

DEXON® II
3.5 Metric

BI-COLOR"* Braided Polyglycollc
Acid Suture with Potycaprotete™
T 1 2
*
Coattug Syttam
37 mm

CX10

£3 (3 ®

SAW8»ltfC* CYANAMID CANADA INC. MONTREAL,

QUE. H3X 9N7

DAVIS+GECK
Cyanamid Canada Inc.
M arkham
“ / “ Registered User: Cyanamid Canada Inc.

DEXONII, the newest generation
in the evolution of synthetic
absorbable sutures, offers markedly
different performance in handling,
tying and knot snug-in.
The unique new Polycaprolate™
Coating System...
• Allows the sutures to pass through
tissue smoothly with little or no
chatter or drag
• Provides superior suppleness and
silk-like feel
• Ensures minimal out-of-package
memory
In addition, DEXON ll offers unequalled out-of-package tensile
strength* and excellent knotsecurity.

There is a difference.
See it.. .feel it.. .try it!
•DEXON compared to Vicryl.t Data on file.
tTrade mark of Ethicon.
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